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I) IDENTIFICATION OF THE TASK
This work originated as an unsolicited proposal No. JSC6-82-7994,
submitted July 23, 1982, to study the physiological responses of
women to bedrest. This proposal was funded during years I and 2
(1982-83) under contract # NAS9-16703. At this point the contract was
renegotiated because of a NASA budget reallocation. The work during
year 3 was performed under contract number NAS9-17199. In June 1985
an extension was granted without further funding.
II) PURPOSE AND SCOPE OF THE STUDY
With the development of the space shuttle program, space flight for
the first time is available to individuals who have not be_n
specially selected and trained to be astronauts. In addition, women
are being actively recruited into the space program, both as mission
specialists and as career astronauts. One purpose of this project
was to examine some of the physiological responses of women to a
simulated weightlessness program (12-day horizontal bedrest), to
compare their responses to those reported in men during similar
programs, and to test whether menstrual function might alter some of
the physiological changes which occur during bedrest, specifically
changes in the plasma volume, exercise tolerance, and venous
compliance before and after bedrest. Specific hypotheses tested
include:
I) that an elevation in blood estrogens might be associated with a
retention of body fluids, and thus reduce the hypovolemia seen during
bedrest. It was predicted that a smaller reduction of plasma volume
would occur during bedrest when a woman is in a stage of her
menstrual cycle when estrogens are elevated. Further, the use of
estrogen-containing oral contraceptives may prevent or reduce the
decrease in plasma volume seen during the first several days of
bedrest. The body fluid-retaining effect of estrogens was postulated
to occur through an increase in sodium reabsorption in the distil and
collecting tubules. Therefore urine output would be predicted to be
lower during bedrest when estrogens are elevated, than when estrogens
are lower.
2) that the reduction in plasma volume which occurs during bedrest
contributes significantly to the reduced exercise tolerance reported
following bedrest. Therefore, if the loss of plasma volume during
bedrest could be prevented (through an effect of elevated estrogens),
then exercise tolerance following bedrest should be significantly
improved over results seen when plasma volume is decreased. Specific
exercise responses postulated to be influenced by the decrease in
plasma volume during bedrest included exercise heart rate, stroke
volume, body temperature regulation, sweat rate, and venous
compliance.
Specific questions which arose during the study include:
I) Is there a significant danger of lower leg edema occurring in
women (not previously reported in men) following bedrest .
2) Based on the changes in plasma volume seen in women with normal
menstrual cycles (not on oral contraceptives) and in two women who
took oral contraceptives, it appeared that elevation in estrogen
concentration in the presence of high progesterone, did not
consistently result in retention of plasma volume during bedrest.
However when blood estrogens were elevated in the presence of low
progesterone, the data suggested that there was at least a temporary
maintenance of plasma volume. Therefore the original hypothesis that
elevated estrogens would retain plasma volume was revised to now
state that, women administered natural estrogens (premarln) during
bedrest without progesterone supplement, may maintain their plasma
volume during bedrest.
Physiological questions which have not been previously addressed
include:
1) What specific changes occur in exercise thermoregulatory
responses following bedrest? It was hypothesized that there would be
a decrease in sweating sensitivity (slope of the sweat rate/core
temperature (Tes) relationship), and possibly an upward shift in the
Tes sweating threshold.
2) Would the exercise venoconstrictor reflex be attenuated (by a
loss of sympathetic nervous system responsiveness) or potentiated (by
the decrease in plasma volume) followlng bedrest? A loss of
venoconstrictor tone could contribute significantly to the"
orthostatlc intolerance reported in astronauts followlng spaceflight.
3) It has often been hypothesized that estrogens are involved in
the lower sweating responses seen in women than in men. The effects
of elevated estrogens to alter the sweating sensitivity (the slope of
the sweat rate/core temperature relationship) and sweating core
temperature threshold was examined in 7 women with and without
premarin administration (1.25 mg daily) for 7-10 days. It was
hypothesized that estrogen administration would reduce sweating
responses, resulting in significantly higher body temperatures for a
given exercise task.
111") MATERIALS AND METHODS
A) The overall protocol
The study was performed during three years, in which all data
collection was performed in the summer months (late May to early
September) because of the increased likelihood of recruiting subjects
in these months. A total of 22 women between 21 and 39 years of age
participated (see Table 1 for their physlcal characteristics).
i) Year I
During the first summer (1982), six "normally cycllng" women
completed the protocol shown in Figure 1. The overall protocol
consisted of a control month with testing at two week intervals (CI
and C2), two 12-day periods of bedrest, and a recovery month after
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each bedrest, with testing performed after 2 and 4 weeks of recovery.
Before beginning the study, there were several training sessions in
which each woman was taught the Farhi C02 rebreathing technique, how
to position the esophageal thermocouple, and how to pedal a low-sit
cycle ergometer while keeping the left arm steady enough for forearm
blood flow measurements. Once these basic techniques were mastered,
"practice" submaximal exercise tests were performed to further
familiarize the subjects with the protocols, and to insure that they
were sufficiently trained to produce reproducible data.
Two 12-day horizontal bedrest periods were performed with an
ambulatory interval of from 3-4 weeks between bedrests. This timing
was chosen so that each woman began the second bedrest 5-6 weeks
after the start of the first bedrest. Since all of the women were
expected to have menstrual cycles of from 25-32 days, the bedrest
procedures were designed so that each woman would begin bedrest in
different phases of the menstrual cycle, and thus should have a
differing hormonal millieu. No attempt was made to begin the bedrest
at a particular day or phase of the menstrual cycle. Table 2 presents
the menstrual cycle stage (see methods) for each of the women on the
first day of bedrest. During the recovery and control months,
subjects resumed their normal lifestyle.
One additional subject began the bedrest protocol during the first
year of this study. However, within 2-4 days after the end of bedrest
I, she developed severe edema in both lower legs. She was tested
with the venous impedance technique for venous obstruction (blood
clotting), and the results were negative. A report of this incident
was immediately sent to the Committee of Human Volunteers of the
School of Public Health, and all further testing was stopped until an
inquest could be held to determine whether this event was likely to
occur again or in other subjects. During this interval, 2 week
recovery data collection was not able to be obtained. The inquest
resolved that this was an unusual event, possibly provoked by the
inactivity of this particular subject after bedrest, which may have
delayed the recovery of venous tone in her lower legs, resulting in
blood pooling and edema. Although the committee thought it unlikely
that a similar incident would occur again to this subject, it was
recommended that she should not undergo the second scheduled bedrest.
Permission to continue the study with the other subjects was obtained
in time for the 4 week recovery collections and the start of bedrest
2. (see appendix I for copies of correspondence with the Committee of
Human Volunteers about this incident).
ii) Year 2
Six additional "normally cycling" women were recruited during the
summer of 1983. Each woman performed the protocol illustrated in
Figure I except that, I) in order to randomize the presentation of
the control tests and to evaluate possible seasonal fluctuations, the
control month was perfomed before the start of bedrest I, rather than
after the end of the second recovery month, and 2) since no
significant differences were seen between the duplicate maximum
oxygen consumptions (VO2max) during the control month, C1 and C2 V02
max tests were omitted.
Non-Premarin Group
I I 3
2 I 2
3 3 3 (NO)
4 I 3
5 3 2
6 4 3
7 3 3
8 2 3 (LD)
9 I 3
10 1 3
11 4 1
12 2 (LD) 3 (I/))
+ where stage I = early follicular (cycle days 2 - 6, prior to
estimated ovulation)
stage 2 = periovular (5 days prior to estimated ovulation to I
day after estimated ovulation)
stage 3 = early luteal (2-9 days post estimated ovulation)
stage 4 = late luteal (I0 days past estimated ovulation to
cycle day 1 of next cycle).
LD = luteal phase deficiencysuspected from homonal
results.
NO = No ovulation suspected based on hormonal results.
Two women were recruited who were taking estrogen-contalnlng oral
contraceptives (Ovulen 21 or 0rthonovum). Both of these women
performed the protocols from the control month, a single bedrest, and
the recovery month.
lii) Year 3
During the last year of the study, 7 women performed the protocol
f_om the control month, a single bedrest, and the recovery month.
Similar to year 2, the control month occurred before the bedrest
procedure rather than after the recovery month. Each woman ingested
1.25 mg of an estrogen supplement (premarin), starting on the third
cycle day of the month in which she would undergo the bedrest
protocol (7-10 days before bedrest day 1). The premarin was
continued during the bedrest, and for five days after bedrest.
Progesterone supplements (10 mg /day Provera) were taken £or 5 days,
starting on the second day after bedrest in order to allow normal
endometrlal sloughing. A single blood volume determination (with
technetium radioisotope labelling) was performed during the control
month, since no significant differences were seen in any of the
previous results of the duplicate measurements during the control
month. This was done to prevent unnecessary exposure of these
subjects to repeated radioisotope testing.
B) The Bedrest Protocol
i) The environment
Bedrests were performed at the Sheraton Johns Hopkins Inn located
at 400 North Broadway. Each summer, 4 rooms were reserved for
subjects (2 subjects per room), and one room was reserved for the
"nurses" (persons trained and hired to look after the subjects during
the bedrests), and one room was the impromptue blood chemistry
laboratory. During the second and third summers, a sixth room was
reserved and tranformed into a pulmonary function laboratory_ The
hotel provided maid service and most of the meals. Occasionally food
was obtained from local restaurants chosen by the subjects. No
restriction was placed on the amount or type of food eaten, although
alcoholic beverages were restricted.
Each room consisted of 2 single beds and a bathroom. The beds were
normal hotel beds, except that a small pressure-sensitive platform
was placed under the castors at the foot of the bed. These pressure
sensors were connected to automatic timers to record the time spent
out-of-bed by each subject. Each morning the accumulative time for
the previous 24 hours was recorded by the nurse. The installation of
the platforms resulted in a 4 degree head-down tilt of the beds.
However, since each bed contained one pillow, when the subject lay
with her head on the pillow, her head was positioned approximately
horizontal to her feet.
ii) Daily activities
On the first day of bedrest, a subject ate a light breakfast and
reported to the nurse at the hotel at 9 am. She unpacked her
suitcase, emptied her bladder and immediately began the bedrest. One
hour later, the first venous blood sample was obtained. Subjects
maintained the horizontal position for the remainder of the bedrest,
except for time allowed for bathroom activities. Subjects moved to
and from the bathroom in wheelchairs, without supporting their weight
on their feet. Baths, not showers were taken, and each subject was
instructed to spend no more than 15-20 minutes in each 24-hour period
in the sitting position, and no time standing. Sitting in bed was
not permitted, although they were allowed to rest on one elbow to
eat. The amount of time spent out-of-bed during each bedrest is
listed in Table 3. No significant differences occured in the time
out-of-bed between bedrest days (ANOVA, one-way, repeated measures
design), between duplicate bedrests during years I and 2, (ANOVA,
2-way, repeated measures design) or between the 3 years.
For each succeeding day of bedrest, the subject was awoken at 7 am.
She then took her oral temperature, emptied her bladder into a
24-hour urine container (second and third years), and ate a light
breakfast. Two hours later, the morning blood sample was obtained,
making sure that the subject had been horizontal during the previous
60 minutes. In this way, blood samples were controlled for posture,
time since last food intake, and circadian variation.
During the second and third years of the study, pulmonary function
tests were added to the bedrest protocol. Each subject performed
these tests on at least 3 days before bedrest, on each day of
bedrest, and on the day after bedrest. Subjects were transported to
the pulmonary function room on a gurney, in order to insur_ that the
subjects did not alter their posture from the horizontal position.
iii) Measurements obtained during bedrests
From each daily blood sample the following measurements were
obtained: hematocrit (microhematocrit technique), hemoglobin
concentration (cyanomethemoglobln), total solids (refractometry), and
plasma osmolality (freezing point depression). Plasma estrogen and
progesterone concentrations were determined from the blood samples on
each day of bedrest during year 2, and on every third day of bedrest
during year 3. Throughout the bedrests, urine osmolallty was
determined each day of bedrest. Twenty-four hour urine volumes were
recorded durln8 years 2 and 3.
Daily diaries were kept during the entire study. Each subject
recorded her fluld and food intake during bedrest, her morning oral
temperature, and the time at which she took estrogen medication (the
oral contraceptive users and premarln subjects). Other medication
and medical or menstrual symptoms also were noted.
Pulmonary function tests consisted of lung volume measurements,
total lung capacity (helium dilution), forced expiratory volumes,
lung diffusing capacity for carbon monoxide, the slope of phase 3
(Nitrogen washout), and maximal inspiratory and expiratory pressures.
An exploratory study was performed on one subject during the third
year to determine whether brain caudate D2 dopamine receptors would
be altered during the bedrest procedure (this was a special study to
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test whether acute changes in fitness alters the binding of caudate
dopamine receptors). Dopamine receptor binding was assessed by
positron emission tomography (Wong et al, 1984), vlth imaging
performed after intravenous injection of 11C-labelled
3-N-methylsplperone• The prebedrest imaging was performed 2 days
prior to the start of bedrest in subject 19, and repeated on the last
day of bedrest. During imaging the subject did not change from the
horizontal position. She was transported by ambulance to the Nuclear
Medicine Department in the Johns Hopkins Hospital, and immediately
afterwards, performed the postbedrest submaximal exercise test.
C) Maximum Oxygen Consumption (V02 max) Protocol
Maxlmal Oxygen Consumption determination was performed
approximately every two weeks during the study (C2 tests were not
performed during years 2 and 3).
Prebedrest tests (PREBR) were performed within 48 hours of the start
of bedrest, and postbedrest tests (POSTBR) were performed within 48
hours, but usually within 24 hours, after bedrest.
Oxygen consumption was determined at progressively increasing
exercise intensities for each woman pedalling an upright cycle
ergometer. Ventilation was measured in either a tissot tank (year 1)
or with a dry gas meter (years 2 and 3). The oxygen concentration of
the expired air was measured with a Beckman OM 11 gas analyzer, and
C02 concentration with either a Beckman LB2 (year 1) or an Applied
Electrochemistry C02 Analyzer (years 2 and 3). Each subject pedalled
at a rate of 50 revolutions per minute while the exercise intensity
was increased (in 25 Watt steps) every 2 minutes. For the first V02
max determination, tests were performed at least in duplicate (on
separate days) in an effort to obtain a plateau of the oxygen
consumption curve during the final two exercise intensities. Control
tests were repeated until this criteria was met in order to
accurately establish the fitness level of each subject before
bedrest. Following bedrest however, the plateau criteria could
seldom be met, as most women seemed limited by leg fatigue before
attaining the plateau. Non-plateau values are therefore referred to
as "peak VO2" values. Heart rates were also measured during these
tests with either a 12-lead E[G system (for the first test on each
subject), or with a respironics heart rate monitor (for all further
tests).
D Submaximal Exercise Protocol
Submaxlmal exercise tests were performed in approximately 2 week
intervals during this study (except when the 2 week recovery data was
missed during year I). The postbedrest tests were performed
immediately following the bedrest procedure. Subjects were
transported in wheelchairs and by car (less than 5 minute ride) from
their bed in the hotel to the Stress Physiology Laboratory in the
School of Public Health. The ambient temperature for these tests was
maintained at 30 °C + 1°C and 50-60 Z rh Be£ore the submaximal
exercise test, subjects supported their weight only briefly, during
the pre-exercise body weighing procedure. Next, they sat in the seat
of the low-sit cycle ergometer for at least 40 minutes before the
start of the exercise test to control posture before blood sampling,
12
and to allow time for attachment of measurement devices.
Each subject pedalled for 30 minutes at an exercise intensity that
was 70Z of her V02 max determined just prior to the bedrest.
However, exercise was stopped earlier if a subject's core temperature
exceeded 39@C, or if her heart rate approached 95X of her maximal
heart rate value, which was determined during the prebedrest VO2 max
test. For any given subject, all exercise tests were conducted at the
same time of day (_ 2 hours), not more often than once a week (to
avoid training or accllmation effects), at least 2 hours after a
light meal, and about I hour after drinking 200 ml of water to assure
adequate hydration.
During the first two years of the study, subjects were instructed
to stop pedalllng immediately at the end of the submaxlmal exercise
test in order to obtain resting recovery data. Following the
postbedrest tests (but none of the other tests), 7 out of 15 of the
women felt faint and had to be moved to a horizontal position (two
actually fainted). Thereafter, to avoid this traumatic experience for
the subjects and investigators, subjects were instructed to
free-pedal during recovery in order to assist cardiac return. During
the third year of the study, all subjects free-pedalled after
exercise and none experienced fainting episodes.
During each submaximal exercise test the following measurements
were obtained:
- exercise time, in minutes, was recorded for each test.
- body weight, before and immediately after exercise, was measured
with the subject wearing a dry scrub suit. After exercise, the
subject dried herself and removed all wet clothing. Weights were
obtained on a Homs scale (accuracy _ 50 gms) and were adjusted for
any water drunk while placing the esophageal thermocouple.
- heart rate (HR) was measured each minute with a respironics heart
rate monitor
- body core temperature (Tes) was monitored continuously with a
thermocouple positioned in the esophagus at the level of the right
atrium (Nenger, 1975).
- skin temperatures (Tsk) were recorded every 5 minutes with
uncovered thermistors (Yellow Springs) postioned over the chest (TI),
lateral upper arm (T2), lateral thigh (T3), and lateral calf (T4).
Mean skin temperature (Tsk) was calculated by the formula:
Tsk _ 0.3 TI + 0.3 T2 + 0.2 T3 + 0.2 T4.
- forearm venous compliance (FVC) was measured every 2-3 minutes
using the technique of venous occlusion plethysmography (Wenger,
1980). Changes in forearm circumference were measured using a Whitney
mercury-in-silastic strain gauge. The forearm was suspended from the
wrist with a cloth sling so that the elbow was level with the
shoulder.
13
- cardiac output was determined after 10, 15, 20,and 25 minutes of
exercise, using the Fahri C02 rebreathing technique (Farhi, 1976).
The rebreathing bag was filled with 100% 02, and the breathing rate
was maintained at 60 breaths per minute during the 15-17 seconds of
the rebreathing maneuver. Calculations of cardiac output were
performed using the CO2 dissociation curve adjusted for the
pre-rebreathing hemoglobin concentration. Heart rates were
determined during the rebreathing maneuver and used to calculate
stroke volume.
-local sweating responses (SR) were measured continuously before and
during exercise, using a resistance hygrometry sweating system
(Bullard, 1962). For determination of sweating sensitivity (slope of
the SR/Tes relationship) and the Tes threshold for the onset of
sweating, the local sweating data (mg/cm2/min) was paired with
corresponding Tes values. A linear regression equation was" used to
determine the slope of the relationship, and the Tes valu_ at which
the line intersected the x axis (Tea sweating threshold).
- blood samples were obtained immediately before the start of
exercise, after 2, 6, 15, 20, and 30 minutes of exercise, and 5
minutes after the end of exercise. Blood was drawn after at least 40
minutes of controlled posture, with the arm in the same position for
all samples, and in a free-flowing manner (without tourniquet or
vacutainer). Between sampling, the butterfly needle was kept patent
with a heparin/saline lock.
From all blood samples, determinations of hematocrit
(microhematocrit technique), hemoglobin concentration
(cyanomethemoglobin), total solids (refractometry), and osmolality
(freezing point depression) were obtained. From the resting and 30
minute exercise samples, blood lactate (Sigma enzymatic reaction),
and arginine vasopressin concentration (third year only) were
determined. The arginine vasopressin assay was used as an index of
antidiuretic activity, and was performed using an immunonuclear
radioimmunoassay kit. This is a delayed tracer technique with the
plasma extraction done on octadecasilyl-silica columns. The assay is
sensitive from 3-80 pg/ml. From the resting samples, plasma estrogen
and progesterone concentrations were also determined with
radioimmunoassay techniques (Diagnostic Products).
E) Red Cell and Plasma Volume Determinations
I) Radioisotope dilution methods
To determine Red Cell Volume (RCV), 40 microcurries of 99M
technetium (Tc) pertechnitate (Brookhaven National Laboratory) was
bound to a sample of red blood cells after first determining the
background radiation of the sample. Exactly 5 ml of the labelled
blood was then reinjected intravenously and allowed to mix in the
vascular compartment for 20 and 40 minutes. Then 10 ml samples of
heparinized blood were drawn to measure the 99MTc activity of the
mixed blood.
Plasma volume was determined in a similar manner. Twenty
microcurries of 99M Technetium pertechnitate was used to label a
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sample of human serum albumin and saline. This protein solution was
then injected through an arm vein and 20 and 40 minutes later, blood
samples were drawn for counting. Technetium was chosen as the
radioisotope in both of the above tests because of its short
half-life (6 hours), and the need for multiple blood volume
determinations in this study. During each RCV determination,
hematocrits were measured from one of the blood samples in the exact
manner that hematocrits were determined from bedrest and exercise
blood samples.
2) Plasma Volume (PV) calculations during bedrest
The Absolute Plasma Volume on the first day of bedrest was
calculated by multiplying the ratio of the hematocrits from the blood
sample drawn during the plasma volume determination (performed on the
day prior to bedrest) and the blood sample drawn during day I of the
bedrest, by the PV determined on the day prior to bedrest (Van
Beaumont, 1972). The assumptions made using this formula are that,
within the 24-hour interval between the two blood samples, there was
no significant change in red cell volume or red cell size.
Relative changes in plasma volume during bedrest (Z change from
day i) were calculated from the changes in hematocrit and hemoglobin
(Dill and Costi11, 1974). The assumption with this calculation is
that in the interval between blood sampling, there was no significant
change _n red cell volume (see later in results section). PV on each
day of bedrest was calculated by multiplying the relative changes in
plasma volume by the PV on day I.
3) Relative Changes in Plasma Volume During the Submaximal
Exercise Tests
Relative changes in plasma volume during exercise tests (% change
between the resting and each succeeding exercise sample), were
calculated (Dill and Costill, 1974) from the changes in hematocrit
and hemoglobin concentration during the exercise.
F) Menstrual Cycle Determinations
Menstrual cycle data consisted of daily records of morning
temperature and comments written in diaries kept by each subject. In
addition, blood samples were drawn at various intervals during the
study to assess hormonal function (estrogen, progesterone, LH, and
FSH). Each year of the study, samples were drawn before each
submaximal exercise test. Hormonal determinations were also performed
during either each day of bedrest (year 2) or every third day of
bedrest (year 3). From the frequency of the blood sampling (and thus
hormonal determinations), it was not always possible to define the
exact day of ovulation. Therefore menstrual cycle comparisons were
made by comparing different stages of the cycle rather than on
specific cycle days. Each woman's menstrual cycle was divided into 4
stages, in which a differing hormonal milieu would be expected (and
in each case verified by the results from at least one blood sample).
Stage 1 : Early follicular stage - from cycle day 2 (day 1 t the
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first day of bleeding) until 6 days prior to the day estimated as
ovulatlon. (Only in a few subjects could the exact day of ovulation
be identified by an LH peak). In subjects in whom an LH peak was not
obtained, the day of ovulation was estimated by counting back 14 days
from the start of the next cycle, from the morning temperature
records, and from the hormonal data available. During this cycle
stage low estrogen and progesterone concentrations were seen.
Stage 2: Periovular stage - from 5 days prior to the estimated day of
ovulation until one day after the ovulatory day. During this stage,
elevated estrogens and low progesterone concentrations occurred.
Stage 3: Early luteal phase - from 2-9 days after the estimated day
of ovulation. During this stage, estrogen and progesterone
concentrations were increasing.
Stage 4 : Late luteal phase - from 10 days after the estimated day of
ovulation until the first day of the next cycle. During this stage
estrogen and progesterone concentrations were decreasing.
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IV) RESULTS AND COMMENTS
A) Body Fluid Responses Durin R Bedrest
I) Changes in Red Cell Volume
The red cell volume data are presented in Table 4. Since there.
were no significant changes in body weights during the bedrest, the
same patterns of change in red cell responses were found whether the
data was represented as in Table 4 (absolute volumes in ml), or as
the RCV corrected for body weight (ml/kg). The F value from a one-way
analysis of variance test for repeated measures (ANOVA 1-W-RM) was
significant (P < 0.01) when comparing the RCV values from the
non-premarin group, but non-significant for the premarin group (P <
0.20).
i) Non-premarin group, Control I vs Control 2
There was no significant difference in RCV between the 2 Control
tests. (The post hoc comparisions were performed using the Duncan
Multiple Range Test, with the level of significance accepted at P <
o.o5).
ii) Non-premarin group, Bedrest I
Red cell volume (RCV) was measured with the technetium labelling
technique (Methods) within 48 hours before bedrest i and within 48
hours after the end of bedrest I. The decrease in RCV averaged only
85 ml (5.8Z) after the 12 days of bedrest. This difference was not
significant (P < 0.05).
iii) Non-premarin group, Bedrest 2
The decrease in RCV during the second bedrest averaged 63 ml, or
only 4.4Z. Again this change in RCV during the 12-day bedrest was not
significant. However the decrease in RCV since the beginning of the
study appeared to be accumulative, so that the decrease in RCV
between the beginning of the first bedrest and the end of the second
bedrest was significant (p < 0.05) and averaged 6.2Z. The difference
in RCV between the start of the first bedrest and the start of the
second bedrest was not significant.
iv) Premarin Group
Although there was a tendency for the RCV to decrease during the
bedrest (6.5Z decrease), the difference between the beginning and end
of bedrest was not significant. A comparison of the changes in RCV
between the non-premarin and the premarin groups in response to
bedrest and during recovery can be seen in Figure 2. Estrogen
supplementation did not appear to alter this overall pattern of
changes in RCV.
v) Changes in RCV during recovery, non-premarin and premarin
groups
The significant decrease in RCV seen in the non-premarin group
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Cml/min)
Pre Poet Pre Poet
Subject BR1 BR1 BR2 BR2 2-I_ 4-WK Cl C2
1 1407 1449 1435 1350 1358 1285 1418 1330
2 1303 1276 1331 1338 1170 1211 1226 1308
3 1317 1258 1304 1219 1116 1169 1153 1173
4 1489 1430 1393 1264 1272 1286 1303 1200
5 1694 1587 1506 1433 1488 1535 1407 1610
6 1305 .1226 1225 1142 1177 1159 1147 1135
7 1371 1302 1445 1269 1250 1389 1445 1371
8 1531 1542 1688 1595 1440 1600 1432 1531
9 1724 1502 1512 1440 1452 1555 1550 1724
10 1469 1267 1361 1369 1269 1429 1352 1469
11 1359 1194 1432 1376 1221 1201 1459 1359
12 1719 1636 1700 1790 1571 1755 1517 1719
i 1474 1389
SE 44.50 42.38
13 1764 1589
14 924 873
15 1423 1273
16 1318 1128
17 1081 1078
18 1464 1549
19 1305 1190
i 1325 1240
SE 95.02 89.71
1444 1382 1315 1381 1367 1410
39.40 47.86 39.83 53.88 37.02 55.84
1271
866
1352
1181
1295
1436
1344
1249
65.23
1239
A 1273 1412
1651
975
1445
1293
1067
1487
1373
1327
83.21
1402
1275B 1290 1270
1440
1245
C 1253 1341
1460
1290
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Red Cell Volumes (Tc-RBC)
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FIGURE 2: The absolute red cell volumes (mean + SE) determined
24-48 hours before bedrest 1 (PRE BR)| 24-48 ho'_rs after bedrest
1 (POST BR); and after 2 and 4 weeks of recovery from bedrest (2
wk RC and 4 wk RC) for non-premarin (n = 12) and premarin ( n =
7) subjects.
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over the course of the duplicate bedrests, was still continuing after
2 weeks of recovery (RCV was now IO.8Z lower than at the start of
bedrest 1). After 4 weeks of recovery however, the mean RCV was
beginning to return toward the prebedrest value. These results
suggest that there is about a 2-week delay in the effect of bedrest
tO alter RCV, and that only after at least 4 weeks of recovery was,
the RCV no longer significantly different from the prebedrest value.
Although there were were no significant changes in RCV in the
premarin group between any of the measurement conditions, the pattern
of response was similar to the changes seen in the non-premarin group
(see Figure 2).
2) CHANGES IN PLASMA VOLUME DURING BEDREST
The absolute plasma volume values (PV) for all subjects during
bedrest are presented in Table 5. These absolute values were
calculated from the prebedrest technetium results and the ratio of
changes in hematocrlt and hemoglobin concentration (see Methods).
i) Non-premarin group, Bedrest 1.
Plasma volume decreased significantly (P< 0.01) during the first
5-7 days of bedrest and then became relatively stable for the
remainder of the bedrest (see Figure 3). The average decrease in PV
was 505 ml (19.9X) between the first and the last day of bedrest.
li) Non-premarln group, Bedrest 2
The PV at the start of the second bedrest did not differ
significantly from the PV at the start of the first bedrest (Table
5). There was a tendency towards a smaller decrease in PV during the
second bedrest (averaged 12.3Z between day 1 to the last day of
bedrest 2) than during the first bedrest (19.9Z). However, the
difference in plasma volumes between the duplicate bedrests was not
significant (P < 0.05, determined using a 2-way ANOVA, repeated
measures, split plot design, ANOVA-2W-RM-SP).
iii) Effect of menstrual cycle stage on the loss of PV during
bedrest
For the non-premarln group, the change in PV was examined in each
woman as a function of the stage of the menstrual cycle (see Methods)
during the first 5 days of bedrest. There were no significant
differences between the decreases in PV during cycle stages I, 3, and
4. However, if a woman began bedrest in stage 2 of her menstrual
cycle, the periovular stage, the decrease in PV was postponed. There
was also a tendency for women in the late luteal phase of the cycle
(stage 4) to maintain or expand PV during the first 5 days of
bedrest, however this was a less consistent finding and was not
present in every subject. Shown in Figure 4 are the changes in PV for
the six women who began bedrest during year I. The results shown
illustrate PV changes in 3 women who began bedrest in the second
menstrual stage (dotted lines), and 3 women who began bedrest in one
of the other stages (1,3, or 4). The women who began bedrest in
stage 2 showed no significant drop in PV during the first 4 days of
2O
0,,-q ,.-* ¢1_ _ *',.. <r _r_ ('q r.,. c._ o e,_ cO .,qp
,,,_ ,,-o _,-o N ¢',1 _"4 ,,,,,q _"ql L"_I _,,,4 ,,-_ N 4"_1 0
g-I
0
0
m_
O'i
p_
I
o_o_o_ _ _ _
__o_ _ _ _
Plasma Volumes Ouring Bedrest
2800 -
e 2600
G
• 2400
o
> 2200
E
m 2000
i800
Np
I • I . ! I • I A P I •
I 3 5 7 9 II 13
8edrest Day
FIGURE 3: Absolute plasma volumes (mean _ SE) during bedrest
for the non-premarin group (NP) during bedrest I and the
premarin group (P).
• 10
E
-I
o
>
0E
a-
_= -lo
e
c
q
o -2o
I=,
• -30Q.
Relative Loss of Plasma Volume
During First 5 Days of Bedreat
1 _ // ,.'"" _ " _'_
__._IC -" .,e, _ ..
.....-,,,,
•.,\ %" ",I , _
@ Ovula_--
• Non-ovulatory "11"
t J |
0 1 2 3 4 5
Day of Bedrest
FIGURE 4: Relative changes in plasma volume during the first 5
days of bedrest for 6 subjects (non-premarin) who began bedrest
in either the perivular stage (stage 2) of the menstrual cycle,
or in a non-ovulatory staze (I,3, or 4).
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the bedrest, and in 2 cases, PV even increased above the day 1PV
level. These results led us to revise our initial hypothesis that
elevated estrogen levels would be associated with a retention of PV
during bedrest. (Blood estrogens would be elevated during stages 3
and 4 as well as during stage 2). Our new hypothesis now stated
that, when blood estrogens are elevated in the presence of low
progesterone concentrations, the water-retaining effects of the
estrogens may, at least temporarily, prevent the hypovolemia which
occurs at the beginning of bedrest.
iv) Effect of estrogen-containing oral contraceptives on the PV
changes during bedrest.
During the second year of the study, 2 women who were taking oral
contraceptives containing synthetic estrogen (mestranol, 80 and i00
mcg/tab) and a progestin (norethindrone or ethynodiol diacetate),
performed a slngle bedrest procedure. The decreases in P_ seen in
these 2 women (Table 5, subjects B and C), did not differ
significantly from the responses seen in the non-premarin group
(years 1 and 2). The decrease in PV between the first and last day of
bedrest was 20.8Z and 12.5% for these two women respectively, with a
significant decrease in ?V during the first 4-5 days of bedrest.
These data suggest that elevations of blood estrogens in the presence
of elevated progesterone, may not be associated with a maintenance of
PV during bedrest.
v) Effect of Premarin on the change in PV during bedrest
Figure 3 illustrates the mean change in PV from the 12
non-premarin subjects (bedrest I data) and the mean change in PV from
7 women who performed an identical bedrest protocol, except that they
ingested 1.25 mg/per day of premarin for 7-10 days before bedrest and
throughout the bedrest protocol. During the first 2 days of bedrest,
the PV decreased in the premarin group in a pattern similar to that
seen in the non-premarin group. During the 3rd to 5th day of
bedrest, PV remained relatively stable. Then between bedrest days
7-13 (except for day 11), the PV recovered and was not significantly
different from the PV of each woman on the first day of bedrest (P <
0.05, ANOVA-IW-RM, with the Duncan Multiple Range test to compare for
differences between bedrest days).
vi) Changes in PV during recovery from bedrest
Plasma volume recovered to prebedrest levels within 24-48 hours in
most subjects. Figure 5 illustrates the mean PV _ SE, measured with
the technetium-labelling technique. Plasma volumes were measured
within 48 hours before and 48 hours after bedrest (PREBR and POSTBR)
and after 2 and 4 weeks recovery from bedrest. Results are shown for
the 12 non-premarin subjects and the 7 premarin subjects.
For the non-premarin group, the F ratio determined from an
ANOVA-1W-RM was non-significant (P< 0.20), suggesting that the
decrease in PV which occurred during bedrest was completely restored
within 24-48 hours.
In the premarin group, the F ratio was significant (P <0.02).
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FIGURE 5: Absolute plasma volumes (mean _ SE) determined with
the technetium labelling technique 24-48 hours before bedrest I
(PRE BR); 24-48 hours after bedrest I (POST BR); and two and
four weeks after the end of bedrest (2 wk RC and 4 wk RC,
respectively) for subjects in the non-premarin' group (n ffi12)
and in the premarin group (n _ 7).
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Further tests (Duncan Multiple Range), concluded that the PV 24-48
hours after bedrest and 2 weeks after bedrest, were slgnificantly
greater than the PV before bedrest (P< 0.05).
3) CHANGES IN BLOOD PROTEINS AND ELECTROLYTES DURING BEDREST
i) Non-premarin group, bedrest 1
Plasma osmolality increased slgniflcantly (P< 0.01) during bedrest
(see Figure 6) from an average bedrest day 1 value of 279 mosmol/kg,
to a highest average value of 287 mosmol/kg, which was measured on
the 7th day of bedrest. This increase in plasma osmolality occurred
in the presence of an average 18_ net loss of total circulating
osmotically active particles (TCO) from the plasma in this same
interval (see Figure 7). TCO values were significantly lower (P <
0.05) than the first day of bedrest from the 3rd to the last day of
bedrest.
The plasma total protein concentration increased significantly (P <
0.01) during bedrest (Figure 8). At the same time, there was an
average 13Z net loss of total circulating protein content (TCP), as
seen in Figure 9. The above results suggest that during bedrest there
was a net loss of hypotonic, protein-poor fluid from the vascular
compartment.
ii) Non-premarin group, bedrest 2
A similar increase in plasma osmolallty (P < 0.01) occurred
during the second bedrest (Figure 6) and this increase was
accompanied by a significant (P <0.01) decrease in TCO, as seen in
Figure 7. The TCO were signiflcantly reduced (Duncan Multlple Range
Test) below the values obtained on the first day of bedrest from the
second to the last bedrest day.
The plasma total protein concentration did not increase
significantly (P < 0.50) during the second bedrest (Figure 8), and
TCP decreased (average 11.1Z decrease between day i and the last day
of bedrest) in a manner similar to that seen during the first bedrest
(Figure 9).
ill) Premarin Group
The mean plasma osmolality increased during bedrest in the
premarin group (Figure 10), but the difference was not significant (P
< 0.20). During bedrest days 2-5, there was a significant (P <0.01)
decrease in TC0, but by the end of the bedrest, the TCO value did not
differ significantly from the day 1 value (Figure 7).
The increase in plasma protein concentration during bedrest was not
significant (P < 0.50) in the premarin group (Figure I0), and a
transient decrease in the TCP occurred, with average values
significantly lower than the first day of bedrest on only the 4th and
5th days of bedrest (Figure 9). Thereafter, the TCP values recovered
to eventually exceed the day I mean value on the last bedrest day.
4) FLUID INTAKE AND OUTPUT DURING BEDREST
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FIGURE 6: Plasma osmolality (mean f_SE) on each day of bedrest
for the non-premarin group (n - 12) during bedrest 1 (BRI) and
bedrest 2 (BR2).
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FIGURE 7: Total Circulating Osmols (plasma water x osmolality)
mean + SE, for the non-premarin group (n = 12) during bedrest 1
(NP1)--snd bedrest 2 (NP2), and in the premarin group (n - 7)
during bedrest.
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FIGURE 9: Total circulating proteins (plasma volume x total
protein concentration), mean _ SE, for the non-premarin group (n
= 12) during bedrest 1 (BRI) and bedrest 2 (BR2), and for the
premarln group (n = 7) during bedrest.
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i) intake
Fluid intake during bedrest was crudely calculated based on the
information recorded in each subject's diary. The amount of fluid
drunk each day was measured and the water content in the food was
estimated. When an ANOVA-1W-RM was performed on the data from each of
the bedrests, the differences across bedrest days were not
significant during either bedrest 1 of the non-premarin group (P<
0.10) or during bedrest in the premarin group (P < 0.20). There was
a significant difference between fluid intake on various days of
bedrest for the non-premarin group during the second bedrest (P <
0.05). There was no consistent trend however (Figure 11), with the
largest difference seen between bedrest days 6 and 9.
Although there may appear to be a greater fluid intake in the
non-premarin group during the second bedrest than during the first
bedrest, when an ANOVA-2W-RM-SP was performed to test whether these
differences were significant, the differences between bedrest 1 and
bedrest 2 were not significant (P< 0.50).
ii) urine output
Figure 12 illustrates the changes in 24 hour urine volume during
bedrests (the first value does not represent a full 24-hour sample
since the early morning urine collection was not included)_ None of
the differences in urine output between bedrest days were
significant; for the non-premarin group, bedrest I (P < 0.30) or
bedrest 2 ( P< 0.20), or for the premarin group (P < 0.70). These
results represent the data only from years 2 and 3 of this study,
since 24-hour urine volumes were not recorded during year i.
iii) fluid intake - fluid output
The difference between the fluid intake and fluid output was
calculated for each woman during bedrest (only data from the second
year were used in the non-premarin calculations). This is not a true
water-balance calculation, since the output is not corrected for
insenslble water losses or fluid loss in the stool (both would have
to be estimated, and large errors would occur). As seen in Figure
13, during the first 4-5 days of a bedrest, a negative fluid balance
was seen in each bedrest condition, with the difference between fluid
in and urine out closer to zero during the later days of the
bedrests. Differences between bedrest conditions were not
significant.
4) URINE OSMOLALITY DURING BEDREST
The osmolallties (mean value _ SE) determined from the 24-hour
urine collections are shown in Table 6. The urine osmolality
decreased, especially during the first few days of the bedrests.
This difference was significant during bedrest 1 in the non-premarin
group (P < 0.05), but not significant during the second bedrest (P <
0.20). The changes in urine osmolallty during bedrest in the
premarin group were not significant (P < 0.70).
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FIGURE 12: Urine output (mean _ SE) during bedrest for the
non-premarin group (NP) during bedrest 1 (NPI) and bedrest 2
(NP2), and for the premarin group (P) during bedrest.
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B) MAXIMAL EXERCISE RESPONSES
i) Effect of menstrual cycle
For the non-premarin subjects, there were at least 5 determinations
of maximal oxygen consumption (V02 max) which were performed during
varying stages of each woman's menstrual cycle, and which would not
have been affected by bedrest. These tests included control months
(CI and C2), prebedrest tests (PREBR1 and PREBR2), and the 4 wk
recovery from bedrest. The data from these tests were compared for
each woman, averaging the V02 max data from tests done in the luteal
and follicular phases. The results are shown in Table 7. There was
no significant difference in V02 max in these women between these 2
stages of the menstrual cycle (P <0.70).
ii) Non-premarin group, Bedrest I
The V02 peak value obtained following the first bedrest was
significantly reduced from the prebedrest value, whether the results
were expressed as llters of 02 consumed per minute (average decrease
of 11.2Z), or corrected for body mass by dividing the peak 02
consumption by body weight (IO.4Z), as shown in Table 8.
iii) Non-premarin group, Bedrest 2
Following the second bedrest however, the reduction in V02 peak was
not significant either when expressed as 1/min (average decrease of
4.1Z) or as ml/min/kg body weight (average decrease of 4.3_).
iv) Premarin group
The decrease in V02 peak following bedrest in the premarin group
was significant (P< 0.01) and averaged 21.6Z (I/min) and 24.5Z
(ml/min/kg body weight). There was considerable variability in this
decrease in V02 peak however between subjects, and thus the decrease
in V02 peak between the premarin group and the decrease seen in the
non-premarin group after the first bedrest was not significant
(t-test comparison).
v) Recovery Data
V02 max was almost completely recovered to the prebedrest level by
2 weeks of recovery from bedrest (see Table 8) and this difference
was not significant (P< O.01) for either the non-premarin or the
premarin groups. Also no significant differences were seen between 2
and 4 week recovery comparisons, prebedrest and 4 wk recovery
comparisions, or control and recovery tests.
vi) Correlation between the Pre-Bedrest VO2 max and the %
decrease in V02 peak following bedrest I.
Linear regression analysis was performed to determine the slope and
correlation for the relationship between the prebedrest fitness level
of each subject (prebedrest V02 max), and the reduction in VO2 peak.
The calculations were performed on the non-premarin group for both
the first and the second bedrests. The regression equations and
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TABLE 7 :
CYCLE J_[]t___BJ.,.S_B OF .V._O2BA_. COMBINED DATA FOR
ALL PRE-BEDREST, AND 4, 6, AND 8 WEEKS AFIER BEDREST DATA.
EOLLICU./ . LUTEAL VOzMAX
1 37.8 (N=2) 36.6 (N=3)
2 44.6 (N=4) 47.0 (N=I)
3 39.8 (N=4) 44.0 (N=I)
4 43.7 (N=2) 42.0 (N=2)
5 31.3 (N=3) 31.6 (N=2)
6 40.2 (N=3) 39.9 (N=2)
7 26.4 (N=I) 27.4 (N=2)
8 40.8 (N=I) 42.9 (Nf2)
9 36.4 (N=2) 35.2 (N=I)
10 45.8 (N=I) 41.2 (N=2)
11 38.9 (N=2) 33.5 (N=I)
12 35.7 (N=I) 35.0 (N=2)
X 38.5 38.0
STANDARD DEVIATION 5.5 5.7
STANDARD ERROR 1.5 1.6
NS (P < 0.70) PAIRING DESIGN TEST
MENSTRUAL CYCLE STAGE WAS VERIFIED FOR EACH WOMAN FROM
RECORDS OF MORNING TEMPERATURE, FROM PERSONAL DIARIES,
AND FROM BLOOD ESTROGEN/PROGESTERONE CONCENTRATIONS
36
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Subject
Pre Post Pre PosC
BR1 BR2 BR2 BR2 2-_ 4-k'E C1 C2
Non-Premarin
I 33.2 33.5
2 37.1 38.7
3 34.7 31.1
4 44.4 41.1
5 28.4 26.2
6 40.1 38.0
7 28.5 24.4
8 42.5 36.7
9 36.8 32.1
I0 45.8 37.6
11 41.7 28.9
12 36.7 34.7
i 37.4 33.5
SD 5.46 4.99
34.3 34.6 35.8 36.8
40.3 39.7 41.0 47.2
35.5 31.7 38.3 44.0
42.9 46.2 42.7 40.8
32.1 31.4 28.8 32.1
42.0 37.9 38.8 39.1
26.3 26.0 26.3 26.4
4302 36.8 41.2 40.8
36.0 32.3 35.4 35.2
44.9 37.4 39.5 37.4
33.5 34.9 33.6 36.1
33.2 35.4 33.9 35.7
42.2
47.0
46.9
43.1
33.4
38.4
38.7
51.9
42.0
47.0
31.0
40.7
37.0 35.3 36.2 37.6 41.8 41.8
5.39 4.79 4.81 5.19 4.79 6.53
13 30.8 26.3
14 28.3 22.2
15 28.4 16.3
16 44.6 35.5
17 44.7 36.4
18 43.6 31.0
19 40.1 28.7
• 37.2 28.0
SD 7.15 6.65
A 27.2 27.3
B 26.9 27.3
C 36.0 29.0
26.4 30.2 29.3 27.2
28.4 27.3 26.8 26.9
39.3 40.5 39.4 36.0
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correlations are shown below:
Bedrest 1, VO2 values expressed as 1/minute.
y - -17.8x + 29.1. r - - 0.48.
Bedrest 1, V02 values expressed as ml/min/kg
y = -4.6x + 6.0 r - -0.12
Bedrest 2, VO2 expressed as 1/minute
y - -0.49 + 8.3 r - -0.31
Bedrest 2, V02 expressed as ml/mln/kg
y - -0.20 = 2.9 r ffi-0.27
C) SUBMAXIMAL EXERCISE RESULTS
i) Exercise duration
The total exercise times during the submaximal tests are listed in
Table 9. Durlng control or prebedrest tests, the exercise duration
was about 30 minutes. Occasionally, there was difficulty obtaining
the final 30 minute blood sample, and the exercise time wa_ prolonged
by one or two minutes. For tests in which the exercise was stopped
earlier, the subject's heart rate exceeded 95Z of her prebedrest
maximal heart rate, which was measured during VO2 max determination.
The only exception was subject 17, who was stopped during her
postbedrest and recovery tests because of the core temperature
limitatlon. (An exercise test is immediately terminated if core
temperature exceeds 39 degrees C).
The average exercise times in the prebedrest and control tests were
all between 28 and 30 minutes. Following bedrest however most women
could not finish the entire protocol without reaching the heart rate
or core temperature criteria. The average exercise duration for the
non-premarln group was 21 minutes for both the postbedrest I and
postbedrest 2 tests. A similar decrease in exercise duration
occurred followlng bedrest in the premarin group (the postbedrest
duration averaged 16.9 minutes).
Most of the women in the non-premarln group completed the 30-minute
exercise test after both 2 and 4 weeks of recovery from bedrest. For
the premarin group, 4 of the women were told to stop exercise early
during the 2 week recovery tests, and 3 stopped early during the 4
week recovery test.
li) Changes in plasma volume during exercise tests
Plasma volume decreased significantly (P < 0.01) in all tests
during exercise. Figure 14 illustrates the PV changes which occurred
in the non-premarln group during the pre and postbedrest tests.
Plasma volume decreased rapidly with the onset of exercise, with most
38
UUs-4
6.1
U
41
*e-i
:l
_J
"*"O_O P'-Or',.OO O O e0 _j
O u'_ O r*,. O Otn O,-,t_ ¢'_ u_ (e.),_
¢r_ _ O O O a0 .4'
o_oooooooo _
_ooo_ooooo _
oo _m oo
__@ _ IN
mo
O O Oo O
__ .0 e*_
__ _o __
OOO_OOO m_ _OO
2600
24O0
PLASMA
VOLUME
(ml.)
2000
18OO
16OO
O
Plasma Volume
During Exercise
B
R
• L ]
_ B_ ¸ _..°
"_\" " in
_4_ j J;
10 20 30 FC
, preBR 1
o post BR 1
I + pre BR 2mpost BR 2
EXERCISE TIME
(min.)
FIGURE 14: Absolute plasma volume (mean i SE) during the
submaximal exercise tests for the non-premarin group (n = 12)
during the pre and postbedrest tests before or after bedrest 1
and bedrest 2.
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of the changes occurring within the first 10-15 minutes. Thereafter,
the decrease in PV was attenuated, and even in some subjects
partially recovered. Significantly smaller PV were seen during
postbedrest tests than during prebedrest tests in the non-premarin
group (P < 0.01). Absolute PV did not differ slgnificantly (P <
0.50) in the premarln group between the pre an postbedrest tests
(Figure 15).
A slmilar pattern of plasma volume decrease during exercise
occurred during all exercise conditions despite the significant
differences in absolute PV. Figure 16 illustrates the changes in
plasma volume during the pre and postbedrest exercise tests, where
the data are presented as the Z change in PV (X difference from the
resting sample). The decrease in PV during bedrest was significant
(P < 0.01) for each exercise test condition (PREBR, POSTBR, CI, C2,
2wk RC, 4wk RC). However a comparision of the Z changes in PV between
the pre and postbedrest results (ANOVA-2W-RM-SP) was non-significant
(P < 0.i0) for non-premarin bedrests 1 and 2 as well as for the
premarin results (P < 0.I0).
lii) Changes in blood electrolytes and proteins during exercise
tests
Plasma osmolality increased during all exercise tests (P < 0.01).
Figure 17 (upper panel) illustrates the increase in plasma osmolality
during exercise for the non-premarin group, comparing pre and
postbedrest results. The bottom panel of this same figure
illustrates the changes for the premarin group. An ANOVA-2W-RM-SP
was used to compare the differences in osmolalities between pre and
postbedrest conditions. Non-significant differences between the pre
and postbedrest tests occurred in the non-premarin group during both
the first (P < 0.80) and second (P < 0.90) bedrests, and also between
pre and postbedrest tests in the premarin group ( P < 0.70).
Total protein concentration increased significantly (P < 0.01)
during each exercise test. Figure 18 (upper panel) illustrates these
changes in total protein concentration for the non-premarin group
during the pre and postbedrest tests (bedrests 1 and 2). During the
first bedrest, the total protein concentrations were significantly
higher (P <0.05) during the postbedrest test than during the
prebedrest test. During the second bedrest, though the average total
protein concentration was higher at each exercise interval, this
difference was not significant (P < 0.30).
In the premarln group, an increase in total protein concentration
occurred during the exercise tests. There were no significant (P <
0.10) differences in these protein values between the pre and
postbedrest tests.
iv) Cardiovascular responses during exercise
Exercise heart rates
Figure 19 illustrates the exercise heart rates during the pre and
postbedrest exercise. The exercise heart rate following bedrest was
significantly higher than the prebedrest value for the non-premarin
group following bedrest I (P < 0.05), but not quite significant
following bedrest 2 (P < 0.I0). During the 2 and 4 week recovery
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exercise testa, the exercise heart rates were not significantly
different from the prebedrest teats ( P < 0.10) for the 2 week
recovery test, and P <0.50 for the 4 week recovery comparison. The
heart rate responses between the two prebedrest testa did not differ
significantly (P < 0.50).
For the premarin group, heart rate changes similar to those sees
in the non-premarin group occurred. Following bedrest, exercise heart
rates were slgnificantly higher than during the prebedrest test (P <
0.05). The exercise responses seen during the 2 and 4 week recovery
tests did not differ significantly from the prebedrest test (P < 0.30
for the 2 week recovery test, and P < 0.80 for the 4 week recovery
test).
In both the non-premarin and the premarin groups, the postbedrest
heart rate was higher (paired t-test comparision, P < 0.05) than the
prebedrest value even before the start of the exercise.
Exercise Cardiac Outputs
Cardiac outputs were performed at 4 exercise intervals; after I0,
15, 20, and 25 minutes of exercise. As there were no significant
differences between the sampling times (F < 0.05), aii cardiac
outputs from a given test were averaged and these mean values are
presented for each subject in Table I0.
No significant differences occurred for either the non-premarin, or
the premarin group between experimental conditions. An ANOVA-IW-RM
was performed on each set of data, where the F ratio for the
non-premarin group was 1.83 ( P < 0.i0, n - 77), and for the premarin
group was 1.75 (P < 0.20, n - 30). Thus cardiac output did not differ
significantly during exercise after bedrest or during any of the
recovery tests.
Exercise stroke volumes
Stroke volumes were calculated by dividing the cardiac output by
the heart rate during the rebreathing technique. The values shown in
Table II are the average stroke volumes, calculated from the cardiac
outputs performed during the submaximal exercise tests.
Significant differences in exercise stroke volumes occured in the
non-premarin group (ANOVA-IW-RM), where the F ratio was 3.05,
significant at the P < 0.02 level. Post hoc analysis (Duncan Multiple
Range Test) found that the stroke volumes during the postbedrest 2
test were significantly lower than stroke volumes during either
prebedrest i or 2 tests. Stroke volumes were lower during
postbedrest I tests than during the prebedrest I condition for I0 out
of 12 subjects. However this difference was not significant at the P
< 0.05 level.
For the premarin group, the F ratio was 7.63, significant at the P
< 0.O1 level. A post hoc analysis (Duncan Multiple Range Comparison)
determined that stroke volumes were significantly lower during
postbedrest tests than during prebedrest tests (P < 0.05). No
significant 4ifferences occured between prebedrest and recovery or
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TAm_ lOz llr_J[ c_m_c _3__
(ul/u£n)
Pre
Subject BR1
I 13548
2 11254
3 9804
4 9017
5 11840
6 14261
7 10314
8 12374
9 1580 3
10 10298
11 11050
12 13205
i 11897
SZ 555
Pr_ariu f_r._m
Post Pre Post
BR1 BR2 BR2 2-_ 4-WK Cl C2
13041 10592 10157 12583 10512 8517 11083
8965 10021 10367 11852 12647 11684 9160
11517 10663 11126 10171 9211 13985 12081
12459 10380 12023 12448 9023 8953 9305
12145 14644 8738 12506 14023 12112 7573
15305 13110 16982 14955 13681 13195 13392
11005 11791 10345 12475 11833 12120 10314
12799 9838 9194 11673 10630. 12988 12374
14207 14630 11630 14124 14165 15289 15803
10730 11726 9130 12223 10519 11709 10298
12239 9539 8699 12771 10527 10671 11050
12322 10457 11360 12154 9302 13595 13205
12227 11449 10812 12494 11339 12068 11303
451 490 621 327 521 546 615
13 10521 9571 9077 8360
14 8997 7673 7142 7386
15 9438 9771 9662 9426
16 11673 11902 11354 7156
17 12437 11728 11335 12003
18 13920 12327 13634 12903
19 9970 7584 10420 10934
i 10993 10079 10374 9738
SE 470 297 547 605
A 11866 11456 13082 6316
B 9340 8841 13082 10560
9219
5934
10235
11495
11891
14793
10951
10645
723
11093
10696
9570C 11171 7951 10365 9570
10521
8997
9438
11673
12437
13920
9970
10993
470
11866
10911
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Pre Post Pre Post
Subject BR1 BR2 BR2 BR2 2-_ 4-W[ Cl C2
Non-Premarin
1 96 85 78 68 81 76 56 81
2 85 63 70 65 72 78 71 59
3 58 64 63 64 59 51 78 67
4 55 75 71 68 73 53 52 53
5 75 69 79 49 70 82 74 46
6 97 96 95 101 93 88 85 91
7 70 69 75 64 84 83 82 70
8 74 70 6.5 55 67 6.5 74 74
9 109 89 106 72 99 97 106 109
10 73 63 75 55 76 66 76 73
11 76 74 61 50 78 64 74 76
12 91 77 90 74 78 63 88 91
i 80 74 77 *65 78 79 76 74
SE 4 4 4 4 3 4 4 5
Premarin
13 69 55 59
14 53 42 41
15 62 59 60
16 70 65 64
17 72 64 65
18 90 69 79
19 67 44 69
i 69 *57 73
SE 4 4 4
A 69 60 80
B 59 51 83
C 78 48 65
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69
84
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62
5
102
83
73
59
35
65
70
65
80
74
64
5
68
67
65
69
53
62
70
72
90
67
69
4
78
66
78
Sisni£icantly dif£erent £rom pre-bedrest value.
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control tests.
v) Thermoregulatory responses
a) Thermoregulatory responses as a function of menstrual
cycle phase
Data from the control and prebedrest tests from this study were
combined with other data collected in a separate study to analyze the
effect of menstrual cycle phase on thermoregulatory responses. Using
each woman as her own control, 8 normally cycling women were studied
in the folllcular and luteal phases of their menstrual cycles. We
reported no significant differences in body temperature responses
during exercise (except for the expected increase in body core
temperature in the 1urea1 phase), and no differences in either total
body sweat losses or local sweating responses (see abstract entitled
" Thermoregulatory response to exercise at different phases of the
menstrual cycle" in Appendix 3.
b) Effect of Premarin on thermoregulatory responses
The control and prebedrest data from the women in this study were
used to test the effect of premarin on thermoregulatory responses.
Five women in this study performed the control exercise tests without
taking either oral contraceptives or premarln. Each woman also
performed premarin exercise tests, after ingesting 1.25 mg_remarin
for 7-10 days. We reported no significant alteration in body
temperatures, skin conductances, total body sweat loss, sweating
sensitivity or sweating threshold with the use of premarin (see
abstract entitled "The lack of an affect of elevated estrogens on
exercise thermoregulation" in Appendix 3).
c) The effect of bedrest on esophageal temperature durin R
exercise - non-premarin group
The esophageal temperatures (Tes, mean _ SE) during the submaximal
exercise tests are illustrated in Figure 20. During each submaximal
test there was a significant increase in the Tes during exercise.
During the first bedrest, the Tes values during the postbedrest
exercise were significantly higher (P < 0.05) than the temperatures
during the prebedrest condition (ANOVA-2W-RM-SP). No significant
differences were seen between the prebedrest and the 2 week (P <
0.70) or the 4 week (P < 0.90) recovery tests. Even before the start
of exercise, the resting Tes in the postbedrest test was
significantly higher (paired t comparison, P < 0.05) than the
comparable prebedrest value.
Although Tes values were consistently higher during all postbedrest
tests, these differences were not significant (P < 0.90 for the pre
to postbedrest I comparison, and P < 0.20 for the pre to postbedrest
2 comparison). The difference between the pre and postbedrest Tes
values after 15 minutes of exercise (the last value obtained in most
postbedrest tests) was significantly higher than the prebedrest Tes
at the same time interval (paired T comparislon, P < 0.01). Thus
during the postbedrest tests, Tes values were not significantly
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higher than the prebedrest values during the beginning minutes of the
exercise test, but by the end of the test they were significantly
higher.
Esophageal temperatures during submaximal exercise_ premarin
_rouv
No significant differences occurred between the Tes responses of
the prebedrest and the 2 or 4 week recovery tests. Although the
resting postbedrest Tes was significantly higher than the prebedrest
resting value (P < 0.05), as the exercise continued the differences
between the pre and postbedrest values were no longer significant ( P
0.09, ANOVA-2W-RM-SP). Although the mean Tes at each exercise
interval was consistently higher in the postbedrest tests (Figure
20), even a comparision of the 15 minute values (paired t comparison,
P < 0.09) showed a non-significant difference between the pre and
postbedrest Tes values.
d) Mean Skin Temperatures During the Submaximal exercise tests_
non-premarin Rroup
The mean skin temperature was calculated from 4 skin sites
(Methods) and are illustrated in Figure 21. Although the mean skin
temperatures during the prebedrest tests (both first and second
bedrest) decreased during the exercise tests, while the postbedrest
values either did not change or increased slightly, there _as
considerable variability among the individual responses. For any
given exercise condition, the changes in mean skin temperature during
exercise were not significant; prebedrest I, P < 0.80; prebedrest 2,
P < 0.50; postbedrest i, P < 0.70; postbedrest 2, P < 0.70. No
significant differences occurred in mean skin temperature responses
between any of the exercise conditions (ANOVA-2W-RM-SP), P < 0.20).
Mean Skin Temperatures during Submaximal Exercise Tests_ premarin
KEEEE
The pattern of change in mean skin temperature during the exercise
tests appeared different from the pattern seen for the non-premarin
group. Again, there was considerable variability among subjects, and
the increase in mean skin temperature during exercise (Figure 21,
bottom panel) was not significant during either the prebedrest (P <
0.20) or the postbedrest (P < 0.50) condition. No significant
differences occurred in mean skin temperature response between any of
the exercise conditions (ANOVA-2W-RM-SP), P < 0.50).
e) Total body sweat losses during submaximal exercise tests
Total body weight loss was used as an estimate of the total sweat
loss during the submaximal exercise tests. The change in body weight
(in grams) during exercise was divided by the number of minutes of
exercise and by the surface area of each woman (from Dubois nomogram
based on height and weight). The results presented in Table 12 are
the sweat rate results (g/min/m2 body surface area) obtained during
each exercise test.
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Cglmi.nlu 2)
Pre Post
Subject BR1 BR1
Pre Post
BE2 BR2 2-,me 4-WK C1 C2
1 11.33 8.97 11.63 9.92 11.68 10.00 9.56 11.33
2 12.66 17.79 13.28 17.92 12.24 10.97 11.31 12.66
3 9.79 19.22 11.46 14.99 11.15 14.47 15.22 9.79
4 13.35 14.72 16.28 16.65 16.89 19.54 17.08 13.35
5 8.58 8.48 7.74 12.14 16.62 9.36 8.65 8.58
6 14.94 13.71 7.82 5.22 8.99 8.50 11.87 14.94
7 10.36 13.24 15.93 16.09 15.17 13.05 12.17 10.36
8 7.57 10.19 8.99 9.54 9.78 8.77 8.82 7.57
9 10.31 12.59 9.58 14.30 9,80 8.73 10.52 10.31
10 9.44 12.79 10.67 10.98 12.00 11.78 8.74 9.44
11 9.18 11.50 9.38 13.50 10.40 11.18 6.74 9.18
12 10.33 14.48 17.54 13.45 10.33 12.28 14.51 10.33
i 10.65 .13.14
Sg 0.58 0.89
1 10.45 19.12
2 7.48 18.72
3 8.06 9.04
4 11.71 18.79
5 10.37 16.38
6 8.85 11.50
7 8.88 10.81
i 9.40 14.91
SE 0.52 1.51
11.69 -12.89 12.09 11.55 11.27 10.65
0.93 0.98 0.75 0.87 0.85 0.58
10.58
8.92
8.24
13.02
12.20
9.70
9.80
10.35
0.60
9.20
7.58
9.46
A 7.36 10.20
10.39
10.68
7.37
11.36
8.87
8.81
9.30
9.54
0.47
11.84
6.71
12.42
B 10.23 12.57
11.63
7.41
6.59
11.45
11.59
8.52
8.47
9,38
0.75
9.20
6.82
C 11.90 15.53
10.45
7.48
8.06
11.71
10.37
8.85
8.60
9.36
0.53
10.05
10.23
11.90
* Significantly different from pre/bedrest 1. 4-
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There were no significant differences in the total sweat losses
between the non-premarin and the premarin group, which averaged 10.85
g/mln/m2 for the non-premarin group and 9.40 g/mln/m2 for the
premarin group.
For the non-premarln group, significant differences (P < 0.05)
occurred in the total sweating results between exercise conditions
(ANOVA-IW-RM). The total sweat loss was significantly greater (P <
0.05) than the prebedrest condition during postbedrest I and
postbedrest 2 (Duncan Multiple Range Comparislons). No significant
differences occurred between other exercise conditions.
For the premarln group, the F test ratio comparing all conditions
was not significant (P < 0.10). However for every subject, the total
body sweat losses were greater during the postbedrest test than
during the prebedrest test (see Table 12).
f) Sweat sensitivity and Tea threshold determinations
Local sweat rates (SR) were obtained froa sweat capsules placed
over a skin site on the chest and plotted as a function of the
corresponding Tes (see Methods), and the slopes of these SR/Tes
relationships are shown in Table 13.
During the first year of the study, the sweat system was not yet
built, and so local sweat records for subjects 1-6 could not be
obtained. Also any subject in whom the data was "missing" from more
than one exercise test was not included in any of the data analysis.
(This included subjects 7, 9, and A). Data became "missing" if the
sweat capsule leaked during the test.
The statistical analysis was affected by the small number of
subjects in each group (4 non-premarin, 7 premarin, and 2 oral
contraceptive users) and by the fact that, since sweating slopes and
threshold values are not normally distributed, non-parametric
statistical analysis were required. In order to obtain the largest
number of comparisions, all pre and postbedrest data (from the
non-premarin, the premarln, and the oral contraceptive users) were
combined to test whether bedrest reduces the slope of the sweating
response, and the significance of this comparison was tested using a
Hann-Whltney U test. The Z statistic was 1.79, which is significant
for a one-tailed design at P < 0.04. Decreases in the sweating slope
followlng bedrest occurred in 6 out of the 8 bedrests in the
non-premarln group, in 6 out of 7 of the premarin group, and in both
of the oral contraceptive users.
g) Sweating thresholds
The same limitations as above applied to the calculations of the
sweating thresholds. These results are presented in Table 14, and
the pre and postbedrest data were also analysed by combining the
results from all groups and performing a Mann-Whltney U test. The Z
value was 0.82, which was non- significant for either a one-tailed (P
< 0.21) or a two-tailed (P < 0.41) analysis.
vi) Venous lactate values during exercise
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F_e
Subject Bll
Post Pre Post
BR1 BR2 BR2 2-WI[ 4-WI[ C1 C2
Non-Premarin
8 0.83 0.88
10 0.88 0.72
11 0.69 0.66
12 0.9 0.62
i 0.82 0.72
SE 0.04 0.05
0.86 0.28 0.26 0.4 0.94 0.83
1.14 2.5 1.13 1.6 0.69 0.88
0.74 0.39 0.76 0.47 0.55 0.69
1.35 1.05 0.79 0.81 0.82 0.90
1.02 1.05 0.73 0.82 0.75 0.83
0.04 0.44 0.15 0.23 0.07 0.04
Premar£n
13 3.88 0.56
14 0.19 0.29
15 1.07 0.49
16 0.44 0.37
17 0.5 0.3
18 1.87 0.61
19 0.9 0.62
1.26 0.46
SE 0.45 0.17
B 0.98 0.51
C 0.46 0.29
2.81 I .74 4.49 3.88
0.3 0.35 0.21 0.19
0.84 0.75 0.93 1.07
0.47 0.67 0.98 0.44
0.31 0.54 0.53 - 0.50
0.68 2.23 1.43 1.87
1.32 1.28 0.99 0.90
0.96 1.08 1.36 1.26
0.31 0.24 0.45 0.45
0.86 0.56 0.78
0.67 0.6 0.59
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_e
Subject BR1
Post Pre Post
BR1 BR2 BR2 2-T,_ 4-_ Cl C2
Non-Fremarin
8 37.43
10 37.15
11 37.1
12 37.15
i 37.21
Sg 0.07
37.49 37.43 37.15 37.32 37.43 37.59 37.35
37.46 37.25 37.47 37.18 37.15 37.11 37.37
37.41 37.44 37.58 37.62 37.1 37.44 37.48
37.43 37.46 37.59 37.36 37.15 37.24 37.33
37.44 37.39 37.44 37.37 37.20 37.34 37.38
0.01 0.04 0.02 0.08 0.04 0.09 0.03
Premarin
_£¢OmL--
13 37.02
14 36.78
15 37.28
16 37.54
17 38.21
18 37.9
19 37.45
36.84 36.9 37.i4
37.19 37.07 37.01
37.47 37.17 37.05
37.02 37.45 37.19
38.11 37.81 38.26
37.77 37.06 37.76
38.26 37.4 37.73
i 37.45 37.52 37.26 37.44
SE 0.17 0.19 0.11 0.16
B 37.59
C 36.56
37.76 37.66 37.29
36.72 37.41 37.56
a_ A
.II,Z
36.75
37.4
37.49
37.73
37.35
37.37
37.32
0.11
37.25
37.00
37.03
36.78
37.28
37.54
38.21
37.90
37.45
37.45
0.17
37.47
36.56
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The individual blood lactate values obtained from each resting
and final exercise sample are shown in Table 15. Blood lactate
increased significantly during each exercise condition (P < 0.01).
For the non-premarin group, venous lactate increased by an average
29.4 and 29.0 mg Z during the prebedrest 1 and prebedrest 2 exercise
respectively. Following bedrest, the increase in venous lactate was
significantly greater (P < 0.01); 47.4 and 45.7 mgZ during the
postbedrest 1 and 2 tests, respectively. Although not as high as the
postbedrest tests, venous lactate values were still significantly
higher than the prebedrest tests during the 2 week (34.8 mgZ) and the
4 week recovery (34.0 ms Z) tests.
For the premsrin group, venous lactates also increased
significantly more (P < 0.01) during the postbedrest test than during
the prebedrest condition (Table 15). However the rise in venous
lactate was not significantly different (P <0.05) from the prebedrest
condition during the 2 and the 4 week recovery tests.
vii) Change in forearm venous compliance during exercise
The change in forearm venous compliance (FVV) which occured
during the pre and post bedrest I tests in the non-premarin group is
illustrated in the upper panel of Figure 22. During exercise there
was an increase in venous tone (decreased FVV), which persisted
throughout the exercise test, despite" the marked increases in body
temperatures. This venoconstriction during exercise was also seen
during the postbedrest tests. Although all mean postbedrest FVV
values were smaller than the prebedrest values, thus suggesting a
potentiated venoconstriction, the differences were not significant
(ANOVA-2W-RM-SP, P < 0.20). No significant differences occurred
between the prebedrest 2 and postbedrest 2 tests (P < 0.20), the
prebedrest 1 vs 2 week recovery ( P < 0.70) tests, or the 4 week
recovery tests (P < 0.02). Figure 23 illustrates that the apparent
differences in the FVV response between pre and postbedrest tests
were due to a shift in the resting values and not the result of a
change in the rate of venoconstriction during the exercise. This is
evident from the fact that the shape of the relative changes in the
venoconstrictor response in the pre and postbedrest tests was almost
identical.
Similar FVV responses occurred in the premarin group (see the lower
panels of Figures 22 and 23). The change in FVV during pre and
postbedrest exercise was not significantly different (P < 0.I0).
There also were no significant differences between prebedrest and 2
week (P < 0.I0) or 4 week ( P< 0.10) recovery tests.
D) 17-bets Estradiol and Progesterone Results
I) During Bedrest
The 17-beta estradiol and progesterone values obtained from blood
samples drawn at the same time of day from each woman during bedrest
is shown in Tables 16 and 17. Normal cycllc fluctuations in blood
estrogens occurred in the non-premarin group, with peak 17-beta
estradiol concentrations of about 200-400 pg/ml near ovulation. The
58
IiS U
-i.I
II ill
Sill
!ll
I
i.i
m
Ill
)4
ill
II
ill
I
lU
illi
I
i.i
el
nil
!
ill
1,4
llll
II
i.i
ti
ill
"I
ol
eo • .0 oe • •
el 0* • • •
_ _ _ 0
oo Ioeooo, I0 . .
ilill|*illil II IIIIlil II I I I
__ _-.=_ _o , , , , , , , , , , , ,
lilililillil _ Ilillii li i
--oe--eee-- --eo• ** iillill I| i ! I
O_Ol_lli_ lO Illllll II I I i
___0_ _0 I I I I I I I I I I I I
_0__ _
• oe, ee • • ,
e,_ emJ p"4 am# _4
ti
II
.s.i
iJ
I.*
li
)l
i-I
li
il
.p4
._,,4
I:1
.r4
t_
- Forearm Venous Volume
No Premarin
3.32 9
m=4
2.5
> i 7
b_
<_ 1.3
.9
0
I I I I l I
5 iO i5 20 25 30
Time (min)
Pro OR
3.7
_- 3.3
u
tJ
o 2.9
0
_. 2.5
u
_ 2.i
> 1.7
b.
<3
.9
Premarin
\ \i-i4-LLLLLLLLLi
I I I I I
0 5
Pre BR
iO i5 20 25 30
Time (min)
FIGURE 22: The change in forearm venous volume (compliance)
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during the submaximal exercise tests for the non-premarin group
(n - 12) before and after bedrest I, and for the premarln group
(n = 7) before and after bedrest.
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progesterone levels in the non-premarin group also showed cyclic
fluctuations as would be expected from normally cycling women.
However in two of the subjects, subject 8 during bedrest 2 and
subject 12 during both bedrests 1 and 2, the progesterone
concentrations during the luteal phase were abnormally low, and the
cycles were defined as a luteal phase deficiency using the definition
of Abraham et al (1974). See Figure 24 for an illustration of the
hormonal responses from one of these subjects. Also during the first
year of the study, subject 3 had an extremely short (18-day) cycle
during the first bedrest, and blood hormonal values obtained during
the post bedrest exercise test and morning temperature data suggest
that this subject did not ovulate during this menstrual cycle.
The 17-beta estradiol and progesterone values obtained from blood
samples in the premarin group are also presented in Tables 16 and 17.
The 17-beta estradiol values averaged from 184 to 365 pg/ml during
bedrest, with consistent elevations seen throughout the bedrest
protocol - except for subject 17 who forgot to take her pill on the
morning of bedrest day 9. Progesterone levels for 5 of the subjects
remained less than 0.1 ng/ml, suggesting that ovulation had been
inhibited for most subjects. Subjects 13 and 19 appeared to have
ovulated despite the premarin. Subject 19 reported "breakthrough
bleeding" and increased the dosage of premarin to 2 mg/day
2) Before the submaximal exercise tests
The 17-beta estradiol and progesterone values obtained_rom the
resting blood sample drawn immediately before the start of the
submaximal exercise tests are shown in Tables 18 and 19,
respectively. The 17-beta estradlol concentration ranged from 35.5
to 336.7 in the non-premarin group during the prebedrest tests, and
from 105.4 to 337.9 pg/ml in the premarin group. Again, the
progesterone data are representative of either a preovulatory stage
or a non-ovulatory cycle for all premarin subjects except subjects 13
and 19 in the postbedrest test.
E) Arglnine Vasopressin Concentrations during the Submaximal
Exercise Tests
To test our hypothesis that plasma ADH (arginine vasopressin) may
be involved in the alteration of thermoregulatory function, plasma
arginine vasopressin concentrations were measured from the resting
and final exercise blood sample during submaximal exercise tests.
Samples were obtained only during the last year of the study
(premarin group), and the resting and final exercise values (pg/ml)
are shown in Table 20. No significant differences (P < 0.30) were
found (ANOVA-IW-RM) between any of the arglnine vasopressin values,
including rest and exercise, and pre and postbedrest values.
F) Pulmonary Function Test Results
Forced vital capacity (FVC) increased in each subject (n=13)
during bedrest. Total lung capacity increased in each subject, while
residual volume and resting volume of the lung did not change. No
change in FVC was found in an ambulatory control group using
identical measurement techniques. (see the manuscript in Appendix 2
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FIGURE 24: Endocrine measurements of one subject during
bedrest. An insufficiency of progesterone secretion was
documented according to the method of Abraham.
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m 18-  I3HII. ]gIIMIUIgL IIILll
(pg/min)
PTe
Subject BR1
llzu=,l =Lc f,.co..un
Poac Pre Post
BR1 BR2 BB.2 2-_ 4-W£
1 220.9 442.8 129.7
2 76.9 49.8 355.0
3 93.6 101.2 222.1 101.8
4 336.7 433.6 57.8
5 77.4 47.9 91.2 271.3
6 60.1 114.9 179.8
7 128.1 29.6 313.6 34.7
8 70.0 50.4
9 68.5 /46.1
10 88.9 162.8 121.4 121.1
11 35.5 184.4 66.2 124.5
12 150.1 74.6 90.4 54.9
C1 C2
197.8 278.5
64.0 219.7 272.7 38.9
127.7 112.5 94.4 309.5
535.4 39.8 56.2
62.6 189.1 114.9
43.3 202.4 109.6 254.6
32.3
81.2
56.1
126.8
70.0
88.9
35.5
150.1
91.9 117.8 181.1 141.1 171.8 173.7 110.4 124.3
SE 35.00 87.5 142.8 91.7 170.7 77.3 72.5 91.9
13 196.4 505.7
14 337.9 216.3
15 220.3 234.3
16 125.0 143.1
17 129.7 297.4
18 105.4 134.8
19 3/40.4 205.7
i 207.9 248.2
SE 91.2 116.9
/t0.2 20.0 20.0 196.4
242.9 66.2 138.5 337.9
172.3 322.0 220.3
120.8 20.0 20.0 125.0
20.0 20.0 20.0 129.7
76.1 121.2 105.4
225.8 93.6 33.2 3/40.4
121.0 73.3 92.3 207.9
86.2 54.9 111.1 91.2
A 281.5 /4./-40.4 105.6 71.2 643.7 119.8 210.7 267.1
B 9340 8841 13082 10560 106% 10911
10365 9570 9570C 11171 7951
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Subject
Pre Post _e _st
B_ B_ B_ B_ 2-_ 4-_ C1 C2
Nou-Premarin
1. 0.3 6.4 0.4
2 5.3 0.5 8.4
3 0.3 0.4 0.5 0.4
4 0.3 0.3 2.0
5 11.8 0.4 0.2 14.2
6 0.3 0.3 4.8
7 7.2 0.6 6.0 0.6
8 0.4 3.7 3.4 1.1
9 0.9 2.8 5.4 0.7
10 2.3 --- 0.6 2.0
11 2.3 0.7 0.6 0.6
12 0.5 0.8 2.2 0.2
7.2 0.3
0.4 9.4 48.6 0.2
0.4 0.5 0.3 0.5
0.3 0.3 0.2
0.3 6.8 7.1
0.2 4.8 0.3 7.8
0.6
3.6
1.9
1.0
1.5
0.4
0.9
0.9
2.3
0.5
i 3.0 1.4 2.4 3.0 1.5 3.7 7.2 2.!
SD 3.9 1.6 2.3 4.1 2.6 3.6 15.7 2.8
Pre=arin
13 0.I 24.8
14 0.1 0.1
15 0.2 0.1
16 0.1 0.1
17 0.I 0.3
18 0.1 0.1
19 0.1 7.2
i 0.1 4.7
SD .0 8.6
A 10..5 8.9 28.8 0.4
B 26.9 27.3
C 36.0 29.0
2.5 0.2 0.1 0.1
0.1 3.2 5.8 0.1
0.2 0.2
5.5 0.1 0.1 0.1
0.1 0.1 0.1 0.1
0.1 10.9 0.1
0.1 9.1 1.6 0.1
1.4 3.4 1.5 0.I
2.0 4.3 2.2 .0
3.0 7.7 16.8 1.6
28.4 27.3 26.8 26.9
39.3 40.5 39.4 36.0
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20: 1___
Cps/ml)
Pre-BedresC
Subject R _ D
Post-BedresC
R EX
13
14
15
16
17
18
19
4.49 7.20 2.71
3.84 3.97 0.13
4.68 4.03 -0.65
3.35 6.52 3.17
4.92 7.40 2.48
4.75 6.08 1.33
3.22 4.18 0.96
4.40
2.92
5.82
4.94
16.45
.5.02
.5.28
10.48
6.45
2.92
5.49
9.29
4.36
6.97
6.08
3.53
-2.90
0.55
-7.16
-0.66
1.69
SE
4.18 5.63 1.45
0.25 0.53 0.50
D = (exercise - rest:)
6.57
0.93
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for a more complete description of these results).
G) Positron Emmision Tomo ra h Result
No change was found in the D2 receptor binding of the caudate
nucleus following 5edrest. See Figure 25 for the slopes of the
caudate/cerebellum binding ratios obtained durin$ the prebedrest
(7/11/84) and postbedrest (7/25/84) tests.
&
5R
A
T
I 4
0
FIGURE 25: The ratio of llC-labelled 3-N-methlyspiperone
binding in the caudate/ cerebellum as an index of dopamine D2
receptor binding in one subject before (7/11/84) and after
(7/25/84) bedrest. The similarity of the two relationships
suggest no change in the number of central dopamine D2 receptors
in the caudate nucleus during bedrest.
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V) DISCUSSION OF RESULTS
A) Body Fluid Responses During Bedrest
1) Comparison to previous studies
A fairly consistent finding is that plasma volume decreases during
spaceflight (Johnson, 1979) and during programs of bedrest.
Greenleaf and coworkers (1977) utilized the data from several bedrest
studies to characterize a hyperbolic relationship between the
decrease in plasma volume as a function of the number of days of
bedrest. According to their calculations, plasma volume decreases to
an asymptote of about 22.5Z below prebedrest level after about 30
days of horizontal bedrest. After 11 days of bedrest, a 13Z decrease
in plasma volume would be expected. Most of the data used in these
calculations were obtained from studies of the responses of male
subjects. In the present study, the hypothesis was tested that women
may have a smaller reduction in plasma volume during bedrest,
especially during the pre-ovulatory and the luteal phases of the
menstrual cycle, through a direct or indirect action of estrogens to
retain body water. This hypothesis was based on early observations
of hemodilution during estrogen therapy (Whitten et al, 1951: Preedy
et al 1956), possibly through a sodium conserving action in the
kidneys (Dignam, 1956). In addition, Gaebelein and Senay (1982)
observed that the decrease in plasma volume during exercise was less
during the luteal phase, when estrogens would be higher, than during
the early follicular phase. Our results however did not stfickly
support this hypothesis. The decrease in plasma volume seen in the
women without estrogen supplementation was similar to that predicted
by Greenleaf's formula; it averaged 19.9Z following bedrest I and
12.3Z following bedrest 2 (Table 5). If anything, the women in our
study lost more plasma volume than that reported for men under
similar conditions.
No attempt was made in this study to control either fluid or food
intake. Therefore some of the day-to-day variations in blood and
urine constituents were undoubtedly influenced by changes in the
diet. Nevertheless, while there was no consistent change in the
amount of fluid or food intake, as assessed from the diary records,
consistent changes in plasma volume, electrolytes and proteins
occured during bedrest. The blood and urine responses seen in this
study were similar to those found in a previous study (Greenleaf et
al, 1977) which studied the body fluid responses of 7 men during a
similar bedrast protocol (non-exercise condition). In both studies
plasma osmolality and protein concentration increased significantly
during bedrest, although there was a net loss in the plasma content
of total protein (TCP) and osmotically active particles (TCO). The
mechanism responsible for this loss of a hypotonic fluid from the
vascular compartment during bedrest is most likely multifactorial.
In another paper by Greenleaf and Kozlowski, the body fluid shifts
during bedrest were divided into 3 separate stages. During the first
day of bedrest, fluid moves from the lower regions of the body into
the thoracic region, stimulating volume receptors, and producing a
diuresis. Then during the next 2 weeks of bedrest, plasma volume
reduction continues, and the extracellular volume is restored and
possibly even exceeds the prebedrest level. After 2 weeks of bedrest,
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the plasma volume is still below the prebedrest level, but it remains
fairly stable; extracellular water is normal, and intracellular water
is reduced. Thus during the early hours of bedrest, the initial
reduction in plasma volume may be due to either a Henry-Gauer type
reflex (Gauer, 1983) or to the stimulation of selective natriuretic
peptides (Greenleaf, 1985). Later reductions in plasma volume could
result from a redistribution of water between various body fluid
compartments, or from potential alterations in protein, electrolyte
or hormonal regulations. The data in this study support a
multifactorial mechanism rather than a simple Henry Gauer reflex.
The diuresis in this study occurred during only the first I or 2 days
of bedrest (Figure 12), yet plasma volume continued to decrease
significantly for another 4-5 days before the plasma volume remained
relatively stable (Figure 4). This lack of correlation between the
changes in plasma volume and urine output under conditions of a
stable fluid intake, suggest that the later decreases in plasma
volume may have occurred at the expense of some other fluid
compartment. The higher urine osmolality on the first day of bedrest
supports the suggeston of the stimulation of a natriuretic factor
during the first days of a bedrest.
Whatever the mechanism by which plasma volume is gradually reduced
during bedrest, it is very rapidly recovered f^11^_., bedrest
Within 24-48 hours after the end of the bedrest protocol, the plasma
volume of the non-premarin subjects averaged only about 3Z less than
their prebedrest plasma volume (Figure 5). Thus studies in which
post-flight plasma volume was estimated from blood samples drawn
several hours after return to normogravic conditions, may have
underestimated the plasma volume changes during weightlessness.
2) Effect of menstrual cycle on plasma volume changes during
bedrest
The effect of menstrual cycle stage on plasma volume changes
during bedrest was minimal. As seen in Figure 3, if a woman began
bedrest in the pre-ovulatory stage (stage 2) of her menstrual cycle,
the decrease in plasma volume at the onset of bedrest was postponed
for one or two days. Thereafter, plasma volume decreased rapidly to
the level of plasma volume seen in the women who began bedrest in
other stages of the menstrual cycle• If a woman reached the
pre-ovulatory stage of her cycle in the latter stages (days 7-12) of
a bedrest protocol, a temporary hemodilution occured, which again
disappeared within one or two days (see abstract entitled "Plasma
volume responses during bedrest in healthy women" Appendix 3). The
predicted retention of plasma volume in the luteal phase of the cycle
was sometimes, but not consistently seen in these subjects. The
plasma volume responses of the two subjects who took
estrogen-containing oral contraceptives were not different from the
plasma volume responses of the non-premarin group. Thus only in
conditions in which blood estrogens were elevated in the presence of
low concentrations of progesterone did consistant plasma volume
retention occur•
3) Effect of bedrest on menstrual function
Bedrest presents both a physiological as well as a psychological
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stress to a woman, and stress is a well-known modifier of menstrual
function. Therefore it might be expected that menstrual cycles would
be altered during bedrest. The potential consequences of disruption
of normal menstrual function during weightless conditions are poorly
understood. Indeed, the consequences and the choice whether to treat
menstrual dysfunction during other stressful conditions (athlete's
ammenorrhea) are currently under debate (Loucks and Horvath, 1985).
During exposure to long-term weightlessnss, a cessation of menstrual
function potentially could have serious consequences. A decrease in
blbod estrogen levels could potentially accelerate the bone mineral
loss in women astronauts. Although this study did not directly
address the problem of menstrual function regulation, it was noted
that for the 6 "normally cycling women" in whom daily hormonal
samples were obtained during bedrest, two of these women had evidence
of luteal phase deficiency. However, the conclusion that the bedrest
protocol specifically produced this menstrual irregularity cannot be
drawn, since control endocrinological data were not obtained from
these two women during non-bedrest conditions.
4) The potential for lower leg edema following bedrest
The potential for lower leg edema following exposure to
weightlessness was emphasized in a review article by A.R. Hargens
(1982). He demonstrated that the interstitial fluid pressure in the
lower legs of male subjects decreased during head-down tilt as
interstitial fluid was shifted from lower body to upper body regions.
Hargens suggested that "countermeasures may be necessary t_maintain
precapillary-muscle tone during long space flight in order to prevent
swelling of lower leg tissues upon readjustment to Earth's gravity".
To date however, there have been no published accounts of severe
lower leg edema following bedrest or spaceflight. In this study,
subject "A" developed edema in both lower legs which probably was a
consequence of her participation in the bedrest study. Upon
finishing the bedrest protocol and the postbedrest exercise tests,
this subject remained in the sitting position for a prolonged
interval (typing a term paper all night). It is possible that this
period of inactivity prevented the restoration of a normal venous
tone in her lower legs, resulting in blood pooling and excessive
fluid extravascularization. Similar conditions of inactivity may need
to be avoided following spaceflight to prevent this painful and
disabilitating experience.
5) Effect of premarin to restore plasma volume during bedrest
In the original hypothesis, elevated blood estrogens were proposed
to be associated with body fluid retention. However from the results
of the two oral contraceptive users (who took pills containing
synthetic estrogens and progestins), and because of the greater
hemodilution seen during cycle stage 2 (pre-ovulatory) rather than
during cycle stage 3 (early luteal), this initial hypothesis was
modified to now predict fluid retention in conditions of elevated
blood estrogens only in the presence of low blood progesterone. The
estrogen supplement used to test the hypothesis was premarin, a
natural estrogen supplement which has been used for estrogen
replacement therapy. Premarin tablets administer about 48Z estrone
sulfate, 26Z equilin sulfate, and 26Z other hormones. One hour after
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ingestion of a 1.25 mg tablet, total estrogen concentrations should
be elevated in the following proportions, 87Z equilin, 8% estrone,
and 5Z 17-beta estradiol (Whittaker, 1980). One disadvantage of
premarin administration is that, although total estrogens are
significantly elevated, the most biologically active human estrogen
(17-beta estradiol) is only moderately elevated (in our study,
17-beta estradiol was elevated in the plasma to 200-400 pg/ml).
However this moderate elevation in 17-beta estradiol is also an
adyantage, since moderate levels may prevent many of the estrogenic
side effects, such as blood clotting and migrane headaches, reported
with estrogen treatment. In future studies however, a better
estrogen supplement may be low doses of estrace, which is pure
17-beta estradiol.
It is clear from the results shown in Figure 4, that the premarin
administration was effective in restoring plasma volume duping
bedrest. During the first 2 days of bedrest, the plasma volume
response of the premarin group was similar to that of the
non-premarin subjects. Thereafter, the loss of plasma volume was
attenuated and then reversed. The mechanism by which premarin
restored plasma volume during bedrest is uncertain. Although the
urine losses in the premarin group tended to be less than in the
non-premarin group, there was much variability in subject responses
and no significant differences were seen between the two groups for
urine loss, fluid intake, or the difference between fluid in and
fluid out. The concentration of blood electrolytes and total protein
in the two groups during bedrest were similar, thus not only was
water retained by the premarin action, but also electrolytes and
proteins.
6) Changes in red cell volume during and after bedrest
A decrease in red cell mass has been reported following both US and
Soviet space flights. The Skylab data indicated teat once a loss of
red cell volume is triggered, it may continue for as long as two
weeks after the cessation of the flight (Nicogossian, 1982). The
precise mechanism for the decrease in red blood cells has been
variously postulated to involve an inhibition of new red cell
production through decreased erythropoietin release and new red cell
formation, increased intravascular hemolysis, or sequestration of the
red blood cells (Nicogossian, 1982). Red cell mass was determined in
this study with a Technetium radioisotope labelling technique. One
advantage of this method is that the half-life of the label is short
enough that eight repeated measurements could be obtained at 2-week
intervals during this study. During a single bedrest, the red cell
mass decreased 4-7% in these women although this difference was not
significant (Table 4). Prior to the start of the second bedrest
(with about a 4-week recovery), the red cell mass was not completely
restored to the prebedrest I level. A further 4.4Z decrease in red
cell mass occured during bedrest 2, resulting in significant
accumulative reduction from the prebedrest I value. This reduction
in red cell mass persisted and increased during the next 2 weeks of
ambulatory recovery. Although these results shed no new light into
the possible mechanism of the decrease in red cell loss, it is clear
that this response is not rapidly reversible (as the plasma volume
response), and that accumulative effects are seen with repeated
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bedrests, which are separated by 4 weeks of recovery.
7) The effect of repeated bedrest
One unique aspect of this study was that repeated identical
bedrests were performed, with the duplicate bedrests separated by a
3-4 week period of ambulatory recovery. (In previous studies in which
repeated bedrests were performed, some alteration in the bedrest
protocol, ie. exercise intervention, precluded direct comparision of
the results from the two bedrests). Several small differences
between responses measured during the first and second bedrest were
seen in this study. First the decrease in plasma volume during the
second bedrest was only about 60Z of the decrease in plasma volume
seen during the first bedrest. Although the starting plasma volume
was slightly smaller during the second bedrest, the average plasma
volume remained higher than the bedrest 1 values througout.the last 8
days of bedrest (Table 5). Also, smaller increases in plasma
osmolality and total protein concentration occurred during the second
bedrest (Figures 6 and 8). These results suggest the interesting
possiblility that there is an adaptation of the body fluid responses
with repeated bedrest. Possibly, during the initial bedrest
exposure, a redistribution of fluid or proteins occurred between body
fluid compartments, such that there was an increase in the volume or
capacity of the interstitial compartment even in the presence of a
reduction in the plasma compartment (Greenleaf, 1982). The mechanism
which altered the distribution of fluid between the interstitial,
plasma and possibly intracellular compartments, might invol:ve
alteration in the local tissue metabolism of these fluid
compartments, or an alteration in the protein composition or content
(reminesent of Senay's theory (1972) of how heat acclimation alters
the regulation of plasma volume). Following the first bedrest, these
body fluid alterations may have been retained until the start of a
second bedrest and been responsible for the smaller disturbance of
body fluid balance during the second bedrest, ie an increase in
prebedrest interstitial volume could function to maintain plasma
volume. Thus a peripheral tissue body fluid "adaptation" may occur
with repeated weightless exposures. Alternately, a "central"
modification may occur with repeated bedrests. The redistribution of
blood volume into the thoracic regions during the first bedrest could
somehow result in a decrease in the sensitivity of blood volume
receptors, resulting in an attenuation of the bedrest-induced
diuresis during the second bedrest.
B) MAXIMAL EXERCISE RESPONSES FOLLOWING BEDREST
I) Difficulty in obtaining V02 max following bedrest
Measurements of maximum oxygen consumption (VO2 max) are often
interpreted as a measure of aerobic capacity, and when corrected for
body mass, is an indication of aerobic fitness. In order to
accurately determine an individual's V02 max however, conditions must
exist in which the subject is able to exercise to an intensity at
which oxygen transport is the limiting factor. If the active muscle
mass is too small, local muscle fatigue occurs before the maximal
aerobic capacity is reached. Evidence of the attainment of a true
aerobic capacity is the presence of a plateau in oxygen consumption
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with further increase in exercise intensity.
Prior to bedrest in this study, the subjects were able to exercise
to their maximal aerobic capacity. Following bedrest however, the
criteria for VO2 max was seldom obtained, and thus the postbedrest
values are referred to as the "peak VO2." In this study it is
unclear what is the primary factor which limits peak VO2 after
bedrest. Potentially, the loss of muscle tone during the bedrest
might limit the working capacity of the leg muscles. Thus during the
V02 max testing after bedrest, the exercise performance was limited
by this local muscle fatigue rather than by a true aerobic capacity
llmitation. Thus following bedrest without muscle training, it might
be impossible to test the decrease in maximal aerobic capacity.
2) Comparison with data in the literature
Previous studies in the literature which claim to have measured V02
max or peak VO2 changes before and after bedrest report decreases in
the range from 17 to 31Z (Miller, 1965; Saltin, 1968; Taylor, 1949).
The responses of 8 women following bedrest averaged 9.7Z following 17
days of bedrest (Convertino, 1977). The decreases in V02 peak
(ml/kg/min) which were measured 24-48 hours after the end of bedrest
"- the present study averaged in_ ..A _ _^11^.J_.. _drests I _.._--_2
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for the non-premarin group, and 25Z in the premarin group. The range
of decrease in peak V02 following bedrest however was great; all the
way from no decrease following bedrest to a 31Z reduction. Some of
this variability may have been related to the experiences of the
women during the submaximal exercise tests on the previous day.
Subjects who fainted following the submaximal exercise tests appeared
to be more cautious and refrain from "going all out" during the post
bedrest VO2max test.
3) Lack of influence of premarin treatment
Premarin did not significantly alter V02 max during the control
tests or the decrease in V02 peak seen following bedrest (Table 8).
This is not an altogether unexpected finding as the decrease in
plasma volume which occurred in the non-premarin group was almost
completely restored by the time the maximal exercise test was
performed. For most subjects, postbedrest VO2 peak was determined on
the same day that the postbedrest plasma and red cell volume was
measured, which was 24-48 hours after the end of the bedrest. Figure
5 illustrates that at this time, the plasma volumes in both the
premarin and non-premarin groups were not significantly different
from the prebedrest values. Thus if the absolute decrease in plasma
volume during bedrest has any effect on the decrease in V02 peak,
this effect would no longer be present at the time of testing in this
study. In addition, it would not be expected that alterations in
plasma volume alone, without significant alteration in red cell
volume, would alter significantly V02 peak (Kanstrup and Ekblom,
1982).
4) Lack of correlation between V02 max and the Z decrease in V02
peak
One hypothesis which has been recently tested (Greenleaf, 1982b)
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is that a greater reduction in V02 peak occurs in fit subjects than
in unfit subjects following bedrest. Positive correlations between
prebedrest V02 max and the Z decrease in V02 peak have been reported
in several studies which examined the responses of male subjects
(Chase, 1966; Saltin, 1968; Convertino, 1977). Very little data is
available from women (Convertlno, 1977), and the correlation found in
one study was very low (-0.38). In the present study similar low
correlations for this relationship (-0.12 to -0.48) occurred in the
non-premarin bedrests. This result may have been due to the narrow
range of prebedrest fitness values (28-45 ml/kg/min). Another
contributing factor may have been that the exercise was performed in
the upright posture, which according to Greenleaf et al (1982b)
presents an additional complicating factor in the determination of
V02 peak following bedrest as there are hypothesized differences in
blood pressure regulation with differing fitness level. The postitive
correlations between prebedrest V02 max and Z change in V02 peak have
been reported from studies in which postbedrest V02 peak tests were
performed in the supine position.
C) SUBMAXIMAL EXERCISE RESPONSES FOLLOWING BEDREST
I) What limits exercise tolerance following bedrest?
The submaximal exercise responses following bedrest would be
expected to be reduced because of several concurrent effects. First,
deconditioning would be expected to alter the cardiovascular and
thermoregulatory responses that were studied. The average_prebedrest
V02 max results for the non-premarin and premarin groups were 2.24
and 2.41 liters/min, respectively (a non-significant difference).
Exercise intensities for the submaximal tests were calculated to
require an oxygen consumption of about 70% of each subject's
prebedrest VO2 max; The actual oxygen consumption of each woman
during the submaximal exercise was determined during the control
tests, and found to average 68 _ 1.3% VO2 max for the non-premarin
group, and 69 _ 2.7% for the premarin group. Since the average
decrease in V02 peak was 11% in the non-premarin group, then the
postbedrest exercise test was performed at an exercise intensity of
approximately 76.5g V02 peak. For the premarin group, the average
decrease in V02 peak was 22g (non-signlficant from the non-premarin
group because of the great variability in responses), and would have
resulted in an exercise intensity of about 88.0Z V02 peak during the
post bedrest test. Although the decrease in aerobic capacity was
probably not as great as suggested by the decrease in V02 peak
following bedrest, the postbedrest exercise was likely performed at a
significantly higher relative exercise intensity.
Secondly, in order to assist in subject recruitment, this study was
performed during the summer months. Thus during bedrest, it is
possible that changes in the state of heat acclimation occurred,
which would affect the postbedrest thermoregulatory responses. The
magnitude of this effect would be expected to be very small in this
study, as all subjects were employed in jobs in which they worked in
air conditioned buildings, and none were athletes or consistently
exercised out-of-doors. No significant difference was seen in the
thermoreguatory data between control and prebedrest responses where
the control tests were performed at the end of the study (late August
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and early September) in year I, and at the beginning of the study
(end of May and early June) during years 2 and 3.
Third, the decrease in plasma volume which normally occurs during
bedrest would be expected to significantly alter cardiovascular,
venoconstrictor (Fortney, 1983) and thermoregulatory (Fortney 1981)
responses during exercise.
Finally, a loss of venoconstrlctor tone during bedrest might result
id greater blood pooling in lower body regions, decreasing cardiac
return and thus exerting effects similar to the responses seen with
hypovolemia.
All of the above effects would be expected to influence the
submaximal exercise responses in this study. However, the magnitude
of the effects due to losses of training, heat acclimation and venous
tone would be expected to be comparable between the raring bedrest
conditions. Any change in the cardiovascular or thermoregulatory
responses caused by the decrease in plasma volume during bedrest
should be evident from comparisons of the responses of the
non-premarin (who had a 19.9 g decrease in plasma volume during
bedrest) and the premarin subjects (plasma volume decreased only 0.2Z
during bedrest).
2) Body Fluid Responses during Exercise
In 1969, Hyatt et al proposed that at least part of the postbedrest.
orthostatic intolerance during tilt was due to a greater loss of
plasma volume during the tilt. They speculated that during bedrest
the extravascular compartment become dehydrated, and during
post-recumbancy tilt, a large transudation of plasma water occurred
into the leg tissue spaces. The resultant decrease in plasma volume
during tilt would then account for some of the decrement in stroke
volume and cardiac output seen after bedrest. It is now known that
the extracellular compartment is not dehydrated during bedrest, and
thus this mechanism for a greater plasma water filtration after
bedrest seems unlikely.
Moderate cycle exercise in a warm environment is also a stress in
which decreases in plasma volume occur (Harrison, 1985). Thus if
Hyatt's theory is correct, perhaps a greater loss of plasma volume
would occur during exercise following bedrest than during the
prebedrest tests. In this study, plasma volume decreased during all
of the submaximal exercise tests, but the Z loss of plasma volume was
similar in pre and postbedrest tests (Figure 16). There was no
evidence of an increased extravascular fluid loss which may have
contributed to the greater cardiovascular and thermoregulatory strain
seen in the postbedrest tests. Indeed in the non-premarin group, the
same relative decrease in plasma volume occurred in the pre and
postbedrest tests, despite the different absolute plasma volumes at
the start of the exercise. This suggests that in the hypovolemic
condition (postbedrest), a smaller rather than a greater, absolute
loss of plasma volume occurred.
3) Cardiovascular responses following bedrest
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The cardiovascular responses were altered significantly in all
postbedrest exercise tests. Heart rates were higher at all exercise
times and stroke volumes were lower during the postbedrest exercise.
The increase in heart rate was able to compensate for the lower
stroke volume in these tests, and cardiac outputs were not
significantly lower postbedrest. For all but one subject, the
criteria for shortening a postbedrest exercise test was the
attainment of a heart rate of 95_ of the prebedrest maximal heart
rate value (one subject was stopped early because of a high core
temperature). In the non-premarin group, we first speculated that at
least part of the elevation in exercise heart rate and reduction in
stroke volume was due to the significantly lower plasma volume during
the postbedrest test, which presumably would limit cardiac filling.
This expectation was based on the similar changes in cardiovascular
responses seen in a previous study (Fortney et al, 1983) in which an
identical exercise protocol was employed to compare the
cardiovascular responses of men during normovolemic exercise, and
exercise in which plasma volume was reduced 15_ with diuretics prior
to the start of exercise. Therefore we were surprised to find that
the cardiovascular responses of the premarin group were similar to
those seen in the non-premarin group following bedrest. The increase
in heart rate, and reduction in stroke volume and endurance time were
of a similar magnitude as the non-premarin group, despite significant
difference in plasma volume responses during bedrest. Thus a similar
increase in cardiovascular strain was seen in these women following
bedrest, and it appeared to be independent of the level of
pre-exercise hydration.
4) Thermoregulatory Responses following Bedrest
Esophageal temperatures were higher at each exercise time in the
postbedrest condition for each subject group, while skin temperatures
were not different. Higher core temperatures would be predicted
during postbedrest tests, since the subjects exercised at a higher
relative exercise intensity (Saltin and Hermanson, 1966). Since core
temperature is the primary input for the control of sweating,
significantly greater total sweat loss might also be expected during
the postbedrest tests, when correction were made for the shorter
exercise endurance. However, following a decrease in fitness
(Roberts, 1977) or a decrease in plasma volume (Fortney, 1984),
sweating sensitivity is reduced. Thus for a given change in core
temperature, a reduced sweat production is ellicited. It has also
been shown that the threshold for the onset of sweating is influenced
by the degree of acclimation of the subject (Roberts et al, 1977).
Thus if a significant loss of heat acclimation occurred in these
subjects, the sweating threshold would have been shifted so that
sweating would to be initiated at a higher core temperature following
bedrest. Very few studies have examined thermoregulatory responses
following simulated weightlessness and a decrease in heat tolerance
during spaceflight could have important consequences for men
attempting to work in space.
Greenleaf and Reese (1980) reported signlficantly higher increases
in rectal temperatures in men durin 8 submaximal exercise following 2
week bedrests. They suggested that this greater heat intolerance
could be due to combined effects of deconditloning and inhibition of
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sweating. The results of the present study confirm that core
temperature increases to a higher level during exercise following
bedrest. Part of the greater increase in core temperature
postbedrest, was probably due to the significant decrease in the
slope of the sweat rate/core temperature relationship (Table 13).
Such a change in sweating sensitivity would be expected because of
the bedrest decondltioning. However, the contribution of the decrease
in plasma volume to this decreased sweating sensitivity is difficult
to identify in this study, because of the variability and small
number of non-premarln subjects in whom local sweating records were
obtained. Three out of four of the non-premarin subjects, both oral
contraceptive subjects, and 6 out of 7 of the premarin subjects had
reductions in sweating sensitivity.
In a previous study (Fortney et al, 1981), we postulated that in
conditions of hypovolemia, increased titers of anti-dluretic hormone
may be released which act either at the sweat gland to reduce sweat
output, or centrally in the hypothalmus to inhibit the output of the
heat loss thermoregulatory neurons. In this study, we found that
following bedrest the sweating sensitivity was significantly reduced
despite non-significant changes in blood ADH concentration. These
results would tend to present evidence against a role of blood ADH to
inhibit sweat gland function. However because of the small number of
subjects in whom local sweating records and plasma ADH were obtained
it is difficult to draw any firm conclusions.
5) Forearm Venous Compliance Changes after Bedrest
The decrease in orthostatic tolerance following actual or simulated
weightlessness as been variously ascribed to the reduction in blood
volume, reduced cardiac fillin$ or muscle pumping, reduced arterial
mechanoreceptor activity, decreased responses of vascular muscle to
adrenergic neural activity, decreased skeletal muscle tone, decreased
vascular tone, or increased distensibility of the lower limb veins
(Levy and Talbot, 1983). That at least part of the orthostatic
intolerance is probably due to factors other than the decrease in
blood volume, is evident from studies in which the decrease in
orthostatic tolerance persisted following bedrests where plasma
volume was restored prior to orthostatic testing, by either oral
rehydration (Hyatt, 1977)or administration of a mineralocorticoid
(Bohnn et al, 1970).
One hypothesis in the present study was that following bedrest,
there might be an attenuation of the sympathetic venoconstrictor
response to exercise. The prolonged inactivity combined with a
reduction in the lower body vascular volume was predicted to result
in a relaxation of the vascular smooth muscle tone in the leg veins
and/or a decreased responsiveness to hormonal or sympathetic nervous
stimulation. In addition, the increased thoracic blood volume could
result in an attenuation of the low-pressure baroreceptor
responsiveness, resulting in delayed or unresponsive sympathetic
venoconstrictor reflex response. Bevegard and Shepherd (1966) first
demonstrated that during exercise, there is a sympathetic
venoconstrictor response which is proportional to the intensity of
the exercise challenge. Peripheral venous constriction during
exercise helps to prevent blood pooling and enhance cardiac filling.
79
An impairment of these venous reflexes following bedrest would
reduce, not only orthostatic, but also exercise tolerance.
In the present study, followlng bedrest the forearm venoconstrictor
response to exercise was not significantly altered from the
prebedrest condition. There was no evidence of a delayed or
attenuated reflex venoconstriction, either at the beginning or at any
time during the exercise test. Instead, following each bedrest there
was a greater decrease in forearm venous compliance during exercise.
This increased postbedrest venoconstrictlon might have occured in
response to the increased relative exercise intensity (Bevegard and
Shepherd, 1965) or in response to the decreased plasma volume
(Fortney et al, 1983), at least in the non-premarin group. The
similar forearm venoconstriction between the non-premarin and the
premarin subjects suggests that either the decrease in plasma volume
during bedrest does not alter the venoconstrictor response, or that
significant blood poollng may have occurred in both groups following
bedrest to negate any beneficial affects of the relatively bigger
plasma volume in the premarin group.
These findings of a "normal" exercise venoconstrictor reflex
following bedrest, agree with several other studies in which normal
sympathetic nervous responses were seen after simulated
weightlessness. Chobenian et al (1974) reported no change in
postbedrest pressor responses to norepinephrine and angiotension
infusions. The plasma catecholamlne response to tilt also was
unaffected following bedrest and the apparent turnover rate of
norepinephrine was normal (Blomquist, 1983). Thus the superficial
venoconstrlctor responses appear to be maintained following periods
of simulated weightlessness. However it is still possible that
significant pooling of blood may occur in splanchnlc or in dependent
deep venous regions, such as in the lower legs. The deeper veins
have less smooth muscle and are not as richly innervated as the
superficial veins (Ludbrook, 1966). Thus the technique of measuring
forearm venous constriction may resolve only that the superficial
venoconstrictor reflex is maintained following bedrest, and may even
attempt to compensate for the increased blood pooling which may
simultaneously occur in dependent deeper veins. Therefore in the
present study, as long as the women continued to perform rhythmic leg
exercise, there was no problem of orthostatic intolerance. Only after
they stopped pedalling, and the muscle pump action was no longer
operative, was hypotension and fainting a common occurrence in the
postbedrest test.
VI) CONCLUSIONS
The following conclusions may be drawn from this study:
i) Young healthy women have a similar loss of plasma volume during
12-day horizontal bedrest as that reported in the literature from
men. In this study the decrease in plasma volume averaged 19.9Z after
bedrest 1, and 12.4Z following the second bedrest in the same women.
2) Menstrual cycle stage has very little effect of the plasma volume
changes during bedrest. Just prior to ovulation there is often a
water-retaining effect, such that if a bedrest program begins at this
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stage of the cycle, the hypovolemlc response may be delayed for one
or two days. Thereafter, plasma volume is decreased to a level
similar to that seen in other women who began bedrest in other stages
of the menstrual cycle.
3) Oral contraceptive usage (Ovulin 21 or Orthonovum) in two women
did not significantly alter their body fluid responses during
bedrest.
4) There was no correlation between the time-course of the decrease
in plasma volume and the increase in urine output in this study
during the first 5 days of bedrest, suggesting that the decrease in
plasma volume is not a simple Henry-Gauer reflex response.
5) Premarin, an estrogen supplement, resulted in a recovery of plasma
volume during bedrest and may therefore be used to establish a model
whereby the effect of the decrease in plasma volume during bedrest
may be separated from other bedrest effects. The premarin ingestion
alone did not significantly alter any of the exercise responses
studied (as determined from the control studies in the premarin
group).
6) Maximal exercise responses following bedrest were not altered by
........ L -- __plasma volume retention during the bedrest, w_ _imil_ Lu L,u_
reported in men following bedrest, and were not correlated to
pre-bedrest fitness.
7) Submaximal exercise responses were significantly altered following
bedrest. Exercise heart rates were higher, stroke volumes were
reduced, core temperatures were higher, blood lactates were higher,
and sweating sensitivity was reduced. Cardiac outputs, sweating
thresholds, and mean skin temperatures were not different from
pre-bedrest tests.
8) No change in the % loss of plasma volume during exercise occurred
between pre and postbedrest exercise tests, suggesting no change in
capillary permeability following bedrest.
9) Surprisingly, no significant differences were seen between the
postbedrest exercise responses of the non-premarln and the premarin
groups. Alterations of plasma volume of less than 19.9% before
normal ambulatory exercise tests, would significantly alter heart
rate, stroke volume, sweating, and body temperature responses in
normal ambulatory subjects. In the postbedrest condition, the
varying levels of hydration had no influence on these exercise
responses.
10) The sympathetic venoconstrictor response to exercise is not
significantly altered following bedrest.
VII) RECOMMENDATIONS, DISCUSSION OF UNRESOLVED PROBLEMSf AND
PROPOSED COURSES OF ACTION
I) Lack of an increased risk to women in space because of differing
8t
body fluid responses.
function.
Need for further studies on menstrual
From the results in this study, women do not appear to be at
greater risk than men during spaceflight because of differences in
body fluid responses to weightlessness. Although women generally
tend to have a smaller absolute blood volume, the decreases in plasma
and red cell volume found in this study were of a similar relative
magnitude as those reported in men. Thus the absolute decrease in
plasma volume in these women resulted in a Z change in plasma volume
similar to the Z changes which are reported to occur in men.
Menstrual function and oral contraceptive usage had very little
affect on the body fluid changes during bedrest. However further
studies are needed on the potential effects of weightlessness on
menstrual function. It is possible that some aspect of
weightlessness (changes in blood volume, protein population, blood
flow distribution pattern or organ perfusion, hormonal responses,
etc.) might alter normal follicular development and decrease estrogen
production. Further work is needed on the potential effects of
menstrual dysfuncion with decreases in blood estrogens, on bone
mineral losses during long-term exposure to weightlessness.
2) Further study of "fluid loading" countermeasures.
Several recent reports have been published about the success of
fluid replacement through the use of salt tablets Just prior to
re-entry. While this treatment may be useful to prevent oFthostatic
intolerance in resting subjects, its usefullness in preventing an
increased cardiovascular or thermoregulatory strain in men who must
perform physical tasks shortly after re-entry is unclear. From the
results of this study, following bedrest there was a severe
impairment in cardiovascular and thermoregulatory responses to
exercise, and these responses were not improved by preventing the
decrease in plasma volume during bedrest. The additional factors
(other than the decrease in plasma volume) responsible for the
decreased postbedrest exercise tolerance (deconditioning, blood
pooling, myocardial deconditlonlng) need to be further identified and
methods for their compensation developed. To do these studies, models
need to be developed in which weightless responses can be studied
both with and without the decrease in plasma volume. It could prove
useful to study effects of fluld replacement "acutely", just prior to
re-entry vs. "slowly", by maintenance of plasma volume throughout a
weightless procedure. Such a protocol might be useful to identify
certain mechanisms of orthostatic or exercise intolerance which occur
during spaceflight and are not rapldly reversible (le. alteration of
baroreceptor sensitivity, or redistribution of fluid between body
fluid compartments). One could also evaluate potential negative
effects of preventing the welghtless hypovolemia (le. if plasma
volume was maintained at pre-spacefllght levels would faclal
swe11Ing, headache, increased central venous pressure and thus
cardiac prelosd occur) to determine whether plasma volume maintenance
should be a goal during spaceflight.
Fluid loading "treatments" prior to spaceflight might also be
explored. Is it possible to alter the plasma, interstitial, or
intracellular composition prior to launch and minimize the
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alteratlons in body fluids which occur during spaceflight? Would
minimizing such fluid shifts reduce or prolong the initial
readjustments to welghtlessness? Would it allevlate the problems
during re-entry?
3) Potential adaptation to repeated weightless simulations
During the second bedres.t, the changes in plasma volume and the
submaxlmal exercise responses were not as severely affected as during
the first bedrest, suggesting that some sort of adaption may have
occurred. Further studies could be conducted to confirm whether
brief programs of simulated welghtlessness prior to spaceflight might
not decrease some ofthe discomfort experienced during an
indivldual's actual weightless exposure.
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Appendix 1 : Committee on Human
Volunteer Forms
AI-I
Report to Human Volunteers Commit lee concerning possible complications
resulting from continuous bedrest.
Project Title: Bedrest in Healthy Women: Effects of Menstrual Function
and Oral Contraceptives.
Principal Investigator: Suzanne Fortney, Assistant Professor, Division
of Environmental Physiology.
Subject Involved: Subj. A
Description of Incident:
Subj. A along with six other healthy, non-oral contraceptive pill users,
successfully completed the preliminary testing and the first 13-day bedrest
procedures. All of Subject ,_preliminary values, including exercise
responses, blood volume, hematocrit, proteins, and electrolytes, were
within normal values and similar to the values of the other subjects.
July 9_ 1982
Immediately after the bedrest protocol Subj. A performed a submaximal
exercise test without unforeseen complications.
July I0_ 1982
A maximal exercise test was performed. No problems were reported, and
her maximum oxygen consumption was similar to the pre-bedrest value.
July II _ 12
Subj. A noticed swelling and pain in her lower legs and ankles but
did not contact anyone in the study.
July 13
Subj. A called my technician, Claudia Turner and reported pain in her legs.
She was asked to report to the exercise laboratory where she was examined
by Dr. Sol Permutt. Sol further referred her to Dr. Ko-Pen Wang of the
Johns Hopkins Hospital in the Division of Respiratory Medicine. Dr. Wang
is an individual not directly involved in this study. He reported swelling
in both ankles, the right ankle more than the left, but no pain or redness.
His impression was that there may have been a mild phlebitis in her right
foot and recommended that she continue her usual activities. He felt that
anticoagulant therapy was not indicated.
Experimentation on all subjects was cancelled until a full evaluation of
Subj. A responses could be made.
Each subject was contacted to see if they reported similar symptoms.
One subject, Subi. B . reported pain in her lateral thigh. She
was examined by Dr. William Beckett by tests of impedance phlebography of
both legs, and by plain x-ray of the right leg and hip. His conclusionwas
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she may have experienced a slight muscle Strain in the right thigh.
July 14_ 1982
Dr. Beckett contacted sub_. A.and asked to perform an impedance
phlebography test to screen for venous occlusion. Although Subj. A
had reported to work in the morning, she left early because of a
headache and had to postpone the impedance procedure.
July 15, 1982
Dr. Beckett examined Subi. A
edema, with no pain or redness.
test were normal.
legs which now had only bilateral trace
The results from an impedance phlebography
July, 26, 1982
A meeting was held of a special medical advisory committee composed
of Dr. Warren Sumner, Dr. Peter Terry, Dr. Harold Menkes, Dr. Bill Beckett and Sol
Permutt. The following conclusions and recommendations were made --
l) It is still unclear what triggered the swelling following bedrest in
Subj. A Dr. Summer and Dr. Terry thought that the course of the swelling
did not suggest clinical deep vein thrombosis, but the possibility of
a mild episode of blood clotting could not be ruled out. Another
possibility discussed was that muscle tissue damage produced by the severe
exercise after prolonged muscle disuse-" may have caused fluid accumulation
in the lower legs.
2) Because of the unexplained reaction to the bedrest procedure it was
recommended that Subj: A should not repeat the bedrest. However, because
of the importance of further information about possible sideeffects in
other subjects who may also have a similar predisposition to leg swelling
after bedrest, it was recommended that Subj. A be allowed to continue with
all other aspects of the study - exercise and blood volume tests at various
stages of the menstrual cycle. She should not be penalized monetarily because
of not completing the bedrest protocol.
3) Each subject will be contacted and informed of the reactions reported by
Subj. A and advised of the possible risk of a similar reaction. The consent
form will be altered to include special mention of an increased risk of
blood clotting or leg swelling following bedrest. Each subject will be asked
to si,gn the new consent form.
4) Careful monitoring of leg size during and after bedrest was advised durinq
further testing. Leg circumference will be measured on alternate days
during bedrest, and during the first five days of recovery following bedrest.
Venous occlusion plethysmography on a lower leg will be performed on each
subject at rest prior to the submaximal exercise tests both before and after
bedrest. This test may determine whether there is significant loss of venous
tone specifically in the lower legs.
(continued)
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5) If in the future a subject complains of leg swelling following bedrest,
a lOcc venous blood sample will be obtained to determine plasma creatine
phosphokinase levels. Thus we can test for the presence of possible
muscle damage which may account for leg swelling. Impedance phleboqraphy
will also be performed to test for venous occlusion.
6) The initial medical history of all future studies will include specific
questions addressing the occurance of blood clotting disorders in the
potential subject or her immediate family.
7) Anticoagulant therapy in future studies was discussed and discouraged.
This option was also considered prior to the start of this study and
rejected because there is no information present about the efficiacy of
administration of heparin to normal subjects during prolonged bedrest,
and because of the increased discomfort and added risk of frequent
injections (twice a day). A NASA consultant (Dr. Peter Bungo) who has
participated in bedrest studies agreed that anticoagulant therapy is
inadvisable during bedrest in healthy individuals. Elastic stockings
and leg exercise during bedrest were ruled out because these procedures
may alter the blood volume responses being studied in the protocol.
Leg massage was recommended if subjects complain of leq crampinq or tingling
during bedrest.
8) The consent form should also point out the additive risk of blood clotting
in subjects who use the pill and perform bedrest. Subjects who take oral
contraceptives have been shown (Am. J. Epidemiol. 90, 365) to have a
4.4 fold greater risk of pulmonary embolism than non-pill users. This
additional risk must be added to the risk of blood clottinq induced in the
bedrest protocol. (No data is available to evalute the risk of blood
clotting in normal healthy individuals confined to bed). Presumably, the
risk lies somewhere between the statistics of risk in normal ambulatory
women of child bearing age who suffer from blood clots in the legs, about
.22 percent/yr {jAMA 219:583); and women who suffer thrombosis in un-
Complicated but major surgery, 2% for deep vein thrombosis.
9) In summary, this particular subject was considered to be at increased
risk to repeat the bedrest portion of this study and will be asked not to
repeat bedrest. All other subjects will be advised of the possibility of
lower extremity swelling following bedrest. Although critical data has
already been lost pending the decision of the medical advisory committee,
it is recommended that the study continue on schedule as determined by
the menstrual cycle of each subject and the scheduling difficulties of the
bedrest procedure.
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ThE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE
and
THE JOHNS HOPKINS HOSPITAL
BALTIMORE, MARYLAND 21_
Joint Committee on Clinical Investigation
Please address reply to:
Administration 127
School of Medicine
720 Rutland Avenue September 14, 1982
TEl (301) 95_3008
Arthur Bushel, D.D.S.
Chairman, Committee on Human Volunteers
4041 Hygiene
School of Hyglene
Re: RPN Entitled: "Bedfast In Healthy Women: Effects of Menstrual
Functions and Oral Contraceptives"
Deer Art:
Thank you for the report of possible ¢ompllcatlons In the conduct of
the above-referenced research proJect.
Although phlebitis would be the most worrisome ¢ompllcatlon, the
descriptions of the patlents dlfflcultles are not slgnlficantly detalled to
permit any value Judgement on that point. Certainly the studies with
Impedance plethysmography were performed at a stage when the process was
obviously resolved or resolving. My only suggestion for the future would be
that specific studies be Instltuted promptly should thls complication reoccur.
I suggest that the prlnclpal Investigator contact Dr. William Bell, Division
of Hematology, to determine whether any of the studies of fibrin split
products might not provide a more sensitive Indication of thrombosis than
Impedance plethysmography. As you know Dr. Bell's main research Interest over
the years has been Intravascular coagulopathy.
I would like to point out that the printing of the subjects name on
the Incldent report, which recelves wide circulation, Is a violation of
confidentiality. The petlent's name is not In any way Important In
determlnlng the nature of the complication. Therefore, the name should be
deleted from all communlcatlons regarding the reseach proJect, Its conduct and
any adverse effects.
TRH =cap _ j_
Chalrman - J.C.C.I.
c/o 127 S/N Admln. Bldg. n_
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Appendix 2: Pulmonary Function Results
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EFFECT OF PROLONGED BEDREST ON LUNG VOLUME
IN NORMAL INDIVIDUALS
W.S. Beckett, N.B. Vroman, D. Nigro, S. Thompson-Gorman,
J.E. Wilkerson and S.M. Fortney
Division of Environmental Physiology
School of Hygiene and Public Health
The Johns Hopkins Medical Institutions
Baltimore, Maryland 21205
Running Head: Lung function and bedrest
Address corres'>ondence to:
William S. Beckett, M.D.
Division of Environmental Physiology
The Johns Hopkins University
School of Hygiene and Public Health
615 North Wolfe Street
Baltimore, Maryland 21205
(301) 955-3515
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ABSTRACT
Pulmonary function vas assessed in supine subjects before, during and after
three separate bedrest studies of 11 and 12 days duration. Forced vital capa-
city (FVC) increased during bedrest in each subject. Total lung capacity by
helium dilution was measured in one bedrest study and increased in each subject.
while residual volume and resting volume of the lung did not change. No change
in FVC was found in an ambulatory control group using identical measurement
techniques. Ha_ntalning baseline plasma volume during one bedrest by the use of
exogenous estrogen did not prevent an increase in FVC. and decreasing plasma
volume with diuretics in ambulatory subjects to the same degree as seen in the
bedrests Lid not cause an increase in FVC. We conclude that prolonged bedrest
results in a small, significant increase in maximum lung volume, and that this
change is not dependent on alterations in plasma volume.
INDEX TERMS: Pulmonary function, lung volume, bedrest
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mechanical function of the normal lung may be altered by changes in the
gravitational environment or by altering the body's position within the gravita-
tional field (3,4,12,14.15). Within minutes of going from the upright to the
supine position, lung volumes in normal subjects decrease, the largest change
being in the residual volume of the lungs at the end of a maximal expiration
(17). These postural changes in residual volume (RV) and to a smaller degree in
the forced vital capacity (FVC) can be prevented by maneuvers designed to ob-
struct the transfer of blood from the legs to the upper body -- such as placing
tourniquets around the thighs (16). Such i_nediate changes in lung volume are
caused in part by flow of blood from the lower body into the chest; they are
considered static changes in lung mechanics, and have been assumed to persis_
while the supine position is maintained.
Prolonged bedrest places the lungs at 90 ° to the usual upright relation to
the gravitational field for an extended period of time. It has been used-as a
model of a zero gravity environment to induce decrements in intravascular vol-
0
umes. orthostatic tolerance, and cardiovascular and skeletal muscular condi-
tioning such as those seen during zero-gravity spaceflight. Previous studies of
lung mechanics before and after prolonged bedrest have not detected significant
changes other than those seen i_mediately on lying down (9.19). The purpose of
the present studies was to re-examine whether lung function changes occur in
normal subjects during eleven to twelve-day bedrests.
Hethods and
Eighteen healthy adults (Table 1) gave informed consent to participate in
these studies; twelve in the bedrest studies, and seven in the ambulatory con-
trol and diuresis studies. 0nly one subject in the bedrest studies (number 8)
also participated in the ambulatory control and diuresis studies (number 14).
Informed consent was obtained from each subject, and the protocols were approved
by the Hu_,an Volunteers c_ittee of the Johns Hopkins Hedical Institutions.
Before and after each bedrest study and before the ambulatory control
studies absolute plasma volume and absolute red cell volume were determined by
radionuclide dilution techniques (technetium labeled human serum albumin for
plasma volume and technetium labeled autologous red blood cells for red cell
volume). Subsequent changes in blood volume were calculated from alterations in
hemoglobin and hematocrit (10). In each study, subjects received one t_aining
session £or familiarization with the techniques of pulmonary function measure-
ment begore the first control session.
I. Bedrest Studies
Subjects remained supine in bed for eleven days in the first two bedrests
(BR1 and BR2) and for 12 days in the third bedrest (BE3). Subjects did not
exercise while in bed, and were limited to no more than IS minutes in the seated
0
position per 24 hour period.
The first two bedrests, using the same subjects (No. 1-6, table 1), were
conducted consecutively, separated by a four week recovery period. In BR3 a
comparable group of six subjects (No. 7-12, table 1) completed the identical
protocol except that each received daily oral estrogen supplementation
(Premarin, 1.25 mg) to maintain plasma volume under conditions where a spontan o
eous diuresis o£ plasma volume would otherwise occur during the first few days
of bedrest, resulting in a persistent lowering of plasma volume for the duration
of bedrest.
In each bedrest study, two sets of control pulmonary function measurements
2
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were made on two days prior to the start of bedrest. Tests were repeated daily
during bedrest (at approximately the same time of day), one day after the end of
bedrese, and after two weeks ambulatory recovery. All pulmonary function mea-
surements, including pre-bedrest control and post-bedrese recovery measuremenes,
were made with subjects in the supine position.
Daily 4 cc blood samples for calculation of plasma volume were taken with
free flowing technique at the same time each morning within one hour of pulmon-
ary function tests. Each sample was analyzed for whole blood hemoglobin con-
centration (cyanmethemog l ob in technique in triplicate), hematocrit (microhe-
maCocrit Cechnqiue in triplicate), total plasma protein concentration (refrac-
tive index in quadruplicate), and plasma osmolality (£reezins point depression
in duplicate).
Forced expiratory volume in the first second o£ expiration (FEVl) and FVC
were tested using a Stead-Wells survey spirometer and technique meeting the ATS
Snowbird Criteria (1) each day during all bedrests. In BR1 and BR2, the two
largest values of three acceptable spirograms were averaged to determine that
subjectts FEV 1 and FVC for a given day. In BR3, the single largest values from
three acceptable spirograms were used as the subjectts FEV 1 and FVC £or a given
day. All spirograms including pre- and post-bedrest studies were performed with
subjects in the supine position and were interpreted by the same reader. In BR1
and BR2, single breath di£gusing capacity o£ the lungs £or carbon monoxide
CDLco ) was measured by the method of Yorster, et al. (I1), and slope of phase
IIZ of the single breath nitrogen washout test was measured by the method of
Craig ee al. (7), with subjects exhaling at a rate of approximately 500 ml • sec
-1 into a direct-reading nitrogen analyzer. Records were traced on an X-Y
3
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recorder (Gould). and determinations were the average of two consecutive expira-
tory maneuvers. Maximal inspiratory pressure at FRC and expiratory pressures at
TLC were measured by the method of Black and Hyatt (2). In BR3 measurements of
• the resting lung volume or functional residual capacity (FRC) by helium dilu-
tion. and total lung capacity (TLC) and residual volume (RV) by addition and
subtraction o£ spirometrically measured volumes from FRC (6) were made in addi-
tion to measurements o£ spirometry and dif£using capacity.
II. Ambulatory Control Study
Seven healthy adults served as ambulatory controls for the bedrest study.
(Anthropometric data for this group, subjects No. 13-19, are included in Table
1). All pulmonary gunction measurements o£ spirometry and di££using capacity
were made in the supine position using the same technicians, technique and
equipment as is described under Bedrest Studies, above. Each subject per£ormed
six series o£ pulmonary gunction tests over a period og nine to thirteen days.
Measurements were made at the same time each day, and subjects lay in the supine
position for £orty minutes to one hour be£ore measurements were made.
III. Diuretic Study
Plasma volume was altered using diuretics followed by intravenous infusion
of isoncotic fluid in ambulatory subjects to determine the effect o£ plasma
volume change on pulmonary gunction.
Following the ambulatory control measurements, subjects No. 13-19 underwent
rapid reduction of plasma volume and total body water over several days by
. taking a diuretic (hydrochlorothiazide 25 mg plus triamterene 50 mg, every 12
hours). Subjects lay in the supine position for forty minutes to one hour prior
to measurements, and measurements were made at the same time each day. Samples
4
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of venous blood (5 ml.) were drawn each day with care to maintaining horizontal
position of the arm. Analyses of the blood samples were performed as described
above under Bedrest Studies. Diuretic treatment was continued until plasma
volume loss of 15Z or more had occurred. (1-3 days on diuretic). On the last
day o£ diuresis, blood and pulmonary function tests were performed before and
i--_ediately after restoration of plasma volume by intravenous infusion of a
solution o£ 5 per cent human serum albumin suspended in isotonic saline and
warmed to 37°C. Diuretic administration was then stopped and measurements
repeated the following day.
For the bedresC, ambulatory control and diuretic studies, each dependent
variable was tested by a one factor factorial analysis of variance with repeated
measures across time Co determine ig bedrest or diuresis caused significant
changes (alpha = .05) from control measure=ents. If the o=nibus F indicated
significance then post-hot testing was performed on the ordered means by the
0
Neuman-Kuels technique. Student's t-test was used to compare inspiratory
pressures and expiratory pressures before, at the end of, and after bedrest.
For the diuretic study the six ambulatory control determinations for each
lung function test and for plasma volume were averaged for use as the control
value for each subject. I_mediate pre-infusion and one day recovery values were
tested together with the average control value for changes across time and daily
measurements of each lung function test were compared with that day's plasma
volume by least squares regression techniques. Pearson product-moment correla-
tion coefficients were calculated.
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RESULTS
I. Bedrest Studies
Figure 1 shows the rise in FVC and FEV 1 during both BR1 and BR2. During
• BR1, FVC was significantly greater than control on day three of bedrest (P,.05)
and remained significantly elevated throughout bedrest with a maximum rise of
270 ml above control. Significant elevation persisted through the one day and
two week recovery period. An increase in FVC was seen in each subject during
BR1 and BR2. In the second bedrest FVC was significantly increased above con-
trol on day 4 (P<.05) with a maximum elevation 240 ml above control and remained
significantly elevated above control throughout bedfast and the first recovery
day. These increases in volume during 5edrest represent 6Z (BR1) and 3Z (BR2)
of the mean control FVC.
The time course of increase in FEV 1 (Fig. I) closely parallels the increase
in FVC seen in both BR1 and BR2 indicating that the rise in FEV 1 is a volume
dependent flow increase. The ratio of FEVI/FVC did not change significantly
D
during bedrest.
In BR3, FVC again increased significantly over control values by the third
day of bedrest, and remained elevated throughout the remaining days of bedrest,
(Figure 2). The maximum mean increase in FVC, seen on day 9 of bedrest, was
206 ml or 5.4Z over control. To determine whether the increase in FVC seen in
the previous bedrests was due to increased TLC, decreased RV or a combination,
lung volumes were measured in this bedrest using helium dilution. Increases in
- FVC and in TLC were seen in each subject during BP.3. TLC was significantly
greater than control at the fourth day of BR3 and remained elevated above
control through the 12th day. The maximal increase in TLC was 180 ml over
6
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control. One day and two-week recovery values were not significantly greater
than controls. The maximal inspiratory and expiratory pressures, an index of
respiratory muscle isometric strength measured at FRC for inspiration and TLC
for expiration, did not change significantly in BR1 and BR2 comparing pre-
bedrest controls to the last day o£ bedrest and day 1 recovery.
Changes in DLCO did not follow a consistent pattern_ _(hen all bedrest
values for diffusing capacity were compared with all control values by analysis
of variance, they were found to be significantly lower. The mean decrease in
DLCO during BR1 was -1.7 cc_nin-l_nHg -1 (P<.05) and during BR2 -1.55 cc'min-
lunnHg-1 (P<.002). However, day-by-day analysis of DLCO changes during bedrest
and recovery showed DLCO was significantly (P<.05) lower than controls only on
day 1 recovery in BR1, and on bedrest days 5 and 6 during BR2.
Figure 3 shows mean changes in plasma volume, total protein concentration
and osmolality during BR1 and BR2, demonstrating the plasma volume diuresis
which regularly accompanies prolonged bedrests. During the first bedrest the
mean plasma volume for the six subjects decreased a maximum o£ -20X (-487 ml) in
the first six days, and remained decreased from control values during the fol-
lowing days of bedrest. Similarly in the second bedrest, plasma volume de-
creased by -14Z (-317 ml) during the first six days and remained in this range
during the remaining days. Plasma volume was signi£icantly lower than control
(P<.05) on days 2-9 during BR1 and days 2-10 during BR2. At 24 hours after the
end of BR1 and BR2, plasma volume had returned to control levels. Total red
cell mass decreased by a mean o£ -5.9Z or -121 ml (not significant) during the
eleven days of BR1, and by -2.1Z or -50 ml (not significant) during BR2. Com-
parison o£ the increase in FVC in Figure 1 with the concurrent fall in plasma
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volume in Figure 2 suggested an association between changes in total plasma
volume and FVC.
These observations motivated the measurements of FVC in studies using
• slightly diZferent conditions. The first was a repeat of the bedresC studies
(BR3) under conditions identical to BRI and BR2 except that diuresis was inhib-
• iced by the use of exogenous estrogen. The second used controlled diuresis of
plasma volume in ambulatory subjects, (diuretic study below). No significant
overall change in plasma volume occurred in the BL3 subjects taking estrogen,
while FVC and TLC increased significantly as noted above.
II. Diuretic Study
Oral diuretics used in ambulatory subjects produced decrements in plasma
volume in each of the seven subjects comparable Co those measured during bed-
rest. The mean decrease in plasma volume in the seven subjects was -20.4Z,
significantly lower than control (Figure 4). During this induced diuresis there
was no significant change in FVC compared with control measurements (Figure 4).
The maximal decrease in plasma osmolality was -1Z (-3 m0sm • 1 "1) and maximal
increase in plasma protein concentration was 19Z (+1.3 EmZ). Infusion of the
saline and albumin solution after diuresis was completed increased plasma volume
by a mean of 832ml Co 3Z above control plasma volume. After reinfusion, mean
plasma osmolality was at 1Z below control and plasma protein concentration aC
10% above control. No significant relationship between plasma volume changes
and FVC, FEV1, or DLCO was detected by linear regression analysis of all con-
. trol, diuresis, re-infusion, and one day post-infusion values. FVC and plasma
volume during diuresis are plotted against time in Figure 3. The lack of change
" in FVC during diuresis is contrasted with the increase in FVC found during all
8
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bedrests (Figures 1 and 2).
DISCUSSION
The mechanical relationships of the static lung volumes requires that the
significant increase in FVC found in the three bedrest studies must result
either from increased TLC, decreased RV, or a combination of the two. The
finding of increased TLC in BR3 with no significant change in FRC indicates that
all or most of the increased FVC is due to increased TLC.
Explanations for the increase in FVC and TLC can be divided into three
groups: increased neuromuscular force to inflate the lungs, increased chest or
lung compliance, or a change in the mechanical relationship of inspiratory
muscles to chest wall allowing more negative pleural pressures and greater
inflation of the lungs per unit of tension produced by the inspiratory muscles.
Increased neuromuscular force may occur either through increased maximum
neural output to the inspiratory muscles or by augmentation of the maximum
musclar force of contraction to maximum neural stimulation. Some studies of
I
spirometry in normal subjects have shown small increments in FVC on serial
testing which are attributed to a training effect, with better performance
through familiarity with the procedure or conditioning of the inspiratorymus-
cles. Three findings of the present studies suggest that neither a learned
response in the performance of spirometry nor a muscle conditioning effect can
account for all of the observed increase in FVC. First, a significant increase
in FVC was found in BR2 in the same subjects already familiarized with the
procedure from each completing over 50 apirograms during the BR1 measurements
several weeks before. Second, an increase in FVC due to conditioning of inspir-
atory muscles would be expected to be accompanied by increased isometric muscu-
9
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lar force, which would be reflected in increased maximal inspiratory pressure
when breathing against an occluded mouthpiece from FRC. No change in maximal
inspirator 7 pressure was seen during either BR1 or BR2 in these subjects.
, Third. when the same techniques of measuring supine FVC were followed in a
similar group of ambulatory control subjects, no increase in FVC was found.
" indicating that the measured increase in lung volume in the present studies was
related specifically to bedrest and not to a training process.
Increased compliance of the chest wall or the lungs in the presence of
unchanged neuromuscular force would also result in increased FVC and TLC; Al-
teration in airway tone. interstitial water, mechanical properties of the inter-
stitium, or elastic properties of the chest wall as a result o£ bedrest alone
appears unlikely. Hpwever, changes in lung volumes due to alterations of cen-
tral vascular engorgement with blood, leading to alteration in pulmonary com-
pliance or a displacement of air spaces, may occur. Buono (5) has demonstrated
that increasing central vascular engorgement either by head-out water immersion
or by C-suit inflation to 80 torr about the calves and thighs of normal subjects
results in decreases in FVC o£ -S to -6Z below control. Conversely, Potanin et
al. (18) have demonstrated increased vital capacity by applying -30 Torr lower
body negative pressure. Because a spontaneous diuresis of plasma volume during
bedrest was associated with increased FVC. it was suggested that a decrease in
central vascular volume associated with diuresis might account for the increased
lung volumes. However. induction of a comparable plasma volume loss by diure-
tics in ambulatory subjects did not aiter lung volumes, indicating that a 20Z
decrease in plasma volume is not alone suf£icient to produce the changes in lung
- volume seen in bedrest.
10
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Demonstration'of these changes repeatedly in the same subjects of BRI and
BR2, with a return toward control levels in the interval between bedrests, sug-
gests a gradual process independent o£ muscular force or strength. Without
change in either neuromuscular output or chest compliance, a shift in the ana-
tomic relationship of the inspiratory muscles to the chest wall that improves
their mechanical advantage in generating lower pleural pressure without in-
creasing their maximum tension may have this result. Such anatomical adjust-
ments, occurring gradually over several days after the acute decrease in lung
volume on going £romthe upright to supine position, would represent an opposite
and approximately equal compensatory change to the initial postural change in
lung volume. The present results would support such a hypothesis, but do not
indicate the mechanism for such a gradual compensation.
These changes were not seen _n one previous study of pulmonax7 function in
four subjects during bedrest (8). although small non-significant increases in
FVC and TLC were found in another five healthy subjects after 20 days bedrest
(19). Our study of a larger number of subjects or the use of more consistent
measurement with subjects always supine may explain why these changes were seen
in the present but not the previous studies.
_n conclusion, a small increase in maximum lung volume (TLC) demonstrated
during prolonged bedrest in normal subjects appears to be a true alteration in
lung mechanics and not the result of decreased plasma volume alone.
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Figure 1:
Figure 2:
Figure 3:
Figure 4:
Mean forced vital capacity of the lungs (FVC) and mean forced
expiratory volume in one second (FEV 1) for six subjects as a
function of time measured daily during pre-bedrest control (C),
bedrest days 1-11, one day post-bedrest recovery (R1), and two
weeks post-bedrest recovery (R2). Circles indicate days on which
values were significantly (P<.05) greater than control during the
first bedrest (BR1), and squares days on which values were greater
than controls during the second bedrest (BR2) in the same six
subjects.
Mean total lung capacity (TLC) forced vital capacity (FVC) and
residual volume (RV) og the lungs of the six subjects in the third
bedrest study (BR3). Circles indicate days on which volmne w_s
significantly greater than control (P<.05). There was no signifi-
cant change in RV.
Mean values for absolute plasma volume (ml), plasma oemolality,
and plasma protein concentretion (Em%) for the same six subjects
as a function of time during bedrest 1 and bedrest 2. Circles
indicate days on which values were significantly (P<.05) different
from controls during bedrest 1, and squares during bedrest 2.
Forced vital capacity (FVC, mean ± S.E.M.) and absolute plasma
volume (PV, mean % S.E.M.) for seven subjects during pre-diuresis
control measurements, after diuresis (prior to re-infusion of
17
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plasma volume), izmed_ately after re-infusion of plasma volume,
and one day after re-infusion. PV, but not FVC, vas signifi-
cantly d£_ferent from control after diuresis.
18
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TABLE 1: Physical characteristics of subjects in bedrest 1 and 2 (No. 1-6). 3
(No. 7-12) and ambulatory diuresis (No. 13-19).
(Bedrest 1 and 2)
1 F 27 168 57
2 F 27 155 75
3 F 24 166 59
4 F 26 161 50
5 F 36 172 60
6 F 23 175 66
Mean ± S.D. BR1
(n = 6)
(Bedrest 3)
7
8
9
10
11
12
27 ± 5 166 ± 7
F 23 166 57
F 33 173 68
F 24 158 47
F 28 161 57
F 26 169 74
F 24 178 68
61+8
Mean + S.D.
(n = 6)
(Ambulatory Diuresis)
13
14
15
16
17
18
19
M
F
M
M
M
M
F
23 +4
32
33
30
38
25
31
40
168 + 7
184
173
183
187
193
163
172
62+9 .
73
68
71
87
79
87
56
Mean -+ S.D.
(n = 7)
33-+5 179 -+ 10 74 ± 11
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PL_SMA, VOLL._OE RESPONSES DURI_ 8EDRZST IN _EALT_ ;_.M_
S. Fortney, H. Drew, end _. LeFrancs
The Johns Ropktns Medical InStitutions
Decreases in plam no1--- {PV) occur during
spaceflight which could potentially compromise an
_cronaucs' blood pressure maintenance during re-
entry. Such losses of PV are ui,_,l_y attributed
Co • cephalic shift of body pacer during Icy
gravt_/ exposure, and subsequent stimulation of
Icy-pressure bar•receptors which initiate 8 di-
uretic response (3). The pu_-poso of ch£s study
was to critically examine PV responses in healthy
women during simulated weightlessness (bedrest).
Ve tested the hypothesis that the loss of PV
during bedrest (BR) is influenced by menstrual
function, specifically by the water-retaining
properties of plss'_e estrogens.
Six women 23 to 37 years of age who did not
use oral cont_aceptives gave cheer Informed con-
gents and underwent cvo il-day periods of on-
end on the hematocrits obtained on the f£rst day
of BR.
The technettu_ test results ere shown in the
following table. Red cell =ass did not signific-
antly cha_ge du=ing either B_, e_chough there was
s progressive tendency towards docseas£ng levels
during the eight-week program. Plasma voices,
which significantly decreased an average
17._ + 2.1% during BR1 and 9.3 + 1.7% during BRi,
were not significantly different from pre-gR
levels 24-48 hours after BR. Such findings agree
with the rapid recover7 of PV reported in earlier
n studies (5).
Table 1
Plasma and Re__d Cell Vo!L_es Before and Within
_8 hours after Bedresc (mesn:S.L, n=6)
forced BR, where each BR period was separated by _t¢_.e.1.)
four weeks of --bu_acor'y. recovery. A seventh
woman participated in the first bedrest (BRI),
but was prevented from parclcipaclng _n the sec-
ond bedrest (3R2) because she unexniainably de-
veloped pronounced lo_.'er lee. ede_ a couple days
after B_. The possio_itty of such c_--ticacions
foll_ing spaceflight was predic:ed recently by
Eargens ec el. (i)
Bedrest procedures were timed co occur at
opposin 8 stages of the :menstrual cycle for each
vo_n. Menst=-.tal cycles were divided into fot_
separate stages v'hers -
Stage 1 - cycle day 2 (day l=firsc day of
bleeding) until 6 days prior co ov_lecion
(ovulation was est£mnced from -_oru£ng cenpers-
Cures end by counting beck 14 nays fro= day 1).
This is • stage of low estrogens and progester-
ones.
Stage 2 - five days prier to ovulation until
one day after ovulation. _urin_ thls stage there
is 8 large estrogen peak while plasma progestsr-
ones remain low.
Stage 3 = _o to 9 days after ovulation.
FJtrogen and prozescerone concentrations both
gradually increase.
Stage _ = con days after ovulation _ncil
cycle day 1. Estrogens and progescerones g_ed-
uslly decreese.
Each morning of 3R, a 3=1 venous blood
sample was drw,-n :o deteru£ne relative changes in
PV during BR (from he=ecocrlt and hemoglobin con-
centrations), total pro:sin concentration (re-
fractomeCry), end plasma csmo_ality (_reezing
point depression). Periodic 1Oct blood samples
were drawn.to _onicor blood estrogen and prog-
esterone (rsdioi---_-unosssey), and morning tem-
peratures and persona_ diaries yore ob=ained to
monitor mensc_'_'1 function.
Prior to each BR, and v_thin 48 hours after
B_, absolute Red Cell ','olu=e (_CV) and PV were
detez--'-ined usln_ rsdioac:i':: d_luc_on _echnlques
wlth Technetiu: (Tc)-labeile_ red blood cells
end Tc-label}ed Human Seru._ Alb,._..inas :_,e labels
respeccivel.v. Absolu'-e ?',' _u:tn; e_¢h Ca:: of "=R
was calcula:ed b_sed ".'_ :he T_-_e:e.-_.._:ed ._'; and
her.scurries •0rained ourir._ the ?.'e-_ TC :es:,
Pre-_R1 Posc-BR1 ?re-BR2 Post-BR2
1419:57 1371:52 1366:37 1301:_2
PVp,;;;&_) 2305_143 2247_107 2257_121 232&:72
During BR, blood hemacccrit increased sig-
niiicantly, plasma osmolal:t_" remained u:,altered,
and total protein concentre:ton increased sig-
nificantly during BR1 buc not during BR2 (see
Fig. 1) "_'
tO*_}
_Y_t. _KR|m (O**eI4)
" _'l'" -['i-_Trr-r'_ ':
to
Ime_me qj4}
! II :_ 4 • • ? • e 10_5 r_
Plasma volume decreased re?idly during the
first _-5 days of BR, then remained fairly stable
•during the lest 7 days of B_ (see -ig.2). Also
during BR, there was a net loss of Total Circul-
atory Proteins (TCP-PV tL'_es the :otai pro:sin
concentration), and Tctal Circuiatory Os=o!s
(TOO-plasma water times p_esma osmolality).
o- :_,
.,_ _.._ _.,_._.z .._.._
,, .,_ "'_'l_'*'z'6.'_''_ I
.:[
_lty IP I_O/'ebt_
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The 1on (pez_auc decrease) of ?V during the
f£ra¢ five days of BR v_8 analyzed In tens oi
_r._uaA cycle stage (sea FAg.3). The loss of -_/
duZ'lJ_g gg days 1-5 yes progressive and shoved a
s_ar pattern for each VOmln _t_o began S& vhila
£u mm_ct'ual cycle stage" i, 3, o¢ 4. H:vever, in
t_:ee *,mmnvho began BK _'hlle An cycle stage
2, there vlus a :tansies: aCteu,_,cicm in :ha loss
o£ IV. ZlluJcracsd An FIKu=e 3 are r_e relative
--losues'ot PY In the sLz umm= d_- S BR2. The
dotted Zines illuecraca ?V responses for :he 3
mn in scare 2, chile the solid llnes re_:esenc
respo_aas for _he ocher three vo_tn.
D_-lng SPA none ot the rouen vere ;n _cage 2,
earl a 1_ had 1Yf responses sllAJ.ar to che _¢l_.d
_,, Ft4u:e 3.
Pm'_:em
0
• _'#o
,%
OAY OF BF.D_EST
Nmc_,l_ J_tta fro= Sg days 5-12 vere analyzed
in terms of menstrual stage. The e_fecc o_ BR on
FV at this par_.od yes =in_l (see Fi&.2). Dur-
ing _J_e last 7 days of B&, ovulation occurred "
durf_ sLx B_ periods. Figure 4 illustrates the
FV responses in these uomen, _ne_e days 0-6 re--
present the seven days =rlor co ovuiac_on vi=h
day 0 calculated as ovulation. Fluctuations in
PV vere calculated by subtracting :he :san PV for
a given subject durir.g earn 7-day period, _rom
her cLIAly PV. The d-ca vere centered in :hAs
manner in order co adjust _or di_erlnx absolute
levels of PV aeons sub._eccs, thus enabling visual
comparison of changes In PV durlng the days pre-
reading ov_lacion_ For each sub,etc, a transient
increase in PV occurred £_ this interval before
ovulation. These changes _.n PV _ere analyzed
through a _ao-_ey snal_'sis of variance, vhere ob-
servacicms rare ¢lsssi_led by su=ject arm byday
1_rior t= ovulaclon. _nsp_,:clon of _ha dace aug-
seated testing for a quadraclc response (i.e., a
ce_orar_ fluc=_ation f_o_ baseline) in _his ia-
carrel before ovulaclon. ,'hl calculated F-value
of 4.36, based on 1 and 30 degrees of freedou,
si_uAflcanc _Ath P < 0.05.
o
m,
e S • ; I ' :
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Ve began this study v£ch the hypothesis chat
elevated blood estrogens, _usc prior to, and after
ovulation vou4d atten_utte or reverse the decreases
£n PV seen during 3_. _e postulated chac as long
as blood estrogen concent_a_Lons mere elevated,
the£r vacet-recalnAc_ proper¢£es vould oppose the
d_Lureclc e_feccs of BR. We fa£1ed hovever to
accotmc for _he crans_anc nature of cha vacer-
reca£_tn$ properties of estrogens. Several au-
thors (3, 4 ) have studied r.he effects of esc=o-
ge_ on body flu£d responses. E_CrOgen ad_Ln-
_stratAon consistently resu.lts in a reduction In
_£uat'y excretion of sod£,,- and chloride a_d re-
ducts urinary volm=e. Preede and Aickan (_) scud-
Lad urinary excretion during e_ght days of daily
L_Je_t£ous of estradiol in vO=en, b_lle there yes
an increased vacsr retention during chs first five
da_s of treat=eat, on the sixth day the _Ldney
"escaped" fro_ the e_¢ccs of estradtal, and a
dl_zns£a occurred. Such an escape pheno=ena =ay
help to explain vhy only traosleuc changes in PV
occurred in ch£s study durln$ periods o_ expected
prolonged elevation _o blood es:rogens, Thus cha
vater-reca£nln_ effects of estrogens vere only
e_dant during _ens_rual cycle stake 2. _hers an
inAtlal large, transient rise in estrogens =tour
_,, most _o=en. During s_ages 3 and _, the small-
er, and slower rise fn estrogens was much less
e_fect£va ia prevenclo4 the decrease _n PV assoc-
l_cedvich S_.
_n conclusion, :he overall PV responses seen
in chase co=an during _R vere of a similar =ag-
nAcude as that repor=_d for =nn during _o-_eek
bedfast procedures (2). Only small ::ansienc
flu:cuaCions in PV occurred _ust prior co ovula-
tion vh£ch :ay have been due co the influence of
_ncreaslng blood estrogen clears. Therefore, the
procec:ive (vacer-reca_n!ng) effects of estrogens
on PV losses duri=; velgncless conditions are
probably only small a_d =tam, lent.
*The authors gracefully acknovledge the stacis-
ci:al asslscance o_ Lavrence _oulcon.
Su=porced by ._ABA.
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EFFECTS OF ALTERATION OF PLAS_tA VOLUME ON Pt_MONARY FUNCTION.
W. Beckett*_ N. Vroman* S Fortn_v, and J Wilkeraon,, P • • •
The Johns Hopkins Hedical Insti=u=ions, Baltimore, Hd. 21205
In a previous study of prolonged bedrest we demons=rated
a 15Z decrease in plasma volume due to spontaneous diuresis,
¢oncomltant wich a sta_Istically significant increase in
forced vital capacity (FVC) of about 200 ml and decrease in
diffusing capacity of the lun 8 (DLCO) of 2 cc/min/mmHg during
the firs_ 3 to 4 days of bedfast. Both changes resolved
rapidly after bedrest. These findings suggested that de-
creased pulmonary vascular volume migh_ account for these
changes-by increasing lung compliance and decreasing capil-
lary perfusion. In the present s_udy we cested _he hypoth-
esis Ehat changes in plasma volume can cause hl=era_ions in
lung function including FVC and DLCO. Control to_al red cell"
and plasma volumes were measured by radionuclide dilution in
seven heal_hy adults. Control measuremenEs of hema_ocri=,
hemoglobin, protein concen_ra=ion and osmolality, FVC and
DLCO were taken after one hour supine res_ on six normovol-
emic control days, following plasma reduc¢ion wi_h diure=ic,
•and after plasma volume restoration by infusion of an iso-
"Eonic saline and albumin solution. Plasma volumes calculated
from hemoglobin and hematocri= decreased by a mean of 20%
during _he dluresis, while protein concentration and osmol-
allty were no_ changed by dluresis or infusion. FVC and DLCC
did no_ change significantly from controls fol!_ing either
diuresis or re-infusion of plasma volume. Thus changes in FVC
and DLCO wl;h bedrest are no_ due to decreased plasma volume.
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DEVELOPM_ OF TOLEI_NCE TO REPEATED BEDKKb£5. S.M. _ortney, W.S.
Beckett, and N.B. Vrom_n. Johns Hopkins Univ., Baltimore, >_ 21205.
Intro: Deconditioning, as measured by reduction in maximum oxyge_
uptake (VO2MAX), usually occursfollowlng exposure to welghtless
conditions. We examined this deconditionlng response following pro-
grams of si=mlated weightlessness (bedrest) to test for l)an effect
of a previous bedrest exposure on the deconditioning response to a
second bedrest, and 2)for a relationship between initial fitness
level and the degree of deconditioning followin_ bedrest. Methods:
Twelve women, with VO2MAX from 26.3 to 45.g ml/min/k_, performed du-
plicate ll-day programs of horizontal bedrest. Each woman began the
second bedrest (BR2) about 6 weeks after the start of the first bed-
rest (BRI), and between bedrests resumed normal daily activity, vo2
MAX was measured before each BR, and after I day, 2 weeks, and 4
weeks of recovery from BR. VO2MAX was determined as no further in=
crease in VO 2 (42 ml/_in/kg) with increase in exercise intensity.
Results: One day after bedrest VO2_L%X (ml/min/kg) decreased I0.0 r
2.5 per cent followin_ BRI, and 4.0 _ 2.3 per cent following BR2.
The decrease in VO2MAX was significant (P4D.002) following BRI bu_
not following BR2 (P_O.12), despite almost comple:e recovery (to
within -0.9 ± 2.4 per cent) of pre BRI VO2MAX level prior to the
start of BR2. The relationship between Pre-BR fitness (VO2MAX in
ml/min/kg), and the decrease in VO2MAX (per cent change between Pre-
BR and Post-BR VO2MAX) following BR, was not siEniflcant; where the
regression for this relationship was Y= -O._9X + 8.3, K= -_).31. _on-
clusions: The observation tha: there was a smaller reduction in
=
following the second bedrest ,_i.e., less decondltioning) indicates
che development of tolerance.
COMMITTEE USE ONLY:
Abswac_ No. AccepVReject Slide/Poster QuA .r,ry.
A3-7

',
1985 ABSTRACT SUBMISSION FOOM,,.
_ Aerospace Medical Association '. !/
_F pOGR _':" Topic No. (see reverse side): lit ,5 2nd 2
Mode preference (check one): Slide _ Poster __ Either
Name and address for concspondence:
Suzanne Forcney, Ph.D.
School of Hygiene and Publlc Health
of the Johns Hopkins University
615 North Wolfe Street -7032
wBal_imore, Maryland 21205
ork Telephone: 301-955-3515
1. Follow rules---including format--in Call for Papers on
reverse side.
2. Submissions not meeting requirements will be rejected.
3. Prepare absu'act with care and submit ON THIS FORM.
Do not erase; use correction fluid when needed.
4. Type o_.v within blue box.
$. Use electric type',writer with elite type or larger and only
_I.o._i°_ ribbon.
I afFum thaE this is original work which will not
appear elsewhere before the meeting. I hereby grant
perm/ssion for the Aerospace Medical Association to
tape record the verbal presentation (if a slide session).
6, Use the following format:
a) Title in CAPITAL LErTF.RS using significant, de.
scriptive words.
b) Authors (initials then last name) u_rtlned.
¢) Institution where work was done.
d) Indent f'LrStline of text by 3 spaces.
e) Rest of text is a single paragraph, single spaced, with
no photos, and no type smaller than elite. (Printing
redu_ion size willbe 60% oforiginal.)
THIS PAGE AND
5 PHOTOCOPIES OF
THIS PAGE MUST
BE RECEIVED BY
NOVEMBER 2, 1984
DO NOT FOLD!H
MAIL FLAT!!:!!
Send tw
J. Ro_ DIIJe
Program Chairmen
aoraspoce Medical As-
_clation
Washington National
AJrperB
Washington, DC 20001
ATTNs Abstracts
PLASMA VOLUME MAINTENANCE DURING BEDREST ZN I_OMEN RECEIVING
Pt EMA IS. £./G. Rock. S.S. Lco.mm L.
Johns Ropkins Medical ZnsCituCes, Baltimore. Earyland
21205.
_,lJZr_Lq_J,.QR: Decreases in plasma volume have been reported
in both men and women during simulated weight:lessness (bedresc),
and are believed associat:ed witch t:he decrease in exercise and
ore:host:stir tolerance follm,-ing spaceflight. _n a previous st:udy
ve reported an attenuat:ion in plasma volume loss during bedfast
during the _diat:e pre-ovulat:ory phase, which we suggested may be
aC.Cr£but:ed Co t:he vat:st-retraining properties of est:rogen, in t:his
phase of t:he meuse:fuel cycle. In the present st:udy, we lure:her
st:udied t:he effects of female sex ,t:eroide t:o prevent bedresC
hypovolemLa_ METRODS: Nineteen healt:hF women (21 Co 39 7rs)
underwent a 12-day horizontal bedrest:. Plasma and Red Cell Volumes
were determined using t:echnet:iun-labels before and after bedrest Co
verify red cell mass stability during bedrest. Daily plasma
volumes were calculated from hemat:ocrit and hemoglobin ratios.
Twelve women did - *.o. receive eat:rosen supplement, vn£ie seven
addiCiona.l v_n received 1.2_ Praarin daily. _ Plasma
vo_u_e s_uificant:ly decreased by an averse - 20.1 z 3.9Z between
the firsC and last da_+ of bedrest: in Che non-premarin group, and
was not: reduced (+0.3 - 2.8Z) in the premarin users. J_._I_L_:
Premarin, an estrogen-containing preparation, e_fect:ively prevented
the decrease in plasma v_lume associated witch bedresC, and may
serve as a useful nodal Co study the cole of t:he decreasing plasma
volume on post-bedrest responses. Support:ed by NAS9-16703
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MAILINGADDRESSOF FIRSTAUTHOR TOTAL LUItG CAPACITY INCILEASES DURING PIOLOHGED "BEDKES
(Please Print or TyI_ Provide full name rathet Z][_]_]_][TDE_' 0F [_JLBHJL VOLUI{E CRJIJ[;ES. S. _ _ f
,_n in_w..) _ and S. Z£X/JI£_. Johns Hopkins SCress.Physiolog:
Susan Thompson Gorman Laboratory. Baltimore. liD 21205.
Johns Hopkins School of We have previou.sl7 =horn that Jigu.if£cant increases i_
Rygiene and Public Health forced vztal capaczt7 (FVC) of approxzmaCely 6.Z occur vhel
Room 7032, .615 North Wolfe St. using prolonged bedfast as a model for spacefl_ht. Zn th,
present study, seven healthy adult females we.re =tudie,
Baltimore, MD 21205 during 12 days of bedfast to cl.ar£fy the mechanism of th£z
Phoneoff_e (;301) 955-35]:5 increase..FVC, funct;-onal resxdual capacill:y (.FRC), total
:Nome/Ho,c_y (;301)823-3917 . lung capaczCy ('_C), resxdmL1 vol_ (:RV), and szoEle breaC:d£ffusinS capacity for carbon monoxide (Dv.C0) were measure,
on eva ambulatory control days, during e[ch day of bedrest
PRESENTATIONPREFERENCE(Checkone) one day post-bedre=C, and after two reeks recovery. AI_
Ce=t.s were done with the subject _n the supine position
Poster " _ Slide r-1 Minisyml::)ol_um Subjects received exogenous e=Crogen (1.25 rag/day). Plan=;
O Indi,am_ volume (measured £mmediace17 before bedre,t by technetim
Fin,I _ec_n _ing bmsemat_n _ _ label, and calculated daily fro_ henatocri.t and hemoglob_
at me discretion of the !orograming Socmy. values) dzd not decrease significa=Cl7 durzng bedfast as £
had in the previous stud£es without estrogen. A significan
(p < .05) increase in FVC occurred by the third day o
SELECTCATEGORYNUMBERS_TITLES bedfast which persisted throughout the rest of the study
(SeeTol:icCetagoryListsl with a maximal mean increase of 206 ml (5.6¢). TLC ale
£ncreased slgn£ficantly by the fourth day of bedfast an
10-MIN.ORALOR POSTERPREFERENCE remained elevated through day 12, vith a maximal mea
• _-_ _ech_nics of Breachins increase of 180 ml. Post-bedrest TLC values were not signl
__ urav_cac_ona_ ficanC17 d£fferent from control at one day and two week
3. _ recovery. There was. no slgn£ficant change in DtC0, _V an
No. Tit_ 1_C. These results _ud_cate that the _ncrea=e in'YVC £s tb
result of an increase in TLC and usa a decrease £n _V, an
MINISYMPOSIUMPREFERENCE that Chess mechanical changes are not dependent on changes i
_. _ plasma volume. (Supported by NASA).
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FOLE£1M VENOCONSTRZCTOR ILESPONSES FOLLOWII_G BEDREST, 3.E.
N.B. ____ __0 _S Johns Kopkl.nt
Medical Inst:iCuCions, SalCinore, lid 21205.
We have previously observed tha¢ 8inulaced weight-
lessness (Sedrest) augmncs resting and exercise venoconaCricCLou,
u measured by decreases in fortaru venous compliance (FVC). This
vls aCCrilmCed Co a lov pressure beroreceptor reflex response co
bedrest (Bi0oinduced hypovoleuia, The purpose of the present in-
vestigation v88 to determine if maintaining plasma volume (?V)
during Bi vould rtsulC in an attenuation of resting and exercise
vanocoustrictiou, _RODS, FVC yes meMured (venous occlusion ple-
t:hygmography) in 19 healthy yemen !21-39 yr8) at rest and during 30
minutes of cycling (70% VO2maz) _n a varm environment (30"C, 40g
ILK) before and ¢fter Bit, Seven subjects vere given hurin (]P) Co
prevent Bit-induced hypovolemia, sad 12 subjects received no
Preuarin (NP). PV yes calculated from hemg¢ocrit ratios and tech-
netium dilution determinations. _LS_T_F._. PV, prior Co exercise,
decreased crier Sl in 1_ (2389 to 1957 t 317 el) but not ia ? (2567
Co 2537 ¢497 hi). letting FVC yes reduced after Bm in lit (3.72 to
2.97 :!:o8 cc/100cc) and in P (3030 co 2029 _06 cc/100cc). Veaocou--
eCr_ction during the first I0 minutes of exercise vas greater after
ki_m,K=O001 lSl for I_P (2o18 ¢o 1.64 +..7 cc/lOOcc) and P (2.14 to 1021 +_.06
__ cc/100cc). £1Chough _V van maintained in P after BR, there was a
ffreater veaoconscr_cCioa in P than lrP at rest (30.6Z to 20.2% +_6Z)
and during exercise (_% Co 25% .+6%)0 q__._. VenoconsCrictioa
folloving Sl is independent of l_V euggescinl tl_c ocher variables,
e.g, peripheral pooling, ms7 contribute to the greater venocon-
strictiou. Supported h_ lq_q._-167030
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3A ]_.¢k. Johns Ropkin8 Stress Physiolol_y Lab, Baltiamre, -
MD.
One proposed ez_lauation for the lover 8veati=q_ response
of women than of sen, is that estrogens inh£bit sweating. Te
test this hypothesis and to explore other potential estro-
gen£c effects on exercise responses, 5 women cycled with and
without 7-10 d=ys pretreatnent with a _tcural estrogen sup-
plment, 1.25 mg pre==rin per die_ Etch subject exercised
(70: V02max) for 30 minutes in a vat'= (30°C, 60: _) envi-
ro=nent, l;on-pre=arin tests (1_) occured in the follicular
phases of 2 subjects, the luteal phases of 2 subjects, and
in both phases of the menstrual cycle of 1 subject. Esopha-
geal te=pera_ures (Tea) did not differ siEnifimantly between
NP and pre_uarin (P) tests durin_ exercise, nor was there a
siEnif_cant difference in the rise in Tel; 1_=1_5 +_ 0J_l°C,
and P=l.07 ± 0_39°C, mean +_ S_ No significant differences
were seen in mean skin re=pars=urea, skin conductanres,
total body =west losses, Tee matizq_ thresholds, the slopes
of the Tee/sweat rate relationship, heart rates, stroke
volune8, or blood lactates. Plam=a volume did not differ
siEnificantly between _P and P at rest or during exercise.
We conclude that estrogen suppl_=entation with _re=arin at
this do=age does not alter ther=ore_ulatory re=pauses during
moderate exercise in • war= enyiro=nent either by J_hiblting
=wetting, or by altering plasma volume. (Suppo=ted by 1_$9-
17199 .)
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[. Levite. S.M. Z£T_.Z. Johns Hopkins Medical
Institutions, Stress Phys£olo&y Laboratory. Baltimore, MD
It has been suElested that thermoresulatory responses
differ with the phase of the uenst_ual cycle. ThermoreEula-
tory responses to exercise were =easured £n the early fol li-
cular (prolesterone <l.0ng/al, 17-B-estradiol <i00 p$/=l)
and mldluteal (progesterone >6n&/ml, 17-B-estradiol 70-
150pg/ml) phases £n 8 women with regular (28 ±4 daFs) and
endocr£nolo&ical ly normal cycles. Each subject exercised for
30 minute= at 70Z VO2max in a warm (30uC, 60Z LH) environ-
sent,. Lxerc£se tests were performed be_een 8:00 and 14:00h_
at the sims time of day for each woman- EJophageal tempera =
ture_ [Tes) at rest were greater in the luteal phase (37.25
_+0.16_C) than in the _ollicula._ phase (36.91 _+0=15_C). Tee
was approximately 0.3"C higher _n luteal than _ fol licular
phase at all times during the exercise test. Thus, heat
storage du_inK exercise was similar in either phase of the
menstrual cycle. Neither evaporative heat loss estimated
fro_ total body _eat loss, nor akin conductance in response
to exercise differed s_u_£fcantly as a function of the
menstrual cycie. Zn ao_tzon, piaxea voit_es, exercise car-
diac outputs, heart rates, stroke volt_es and metabolic
rates did not differ sig_i£icantly. Thus, although there is
a cons£stant upward shift in bod_ temperature during the
luteal phase o£ the menstrual cycle both at rest and in
response to moderate exercise= no difference in the heat
loll mechanisms measured was detected in th_ study.
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A. ROCX 1 and SUZANN-- M. FORTNF_Y"z
Divi=-.:,_ c; F,'._.'odu_ivc End::ri.c=,':17 , Thc Jch,,'=.Hc_,':ln._ H_.p,'t_l, _ an,d De_"tme_. cf Envircnmentz! H;=.,':h Science=, The Jo.h,'_
Hc;.':i,*tc Un_v¢';_y $c._oc: ¢L [" ._Ec H_lth and Hygic,*re,_.=_a/:/m, ore, Ma.?land
With th 5 c.;sve:cpment of the spz_ shut'tie pro-
gr_m, bc_n men end women will serve as astronauts.
Space. 5i_.hts wi:l be. ma._e avai',z.ble to sp÷:iaiists in
science &n.d technc',c_'=/to conduct expe_i,,'nents in
p!ann=_.5c_!:z_ laboratories. R_ent;y, Sally K. Ride
WaS tr,_ =--',, =: womzn astronaut to enter _'ot,,. weight-
less er,-'ircnment aboard the space shut+Je Ch_l-
_nge: (Fig. 1). Consideration should now be given
• to tn_ i.,-n.7_.ctof wei_htiessness on the repro_uc_ve
-_._.
This r¢.';c,'t P.Jsoreviews the cun',ent methods for
simulzt!:n of we_gh_essness _.nd hypcdynamic
space,qi;ht. With these investi_-tive mode!s inmind,
the _."_'v""'-";",=._,._._._ adaotive, processes both predicL,s<l
and observed atzero-grayly,arepresented.Results
of curr_nt in.'esti'zatioms into th_se r-deprive proc-
esses ;'.'!:h r"=_=Ct tO the "' =-" _"':",-., - _:_,..O,...-.,.,, ER_oorine
syste'r, v':: bs d:,s:'-'_ss_ _r,.d re:c,,mm_.n_-z.tions for
future ...........,' ,.,,....,,,._,'"'"'_investig---:i:n pre._-cnt÷d.
pt "' :_1.._'._1.. (. ¢¢.Sim:_::.;.-:'- ..._.. _,= ...... he__ -"n_ H:,'p:z'_'r;zmL_
_..: zc:f!i_,%t
Tn_. n_.C to ascertain v,h_,,,.r a human c_n .ur-
rive e_ps'iences of long-term "-:': '-"spa.=,,@, with_L:t
harmfu; efi_c, ts has prompted the use of methods
_at prc'::_,P, a simub_tion of ce,_a!n aspects of
we:_';t;._.sness (Table I). Current methods may pro-
vide re-z.::.n_._le complete n_--ticn of ce,_a!n _-s-
pscts c' Crz.vi_' tissue _n,_, ,=.... n. Ho,, .._.,, tn._ are
frequent,;, cf no use in approxi,mzting other aspe.ts
of the v.'-:.!c.ht;ess state.
True a',,-:a.ions in cra Aty cannot be _.chNz.vs5on
this p:z.n;..',but the simulation of one c: m_,'e cf the
Reprint req.,es:._ to: John A. Rc_.k, I/,.D., D;_'io_n cf Rc;,-ed_c-
_ve Endcc_r,c::_.;', Th_ Johns Hop!dns H:sp::z:, E.% :.'c-._ V,'c:.=.
Street, Bz::in'.c.*e, I.'a 21205.
predictable effects of zero-gravity is possible. Im-
mobilizatJon (i.e., casts, spiints, prolong.-=_:lbed r_t)
has been us-_d to simulate effects on the cardic';r-s-
• oular system. Other simulat_ons incluoe tumbling,
immersion, direct acceIsr_t_on, end opposing a._et-
eraticn [i.e., suborb_t_-!and _iic flight).
Bed rest has been _ c_mmon method for sirr_.t-
ing zero---ravity. This is a valuable technique, be-
cause 1) less work is requir.--_Jfor pos:ural support
while a diminished load is supplied to the body
structure, end 2) there is a reduction in the effective
length of the major fluid columns. There are generP.l;-y
four general physiologic re_sponses to bed rest: bone
demineralization,circuI_torydeconditioning,fluid
and e!ectroi)_e aiterations, a_ndmuscular atrophy.
Disadvant_css include prolonged studies (minimum
12-do;, be:l rest) ancl the psycho',og!cal stress favor
associated with this slmulation.
Parabc:ictr_sctcries have _so been used to si,m-
utats ccnd,itions of we!ghti_ssness. The use of iner-
tial prope_b.'s of a mz.ss in producing a we[ght;ess
state can be extenc;sd to gre_ter tLme pedods ff one
t_kes advantage of the physical characteristics of
trajectile mot!on. The duration of fall can be extends-d
and the problems with air frictional resistance over-
come using an aircraft. The fright pettem during
which weightlessness occurs is called a Kep!eri_n
trajectory. The parabolic form of such a trajectory is
that of an et',!pse with one focus at the center of the
gravitation or traction (Fig. 2). In this maneuver the
eJrcraft dives to gain speed end then pu!Is up onto
one leg of the appropriate parabola with the power
of the engines used to negate air friction. The maxi-
mum durz.tion cf exposure possible with this tech-
nique is _bo';t 1 minute. The disadvantages of this
simu!_tion include an ex;_sure of intense G-fis_ds
jusL before the period of brief weightlessness. This
525
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TABLE 1 Simulation of s.=c:'_." zr.*L:i=ztea, c,,..._-",,-+-c,'
w_i_h_e=sne.¢s
D:-e_t reduc_onofm._nzni=', far:- ;n i:c._;;z=.d8re-s (i.e.,p=_i--:
!mm=_;::=at!:n r.=suX; inbun=_,de."n!r.:-a::zztion and mus:le
c2"op_'). _n:_.m%' be._.._,=m_;;_h-=-_v:;:n_ use cf l:Izs'_,."
c,_,._.
£_vitl'. .:
_:... m_: '
FK_,L.a,_;_=s,_r;: .!._: (:u;_.:.': c: _"b_:: -_-b;' j:L" of z")
O;_sitlcn i:'.'i.m_-;;yby rzd::,Tz_-_:_:a:::n: o::-.::z;E:."ht
l,_:-t_.: f,-c_: V,un"-=.', C. C., C-::_2., E., _.._ 5ur_-: ", R.:
!."..'-':,_= cf s!'_',;:_.:_Zwe;;hf.-_---s_.--,c in h;'F.:-.'r.zm'_ _,% hy*
I,;:32:';'. A_._..-:.: F::ss, l{_v: fc.-i:, 1E._-, p. T1.
t==Xr.;zue, h£: ba2n ussd pr:m."--.., f:- stuC!:s of
lmmers!gn -."",. buo:,'_nt su=st,'t,, oT .- s.,_ :.,,, in a
f_uid a!so prc.-ide a method of simulating _hsw.=:.=ht-
I_=ssstz_. The buc,/z.t support prov!dedto limbs
and trunk reduce the work necessary in nc ,'real
postur_ and s-::ppc:'t withcut greatrsst,fict:,cn inmo-
tion, as v,,[:h b-=_ rest. Subjects e_.posed to immsr--
S!cn or 1_:_;72.ff_.i.... _",_:," +_-'p:, _-..... flight re;:."t ,,,.=: s.=,-,sa-
tJz,_s ate s!m::ar; '"'",.,--, is, astronauts a=,%'-.'Y,;ex-c:Jte
On:'-' _l., ,.. ..x,, c&_t:3us .m.ov_m-_nts i_ _,:;.:: -.'":rn.
i_ve_.h._:es:, th =. un_.tural e×temal =,,--::......nm= .t of
imme:s:,a_ ?rcgu:es some expedm-n'..--', d:.-i:u!-as.
., ....a, i.,, r ...... ._.., experimentat!cn is q.'.'T:_d:,h'sutt.
Fu."th_.rmcre, th_ h::n .... :_'- ."-. or,--,.,,,,, heat .,f water re._ults
in abnor.,-._: heat exchange with tha envircnm_mt.
Therefore, b:dy temperature must b3 carefu:;y m_n-
icored if t._m_srature art:factsare n_. to ccnfuse the
stud!es.
The m_thods of s!mulation of v,'ei_ht;_ssness
v'h::h h=ve b_--:n dis:ussed suffer from one or more
d!_2.d','_.=t-=='_s.Although the syst-_m; are less than
c_tlm.---i,imp_."tant predi:tions can be made een:ern-
ino the -'+-_ ""'-"
. +.,_.,_t,.u.,., of man in spacef::;ht. Many of the
cb._s_'ed responses to spaceflight have been pre-
d;:t.ed usmu ,he,_ simulations.
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Fh":::;:;i: ACz_ve Proc_ss_c at Zero-G:=vh'7
T,_s[/UZCL':Cs.':e'.._al Syctem
MUCC!e St,-u..--'ture and, therefore, function is
stronglyds'.erminedby _e combined stressesto
which the musc!e isexpose. During conditionsof
spacefi!_'ht, the s_ess provided by gravity is re-.
moved and _teraticns in musc]e st,'uc,_Jreb_cme
evident wi'.hin the ft,*st week. The most gross evi-
dence of changing muscle structure is seen by the
ovsrE; dscreese in body mass. AJthough most of the
C_rease in body wei;ht during short-term (i-14
d."-ys) spa_fi!ght is due to decreases in body fluids,
_bc_ut on.third of the we!.ght I_ss results ftcm de-
cre---_.ssinleanbody mass and fat (1).
As th._ lzn:th of e×p:sure to wei:htlessness con-
tin' 'ss, f_:._h_.: evi."_nce of an ztrcr.hi: muscle effe_
aFQs--'rs, espscizIiy in muscles invo;vs-zJ in control of
Fosture _nd weight b_._'ing. Ah,er Cn_.Salut 6/Soyuz
l::C:cr,;-: :I ,fi_;h:s, s!_r,!_,:znt r.trcphy of the rear c_.Jf,
l_n_ _.",dw_e c_f mus_es was seen (2). Mc.-pho-
Ic_',c. chzzgss in muscle tissues following simulated
_:'s_;ht]sssnssshow a decrease in tousle mess
brC;:;'h: &_,Out by decreases inmuscle fiber size and
a;soa sm-z.;isrdecrease inmuscie capillari density.
O;:_'gsn transpo_ time beb,veen c_-piI:afies an_ tis-
::s- is_' _ not betieved to be. redL::ed and F.J'teriel-
v.cnccsO= di_erencssdu.'ingexercise inbed-rested
r:,,_:'.=-'_ v-e'e n_t s:.gni,icantiyd!fferentfrom pre-bed
r_s" values (,3).
F.,!cchsmicP.Jchanges in muscles during simulated
V,'3!_._ItiSSSneSS SUC._E_t a =_
. .. n., decrease in those
en:l'm,,s.s z.nd cofzc.tors ns:essz.rC, to supp_,-t o×i-
v.eeK of bed rest was _-ssoci-"_-",'= cz._zci_,.One ' '
P..tsd":'_ " '';.... _ a _2-18 p_r cent reduction in c,:;._b;'e
enzyme activity and 2 weeks v:i_h a ,3,3p_.r cent
resuctien. During spaceflight, increases in plasma
• INet field,OG _ Ce_t. field • IG
Grovity • IG
o o
- .:- ." ;,,,.,.
." = j- . •
calcJum, phcspho'ous, and cre_=t_nineoccu._d. In
_e udne, in¢'e-:.ses in these fa_ots as we:l as so-
dium, magnes!um, totaJ hydroxylysine, N-meLhyIhJs-
tidine, end most amino acids suggest a generalized
musc!e a_ophy. The time course of these bloc,hem-
iceJ chang_ precedes measured changes in maxi-
mum work capacity inbed-rested subjects. An earlier
sign of de,:J'eas_ngmuscle function was a dete_orat-
ine capacity for endurance exercise (3).
Dudng the SKylab missions, metabolic baI_nce
studies were conducted to assess whether c_tabolic
biochemical conditions would persist in {he presence
of ample dietary intake of key muscle-maJntP.Jning
elements. Despite cerefuiiy monitored intake of cal-
cium, nitrogen, phosphorous, magnesium, potas-
sium, and sodiL;m, a n=.gative or onIy slightly posiSve
balance was found for these elements.
The changes in muscle structure reported above
were also ass._cia'.ed with c_hangesin muscle func-
tion. Decreases in mus_e strength, espedzi.:y in
extensor and leg muse!as, with li_Ischange inarm
muscles, occurre_ both i,_Ii]ght and immedizte',y
postflight (1). These decreases in strength cou:d be
ameiiorate_ but not prevented by exercise programs.
Even ._n er.tremely vigorous exercise proto:ot did
not reverse the loss of total body nitzcgsn and
phosphorous. Elsctromyogram changes occur dur-
ing spaceflight which indicate increasing susceptibil-
ity to fatigue and possibly reduced muscular e,_-
ciency (1). Muscle reflexes during and after space-
flight are characterized as a condition of "gener_ized
hypsrref;e×ia." During the long-term Soviet f',_hts
there was a re_.Jction in thresho!_ in tendon reflexes,
=nd the Skylab results suggest an increase in dura-
tion cf the Achi!ies tendon reflex, which return,ed to
prefiigh: levels only after a month or more (1).
One of the most serious compIications of space-
A3-16
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C!.3ht is the continuing loss of bone mineral. Uke
tousle, bone is a dynamic tissue whi_ maintains a
mess depende,_ upon the level of ove_i daily
-¢_'esse.s. The greatest stresses for bone result from
f_rces caused by we',ght and inertia. Passive stand-
in=_exerts a fo,ce pmpo,rtlo,-_Jto an individuaYsbody
we:ght ¢.'_dthe surrounding gravitational fle_d,such
t,h-=t==112-pound mat_ wi]_generate a force equiva-
lent to 66 pounds on the. tib_a./flbu,_t,bones. This
f.:ce, howev_,', is small compared to the forces
caused by musde counte,"fo.'ces during exe:cise.
Jogging or runn!ng may p:o'.ide forces exc_=_d!ng
1000 pounds of t_ansient force, on the bones o," the
f¢ot (4). Conc;iticns of spa:eOight or s!rnu]ated
weightlessness remove most of the major forces
from the musculoskeletal system so that only a
P,z_on of the ine,'_al force-:,rein,a!n. The maj._r med-
i-.._.Jh_.e.rds of pro!onged spao_J;,:ghton bone inclL:de
a leng_y re.very cf lost bone mass following
spaceflight, possible irreversible bone loss, bone
fractures, and toxic effects on soft tissues such as
the kidney due to increased re_ease of calcium and
phosphorous (1).
Loss of skeletal mass becomes an important ccn-
side,orion, however, only in Iong-te,,'rn spacefiights.
Changes in bone density were found even during
_ho,rt-term spaceflights, but the rate of loss of de-
m!n_aJizatJon was gradual. Evidence from the bnger
ApoTlo and Skylab flights support the hypothesis that
bone mineral loss occurs only in weight-bearing
bones dudng spacef!i_ht (i). The mechan!sm cf bone
d.%_eneration is still unknown but may involve
che.nges in eTecttochemical properties, and in hor-
monal and r',-_ra! factors. '-,r,.,-,
_.-,.:_.,. animal studies
c:;;cest that Lh-_loss of bon._ mineral is due to an
i_h_bition of n_'.,'" bone fc..-mz.t!3.:. In tar.n, h_;'._.;'er,
• . U_,,4:._.;s .... ar wh2"J-ter there is reduced bone f_:m_'tion
cr increas:-d bone reso,-_ti:n du_ng space_i_ht. Au-
',:psi_s of C_ree Russie.n ccsm._nauts who die.."after
21 days of s;zce.';i=ht revealed evid_nceof anatom-
i:-=! bon-3 c,h-=n_=.._sugge,_t!ng increased bone re-
¢_:pt!cn (1).
Studies on the reve.'s!b!I_' cl bona loss f3:iawing
_.-.z:ef,;=_.ht ate in:c==:usive. If the decrease in bone
mass is sirr,._:7 d,._ t_ a t_m.=c:r-_' imbz!_.n:e in bone
t.:'.-,3ve:, th-_n bc:$ loss v.'cu'.=:b3 rep',aced at t later
s_,a.=,,.g,,t. On the othert!.me, perhaps following " "_"; "
h-"n._, an alterat!on in th-:. functi:n: of individua! bona
c::'._ could resu'.t in in'evers!b:z bone Io._s (5}.
r==.-t of the d....... ; in the
o: _=n_ Ices with v-e_.;ht[-s:%zs is that, so far,
'..:':,'c'.ztT::', te:hn;qu2s c3 nsL n-.!.T,!3th5 resu::s durin$
spaceflight. During bed rests, a negative ¢_dum
baJance appears within a few days. Udna,'y calcium
increases and plateaus after about 5 weeks, while
fecal ca_c/umincreases until about 10-.12 we-.:-s and
then plateaus. Dudng spa_flight, urinary ca!alum
p!ateaus after about 30 days, but fe_ calcium loss
does not oppear to plateau. Extt-zpolaLed c,_c_um
losses from the Skylab spaceflights suggest that t,
within I year an astronaut would lose about 25 per.
cent of the total body cal_um poe|. Extrapo'.ated
bed rest data give va!ues of only 6 p-- cent (6).
The results reported from long-term Soviet space..
flights suggest that the calcium loss does not contin-
u_',y increase during long-term we'.gh_essness, but
slows considerably between the third and sixth
month when vigorous exercise progr'ams a.-e corn
ducted (2). The effectiveness of exe.-dse as a cou_
termeasure is still uncertain, however, as during
Sk'ylab 3 and 4, weight-loading exercise red=cod
bone loss in only bhree of the six astronauts. Soviet
_nd!ngs reg_d_ng the effects of exercise as a cour_
te,_easure are more hopeful (Ni_gossian and Par-
ker, 1982; 1). Ot,_er countermeasures which have
been proposed include dietary suppIements and
phaJ'rnaco!crg_icalag_ts. One drug, dodronate diso-
dium, effective!y prevented negative calcium ba!ance
in human bed-rested subjects but was discontinued
from use because of evidence of possible c_rcino=
genie properties (6).
Comparisons of bone mineral losses in men and
women suegest that women had significantly less
colt!urn loss than simifP..rly stressed men. Further
stu.d_es are needed to verify th!s finding a,',d to
estab:i_h the mechanism for such d!fferences CI).
R.z:,_frc;oS" S:,,ctem
The c_.-_.-n_esthat occur in the resp!r.--'to'y syc:-=m
duringactual or simulated v =',,,-+,--- _-_.-.-;_;,-._,-
lel:_p_.--,"to b_ ..,._;ht and of littie ore:aT: p,_',_.s;&,.;..cPJ""-"
s!gn;ficznc=.. Pulmo,=a._/functbn m-_as,re,T.en:_ c_
ta!.=e_ from five men dudng a 20-da_, b_.cEzest pro-
tc,.=o_re"_a',_-d nonsignificant chang.us in tote: I,ng
capacib/, forced vital capacib,, 1-second forced ex-
p!zzto,3, vo!ume, residuaJ vo!ume, a_d th_ d2_'-s_ng
cap-=c_ty of the lung for carbon m_noxide. It was
unc'.=.ar in this study, however, wheth-=r a'.imea=-ure--
m_..':ts were controlled for posture (8). In a recent
silo: 7 in wh!:h six women und._r_vent duplicat-_ 11-
d_" bad rests, smaIl but signific_.nt increases in v!tal
capa:ity a_d 1-second forced expir_to_, Volume cc-
c-::..d d::r:,,_ the first 5 days of the b_.drest protocol,
csntinued to be elevated throughout the remainder
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c: th: b:_ rc:ts, _'_d r¢_.'_-:..t tow--,"d sup_n_ pre-
t-_ r_t l-ve'.s gu_.;n_2 w_'.:s of ='nbu1-:.:o_-re:or-
cry. 1_v:zs po._tu_t¢:! by these aut.ho."s that the
,._ .JC'_'_e.': in _ _.:_-._._" _n,d 1-sc:ond fo,,,e., explr-
_tor 3, vo:ums mr.y h_ve bc-s..naes,_ated wiC't the
I5-,33 pz." _nt dc='e=ses in plasma vo!ums v:hi_
c::'_:':zd in _-o sam: tlm._ inte.'v=_LPree,_'m-:b:-'de..
cre_s.%."p!zsrn= vo:ums wcu_:; b3 re_._._ed in a sirn-
i_3r prc-'-c,'_r'.eg de._'e-=sc in t,4ctz_= b:c:. _ v=:ume
¢.',d _.,_in_e_. -_- in lung ca,'np:_z,'::eduffng the fl.'st
few d_-ys cf b_d rest (S). A f=:low_p study, in v.'hi:h
_. 23 .::: cznt d-==zc.s_ in p6:.-:m= vc!-m¢ w_s in.
cf d;u.'a::._-, fa::-=g t: =...--._.._,_":_"=-c.3rT_.:a_cnb?.'_¢:een
ch_.n;-_s in p]zsm=- volume and changes in vitr-! ca-
p_:L"/cr 1-s-c.ond forced exp_r=tory volume (I0).
f_ ccns!=t=..nt_'_'_es in pulmonary lunch, on have
b.:_ re_:.-t=-_ during spacefi;ghts of 28-84 d=_.ys'
Curz.t:c.-t. D'.:._ng one spacefii;ht, vitzJ c_'.pac_ on
mcct days av-_,_ged ab:ut 10 pe,r cent lower th_n
p.-_._:_-htc=ntrc!s in Cnree astronauts, but retu.med to
pre._!:nt levels ra.:_dly a_er I,,.nding (11).
E cdr' F,uids
With the remov_J of hydrostatic pressure gradient
dudng conditions of weightlessness, body flu!ds are
re.d':r.t_buted such that fluid r÷dis='-"ibutes from the
I_v,.'sre×tremities in e ceF..hr_d d:re:tion. The result-
ing increase in t:':orz_c b_ood volume is be;ieved to
in;::,=t_a G_u-_r-Henry reflex, whereby s_etch recep-
to-s in the IoN at_um inhibit the re_.ase of antidiureti¢
hcrms,ne. As a resu;t, a sF.cntznecus diuresis oc-
cur:, resj:tingina decreese inF_.'.a_.mavolume and
el.: :::::_es. _.,n',=...-,,,_ 2-wee;: b_d rest studies in seven
m_n, th".s d:ures_s was see_nCuffn_ :hefL-st 4-5 days
and r:s_::_ed in a 13 per cent re_',.'ctJ'_n in p!zsma
'.'cO=mr (i 2). A s!m;ia- re:at_v_ loss of p_&smsvo:ume
v.'zsreTc,_ed in be.d-rested women dudng l 1-clay
be_ re_.;s. However, it was obsewed that, when bed
rest was Ic=--'Junin the immed{_.te "-" , '-' ,
. _, eovu,=.o_ stage
of a v.'cm_'n's menst,-ua] cycle, e!ther a,nincre_e or
cnty z s.'.,a'.ldecrease in pl_ma volume w_s seen
during the first 4 days of bed rest. These results
su;;_st that the he,,-'non._s asscciate-'J with the preo-
Vu',-:.:C_'st&ae may " c:= +. t_an....n.Jy prevent the d!uresis
-"ss: c;--ted with bed rest (13).
Dud,_ -"" "•--.,us, spacefiichts, however, this early-
cns_', c_:uresis h_s not been seen probzb',y because
of prcb'.._ms in cbt_.!n!n= urine s&m_',es during flight,
an_ b-=:_use of a reduced fluid intake due to motion
sis',:ness _-nd enti-mot_:n sickness dru.=s. [.'-;&sure-
mer, ts cf the net v:&ter b&:znce during Skv;=_.b' -"*-
indicate, however, that although fluid in_.3= is re-
duced, udne output is not reduced to a c_-.,.=:-a::e
level resuWng in a negative water baJ_: d::._ng
the first 6 d£ys of flight, in-flight increases L"zt.,:L"P.ry
sodium, pot_._sium, and c.h[oride, and d.e,'J_-.._esL'_
antJdiuretic hormone lend support for the d_u.-esis
theo._, of _ p_sma vo:ume decrease durirq,v.'3:_ht-
lessness (1).
Thzse f,u_dlosses P-"ebelievedtO conb'ib_a to the
po_.ht c.'_os_-_c intolerance seen in most a.stro-
nauts _nd ¢osm:nauts. Countermeasures to prevent
t;n_diures£sin_ude vigorousexercise programs and
wzt_.r and e!ectro'.,,te supp]em_nts during sp_.=efi_ght
or just before re_.ntty. During long-term Soviet
• flights, the water and electrolyte supplem_'=tation
was combined with Iower._..,ody negative p,'_,_sure
adm_nist_tion to ensurethat the ingested fiuT_were
reta!ned with!n the vascul=_rspace (2). Mi_,_:cor-
ticoid (gq=-f;_orchydroco,"Jsone) ingest_an dudng
bed rest studies has su_ssfui;y prevented theloss
of p!asma volume but the effete on orthostati¢
to_erzncefc:lowingbed rest have been in_,.sive
04, 15).
Ee:_des C_¢_oss cf p!_ma volume, red ce: vc:ume
also decre-=ses d',','ing v/e!ch'_essness. The. effect,
however, now appears to be. se;f4imiting, where with
t_ng-term spaceflight, the red cell mass decreased
until about 60 days into the mission and the.n grad-
ua!ly be-gan to recover (1). Along with the loss in cell
mass, there is a change in the shape of the red cells.
Preflight, 80-90 per cent of the red ce!!s had 8
b!concave (discccyte) shape. During the Soyu% 6
Eight, the.re was an increase in number of e_:!psoidal
end spherical shzped ce:!s. These chang_ were
rap!d:y revers!b!e p:stf;!ght (1).
The most &cc_pted theo,_' to explain the decre.=-,se
L7red Ce!lmass is that" "'_'"re-,I,=, ,, there is a suppression
of nev: redcell production by a direct inhibitoryeffect
cn bone marrow. The reduction in prcpc.-f.cn of
reti_Jlc='_es during ez:iy spz_?,ight woui_ _.-d,-rn
th!s hypothesis. Find_n;s from the Apo._o-Soyuz
flight dispute other theories that increased red cell
destruction or seL=ctive sequestration of red cells
c_use the decreased red cell mass (1).
C_'.rdiovascular System
It is especlatiy difficult to simulate the e_'_ts of
we!ghtlessness cn the cardiovascular system since
simu[atlon procedures, such aS bed rest znd water
immersion, produce physi:al deconditioning in addi-
t;on to the hypo_ravic resp3nses.Most ofthis re'Hew
v:[:;, therefore, focus on cardiovascular responses
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seen during or after spaceflight. Three major
changes in cardiovascular function fol_owing weight-
lessness include decreased orthostatio tolerance,
changes in ca,-di--: e!ectmmechanics, and changes
in exetdse c_pacity postflighL In addition, some
morphological changes have been reported in the
heart fo,owing prolonged space_ight.
One ez_y ccnttove.-sy centered P.'ound how the
¢zrdiovas=JlZ=" system would de_ with the cep,h_ad
shift in body fluids. It was f-c._'e_ thzt a ¢_hronic
e_evatJonin cenLc-aJvenous end L=.P,ztdaJ p:essur,as
would persist du_ng we!ghtiess e_.posums, p:'.en-
t_ally compromising cardiac f',:nct;on. Recent evi-
dence of only _'_siant increases in central venous
pressure during head-down tilt s!mu!zt_ons and nor-
m_ cardL_: function curves duM,ng the Skylab mis-
sions argue ag_nst this theoq, (16, 17). Recently, it
c_._ to examine thehas become possible to co_-_ "- --
ef':ect of long-term spa_f,',ght cn cardiac structure
and func_on. Electroc_dic-g_.phic studies affor the
Skylab missions found decreases in left ven_cutar
dimensions without significant change in c_n_acti]e
propeJ'_es (17). Fo_Iowing SaJyut 7, e:ecJ¢o:_'diog-
raphy studies revealed a smut but reversible de-
crease in left ven_cular mus:ie mass whHJ_ was
restored wit,bin 7 days p.._.h,. The rapidity of
muscJe mass restoration sugg.ests that the changes
v'ere due to aJteration in myocardial interceliular
hydration rather than to myocardial muscle degen-
eration (18).
Decreases in orthostatic tolerance are consistently
reported during en_ a_er spa:afi:ght. At least part
of the into_e.-ance to tilt, lower _""" nP.gative Fes-
sure, or qu[et standing pos_';;;h: is due to the blood
_,_,'__.==h_ .... he.s. Thisvo_,Jme losses 8$son!ate_ '"" "-" "_=¢" =
?_50-500 ml Cu!d loss, howe.us', is too sin--'4 to
a::ount f:." ,_,_ c_-;ree of cz::::,:;'-s :u:-"r dy._,'u.-.ct!:n
re7 :._e_. A[s=', repla:em=.nt of tnc vcTum_ Ices b_
fc,'e orthost_¢ to',erance t_st_n_ C;,dnot ¢omp:-:t_:y
r-:store c,%'_os'_=tJ:to!e,'anca (:i 5}.
_her me:_,--'_isms that may c:.:_bute to t.h- d=--
c,'sased c,-thc-:_tic tc',erznc5 m-:-' inc!u_e an in-
cTease in V_.'I.,CUS r'n_'= "co_p,_.,....es_-'__z:a:.yin_.he!0_.','er
h._y or =.,.....-_"_--'"-',,,,,.:. re;'!cns, or cha_ges in the neu-
;C3en!3 O: hc.'m,c,na! co,ntrc! 1";333_.,'lis,"T1,sth t re-' _-
l:'.e b_::d p-cssure.Venous ccm.:::-:nce m.-:zsur_
msnts du-:n_ S1:_,!ab flights e'.-:--:_.-_an increase in
comp',!zn=3 during the first 10 d_ys of flight, then z
s:.zv,decrease withcont:.nuin2s;.-zefl!cht.The tim=.
cnurS-_ Of th-_se comp:ian:e c;-,'---_;_;sd:,d not concur
,., ,. =.=n_.. to lowerwith ao.omp-:nying chances ;_ '- ....
_--' ' ne:_.t;ve pre-_-sure(!).
Data describing changes in autonomic fun_on
afterspaoe,'_ightor bed rest are in,,_nc:_ive. Upon
b'Itat lower body negative pressure c_:h_ce after
spaceflight, the cardiovascular responses are exag-
gerated with greater increases in h¢_-t rate and a
greater f_ in mean arterial pressure. However, the
norm_ vasocons_ctor responses appe-:.J"int_:L Im
jections of nor,epinephrine or eng!o_nsin p:c_.uce
similar pmssor responses during 2--3 wee!; bed
rests. Although plasma c_t_holam.7..._ are re_/uced.
r..;uringbed rest, their response du:_,g t_;_ is un=
c,hangsd (19). The venoconslziCtOr rec.".onseof fore-.
ann b:ood vessels during exercise was found to be
potent;atsd rather than reduced fo"ovdno bed rest,
suggesting normal sympathetic v=_no,'..onst.dctor
function. The increased venocons_;_on was pro-
portioned to the reduction in plasma volume during
bed rest (20).
E/_'o_-d:ogm;hic and vect._¢,-c-zrd;o;_phic
data, at rest end during lower body negative pres-
sure challenge during Skylab missions, showed an
inc_ase in the QRS maximum vecto:, which may be
re_ated to in.eases in thoracic blood volume _nd a
pro!ong;,tion of the P-R interval, poss_b[ydue to an.
a_oven_cula: conduc_on slowdo;_ caused by an
in.eased v£g_ tone. Frequent arrhythmias during
spaceflight may aJso resu=t from sympathetic-para-
sympathetic imbP.Jance or may be due to fl,u!d or
electrolyte imbaJences induced by the weightless
state (1). Dudng Sa]yut 6 flights, kinetoc_rdiographic
measurements _so revealed a sign_nt shortening
of isometric contraction and relaxa_on of ejection
an_ pos_:Z':_ phases (2).
Exercise capa:{b/ is severely re_.u:ed fc:::,ving
s._-,__ce[;_.h:.Af_.: t.,e 3-11 day AT._::o flights, de.-
craases in exe:c!se intensi_, oxy_:n uptake, and
_rS:.-:.ccut;utv,,_rec_se,'vedatr-nexercising,".cart
rat_ of 163 t:-:.-:.:sp :: m!nute. Oxy_-=_ ccnsu,T,.-_t_on
{:: a given e':_rcis=_ int-=ns[%' (musa'.;.e.'-T,:i_-:).) was
n?.t a__red pzst{;:._ht. Followin_ tY._ ton_-_rS'-:y_ab
E.-h._,. _!m:,:s.:dncrean_.s in exe-c!s5 ,.-z"-z!._. _' were
fcuz_ bu_ ,:,:.'e restored with:.n 3 v.=_::s c" re::ve:'_
% I"
One unexpected finding, howev_ r, was t-e ira.
p:avement in exercise to!erance d'-,r_ng spac=._:!ght.
C_,:e th_ mechanical problems c,' exe.-c!si_g in
v/s_'htiess condi:ions were nego:i=ted, astronauts
during S!:ylab flights were able to a:complish h!gher
exercise intensi:i_s than were pc:s!bte in a cn_
cjrav;t.y environment. An increased maximum oxygen
uptake in zero-gravity conditions is p.;obah:_' not
L'-,_,.=,,v_';"-"= c[ ,--train!n_ respor, se as in normz._condi.
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_:'cmen in SF.--'e,':_;_t r_l
tJons, but may have _..n due to the effe_ of an
inc,oe-"s._dvenous ret_:m _nd maximum c_'-_:= out-
put resu!_n;] from, t,he incre-:.sed cen::_ blood vol-
ume. As a line-"." reL_t]=nsh:p exists be,%,:eznabso',ute
work output and _'dla¢ output, a higher exercise
intens.:ty wou_d be. a._.Jmzb!e. Ox-'ygon consumption
mat,, aJ._o incre-cse because of an in=r¢-=s--_d_='Jve
mus=1-_mass in zero.<j'.av;_,l as the arms p'.zy a more
active role. c_u.'_..gexercJs¢. Rxed subm_L,'n: exer-
cise intensL'ies were a_:=mptished wi_-_lower he_,'t
rates, and b_ood pressures than p,"mfi:.;ht.A more
r_p_d recovery of heart rate after ex=_;c!s._in the
we;;htiessness environment was prob-"L_l,., due to
me grs--te" venc'..,s re.'-,_..m.Thers'cre, in c-_,zr to
ma!nt_Jn a stab!e flmess level while in-flicht, training
exercise intensives must be adjusted in an upward
direction (21).
Eng.:trine Sy_:em
T;-.,=sr,_::_ne resp._nse during so-_,fiicht.. re._ts
the _mb.!ne:l effe_s of stresses in.i;ced through
the removal of gre.vibl, effects from motion s!ckness,
ch_n,_es in d}et, and the psychological stresses as-
scc_-:.,_.i with space travel. B.cause so many
sb'esses are simultaneously combin.=='J,the hormonal
d,,,,cu,, to interpret.responses are o,"[en :"= _"
He-_-dc;','n be_ rest s:udies (22) have b_n con.
duc'.a:l in an a_empt to iden:i;-y some of the tr_.ns_snt
hc,'_,.:na_ fluc,'ua_ons associated ",'"
_,,,n changes in
the hydros'.at:,cgradientexertedon the body.Within
the firs',2 hours abet lyingd:};vn,thereisan increase
in c_.ntr_-;venous pressure wh!ch prob_b!j,tri_.=rs
the dez.r_._seinp'.asmz,c_ncentrationsofantidiuretic
horm.,=nc, ang!:_sns!n, and a!_osterone. In this same
tlme int-c,'v_J,sym:athetio a=tJvity is de,eased as
reS_cte_ b_,deers_so3 in concentrations of ep_nep,h-
fins _'.nd nore:oinephrine. Giomerular filtration rate is
a!so trr-nsisntly d÷creas_=-'J.A,%r 4 hours of bed rest,
cent.';.J venous pressure retLfms to prc--b_.d rest
leve:_ _--d-,,then continues to de.ease. The g!omer-
u:ar fOr:ration rate re;ums to baseiine only after about, '
•F.,hours, at which t_me p!_sma ._.dos._, on. and an-
g ........ n lsve!s have _Iso recovered _.n_ may even
e;:css5 the pr'c--be_ rest level
Dztc fm.,m z..strc,_e.u_ in the space shut't,Ie program
reve,'=-':s5increased p',asma and urinary, a!dosterone,
ang!o:snsin,and urinary antidiuretic hormone post-
ft,=h,, s_m_i_.r:o the r==.,,_ repo,led after 8 h. _,. of
heF.:;-_own bed rest. The plasma leve!s c: these
,_ormones =n-,:,=h_, however, have a!s3 bs--__shov,'n
to _e in'._snce.1 by sa',t and wr-ter in;;::-:.. U:;ns
anEdiuretic hormone concentration during lon_term
Skylab flights was reduced during the first 40-53
days of flight, then began to return toward pr_F,_;ht
leve!s (23). These hormonal fluctuations undoubtedly
occur in response to the fluid shifts with exp_ure
to weightJessness.
During Sl,'ylab spacefligh_s, parathyroid h:._rn,one
was s,._n,,y e:avated (6.4 per cent) above pre?,':;ht
levels (23). Parathyroid hormone normally func'Jcns
to in=e=se p!_sma calcium by first inc.'easing bone
reso.-ption, second by increasing resorption of
cium in the kidney and decreasing excretion, =nd
third b,' increasing caJciumresorption from the intes-
tine. Increz.sed pa._thyroid hormone may fun_on
during spaceflight to oppose the effects of !r_creasing
cortisoi which, exerts a negative calcium bEz.nce
effe=t. The action of para_yroid hormone requires
the presence o: v_tEnin D. It is not yet known what
hap;-=.':s to vitamin D levis during spacefli.ght, al-
though in bed rest studies urinary concentraE:ns of
1,25 dihydroxycholec_cfferol, and vitamin D metab-
o!P,es were decreased.
Inc.-eased co,sol leve!s in spaceflight may have a
s!gnif,cant role in the muscle degeneration. Thymx.
ine and t_hyro!d-stimuIzting hon'none were both found
to be incre_-sed during spaceflight and may also
contribute to an increased metabolism of proteins,
carbohydrates, and fats (23).
Cateoholamine excretion decreased during the
Sky:ab flights, which is within the observation of"
reduced sympathetic responsiveness. During bed
rest studies, the reduction in norepinephrine ex=e-
tion could be prevented by exercise (23).
Both American and Soviet spaceflights have
shown evidence cf a change in energy utilization and
production. Fasting brood g:ucose levels increase
initially, then c_ecrease beiow preflight levels. Plasma
insulin concentrations decreased duffng Sky.lab
flights (23) but were reportediy increased in the
Saiyut 6 cosmonauts (3).
Fundamental changes in _rbohydrate metabolism
are evident after only 2 days o,"bed rest. DoIkas and
Greenleaf (24) found that the degree of g!ucose
intolerance during bed rests is proportional to the
degree of immobility as assessed by the total energy
expenditure each day, and is probably not due to a
hydrostatic effect. Exercise during bed rests was
effective in reducing glucose intolerance. A poss',b]e
mechanism of this decreased g!ucose tolera,",:e is
that, during deconditioning or bed rest, there is a
decreased sensitivity of the tissues to insulin action
through modification of the insulin rece_.;ors.
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Reproductive System
Little work has been done to evaluate the effect
of weightlessness on the female reproductive tract.
Rock and Forthey (25) have domJmented the reduc-
tion of p_asma volume dudng bed rest in women.
Interestingly, a norm=',_.ation of plasma volume was
observed _t m_dcycle with a preovulatory estrogen
peak, Ris+ng estrogens were thou cht to have salt-
- retaining prol_ty that prevented the loss of plasma
vorume.
Recently, Rock, and Fortney (25) have studis_ the
menstru_ cyr..Jein the bed rest pat:=nt. A luteaJphase
defidency as defined by Abmha.m et aJ. (26) was
documented in 3 of 12 patients (Fig. 3).
Further investigations using subjects as their'own
controls are needed to establish th-z.tweightiessness
may result in diminished pregesterone sc--cretion.
Furthermore, studies of the hypothalamic-pitui_.n/-
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ovarian axis may further elucidate a p_thophys_ologic
mechanism.
Recent studies have document:-,J an increased
in_dence of endometriosis among monkeys ex-
posed to proton irradiation simiI_o to that which
would be experienced by an astronz'..,t (27). Thus, it
has been hypothesized that astm,-'_u_s may be at
increased risk for the development of endometriosis.
Furthermore, in an environment of weightlessness,
the no,'maJ egress of menstrual fluid may be less
op,ffmaland tubal reflux more frequent.
Abe,'r_tion of menses may occur in _e we!ghtJess-
hess environment due to anovula_on. This ma r, be
particularly true in long-term space_ght. Alterations
in the metabolism, clearance of stero!ds, and secre-
tion of gonadotropins may result in chronic anovu-
lation. Menomevor_nagia and hyp_.=rmenorrheamay
be serious as it is unknown whe_er the normal
hemostatic mechanisms associated with the men-
strual period are o._..'-atJve in conditions of we!._ht-
lessness.
Surgery in Candit/ons of Weig_Je¢sness
With the increasing frequency and duration of ex-
_aterrestdaJ travel in an environment of weight[asso
ness, the need for medical and surgical care will
most likely increase. In particular, if an injury occurs,
surgical t.,_,hniques should be developed for rapid
hemostasis and tissue closure at zero-gravity if the
mlssion profile precludes the prompt return of an
injured crew member to earth for treatment. Fur-
thermore, prob!ems related to surgi_t t_hnique and
weightlessness shou!d be resolved before planetary
m!sr.isn_, v,h_ch preclude the return of = crew mere-
be, to ea.-th for surgery.
In-_,ZghtS_rge_' has been tested z_cz:d a;rc:.:..=.in
l(epi_.::an pzra_._Iz.s by the Soviet Union (2S, 29).
Spec_ transparent c_ntainers were used to ps.ffc,-m
sur,_L:_.IIap--.ro:cmy on rab_ts unde-tcc."-i ane_:he-
sia. C :_:n; the mesente,_, of _e sm._;; intestine was
accompanied by v!gorous b_cod flow. The blood did
not pump out and scatter into the a,'nosphere but
flowed around injured vesse!s in the f_rm of pu_dies.
Arterial blood f;ow tended to scatter. Ccntamination
of the cabin atmosphere may be prevented by careful
clamping of tissue before the incisTon. The Soviets
repo,-te_ the necessity of limiting tn_ aUdominal in-
cision initially to avoid eventration. The surgeons
noted, however, that eventration eliminated the neec_
for retractors.
Thus, this p:e:!,,-ninary work brc::ght about the
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rea:izati..n th.-t s-,r_-.'y todd be pa.'/orrned in the
we!ght_:.=cn-_.s envirc, nm=nt. Although our under-
standing ¢f _r: £i;c_ of we!ghttessness have rapidly
adv_'_:_, the av_]zb'._, literature on surg_czdtech-
nique_ z: zero%ravk'y is sparse. Studies are primarily
in the Russi-'t I!tem_.'-e a.-,d obse,wz_or, FJin n_,tum
(2o, _3)...
UR.cn ents._ng zero-Gray: _, thee is a slowing
down cf speed a._d a:,cur_ fc,r a pu.'poseful move-
menL In pzr'd_la. °, thare are errors in trying to hit
the cznt_: o f the ta."_et (deviation of hits upv:zrd).
There is, however, ra_:d r.._ap_t;cn _s motor ccor-
dinaL':_n habi.s '= -"'u.u=,, deve!op q'J!t-3 -':"s -;,q (31-33).
Spec:_c;.;:y d-s;';n_ i_$'="uments may "be rsqu:red
to peKorm comp;_x motor reactions required for
de!::ate s'_,rg!czJmaneuvers.
Stz.zhar::-_ et _. (_0) s.==.s_e., th..t th._ limitations
of the s_ze cf th_ _smi¢ cra_ _nd the redu_._,d
im,.'nunc.-ezctivi:-] of man =n space requires a soft
surg!c._Jant!bz_e,",_ chamber ma_e of ttansp--rent
fluo,.plast_c f,im _._dh_ving two to thre-e p_rs of bui_t-
in sleeves with, sur_!cz! Gloves. The authors stressed
the need for deve:c=!ng a compact set of IighbNeight
sure,col inst:_.,msnts meeting the r._u!rements for
surgical int._rven*Jon at zero-gravi_.
Rock (34) has suc_ested an expandable chamber
fo; m_n_r surce,'y in ¢onditSons of we!;htlessness.
Maior consi_e:aScns in developing such a system
for use in a sp._cec:a_ were to provide a sterile
environment _-s we!l as to prevent contamination of
the cab!n v/_th bleed ar:d other debris while perform-
ing the surcery.
The "_'"m,. ,,,_e is a se;f-contained system with a cuff
tourniquet and i_suf_ato'. The stadia g!oves are built
into the system so that the environment within the
ca_.su;=_,is st-=rile, c=.'=tr-"nin§ l:=th c'.oves and instru-
ments, v,h:.:h P.rea_.,_ne_ with Ve_=o straps to the
clear viny; wa[!s of _e cz.psule (Figs. 4 and 5). In the
event of an arm inju_, the a,,'m would be inse,"ted r
thro";h the cuff tourniquet; the tourniquet would
then be infiate_ to a._n;eve hemcstasis. The capsule
than may be insufflatedand the surgeon's hands
inse,'ted into the gloves, the instruments grasped,
an_ th-_ surgery paffc.'med. The surg!cal area may
be preT._ad and '---',,,,._anesthesia a,_ministered within
th!s s=:._!ca! env!ronmsnt. The b!eedsrs may either
be cilp_a& or suture I_ated. As normal hand tying
movemeats may b8 di,icult under conditions of
v,,ei_'i'X:.essness, c;!p systems may be more appro-
priate to a..hieve vessel ligetion and hemostasis.
Contamination o: the spacecraft with b'.cod an_ tis-
sue c;abris is thus avoided, maintaining a clean en-
vironm=.nt.
Sp--:eflic.ht .,r_.3
ollmm Is
i,eoll  mcnry
,-.: . .....
• _I " -_ -_"'-' :_ " -
.,-'_. ." .:,._,. _; o t,&'_E_ .-_,-:-.. .....
.......--:F_-- ,-, "-;-_--=..-_'-;_;--."-:_, --'; ..
\\ i,-.:_ _ _.._ .,..... :£..-:::-'.:.; ,_ _-'_- ":
,-,j_; -.-.---.-._e_.-- _<:L_._.-:
.,"t'-.._ "_,..--.'__,;_;.&,-: ,_ ",-"
." _ ;: ,% _ _" . .-..._. -'%;. _._.ll_ .-; ' t- :',.*
"" _ . .. _'_"¢_.,._,_. ;4 :[_ , . ,-.
.=- _ ._--.-=.--..C*_:._-4.-.- _.- _.-
_,_" ", " --:-_ ,-_.""_-. ,_"*_ _/-'z";.--,4," 4-.
"I . _.._." _ • _'-.__:_.- .- , ._._.,: :.-.i
.) .... .,l.,. ',. .... __. __....
,_'- . -_'_'. . .,-_'_---_ -;-_ , ,.. .....
In,,_.,'y._,i_,. : ', ,_-,.. ,._;':-._'_p,._.:'_,_.-_._.;, " .-_---..: !
/ " -'"_ " : -- "-" 4.--'"' .':_ '_"'" "":"'- ''_
• _it..• .. ' -. : ,_. ',"k"" •:_ . .,_
,.... ,=
: --i- !!;-I " .... "
Rg. 4. An expandab!e chamber for surgery in conditions of
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,surgi:_J c;'_m_: for use in concr_cns of weightles._ess. Aviat
S_.ce =,.n_.%cn.Med. 55: 43,3, 1984. Reproduced with pe:n'_ssion
of _,e Aerospa:e Medical Asso_io_, Washington, DC.
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Fig. 5. The injure:l limb is inserted through the cuff toum!quet,
the toumLsuet in,_;te_, the surgeon's hands inserted in',o the
c:sves, instruments g;_sped, and surgery performed. Frcm Rock,
J. A.: An expt.-,d_b!e surgical chamber for use in ¢on,_i_ons of
wei;htL=ssness. Aviat. Sp--ce Environ. Med. 55: 403, 1£54. Re-
p:o:luc.ed wi_h permission o' the Aerospaca Medica! Assodation,
Washington, DC.
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Adaptation
|logo
G
.
Fk3. 6. The process of adaptat_c_ of man at zero gravitT. ADH, an_d, Jret_c hormone. Adapted from: Leach, C. S., AlexP.,_d_, W. C..
and Fcsc_,er, C. I_: Compensatory change during adaptation to the weigh=ass e_vironmertL Physiologist 13: 246, 1970.
Future Clinic=!Invest_;z_i:_
A_though the process of _daptat_on to zero-gravity
in the human has been studic-d (Fig. 6), _=e eff_ts
o; prolonged weightlessness on t,_e menstrual cycle
_-e unk,nown; thus, a new field of gynecologic inves-
tigation is appP_.renL in pa_cu!P..r, using bed rest for
simulation, the hypoth_amic-pitui:a_-ovarian axis
may be c_reful;y studied and tlne mstab_iic cl=.arance
o," steroids _.'u_dated. Lo_g-te,"rn s?z:eF',!_ht may
arrow dynzrni_, testing in "sLylabs."
immersion in water or the Kep_edan parabda will
provide a n',e'.hod of si,-nuIati_n for testing surgical
moCu:es. Ideatly, the "shylab" v:ii:a;iow careful study
oJ the technical difficulties in performing minor sur-
get 7. Major surgery will be addressed in the space
_tations of the future.
The influenceof the process of adaptation on
svrge.',/may be of great impo_ance. The reduction
c; p'asma volume and increase in central venous
pressure may result in a critica: margin of safety.
I.
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ABSTRACT
Exercise conditioning is usually accompanied by increases in blood volume and
improvements in heat tolerance. Deconditioning on the other hand, especially when
J
p_oduced by extended periods of bedresc, is accompanied by a decrease of blood
volume. In this study, the e££ects o£ bedrest deconditioning on exercise thet'aoregu- •
lator 7 responses were studied, both rich and without an accompany_ reduction in
plasma volume. Two groups o£ women underwent identical 12-day bedrest protocols.
Group 1 (n=12) was ada£nistered no hormonal Creament. and their plasma volumes vere
s£gnificanCly reduced (19.9Z) at the end o£ the bedrest. Group 2 (n=7) received
daily estrogen supplementation (1.25 _ premarin) during bedresc, and they did not
sugger a significant reduction in plasma volume during the last days of bedrest.
Both groups however had _npaired thermoregulaCory responses agter bedrest. Therefore
deconditioning, even i£ unaccompanied by a reduction in plasma volume, results in an
impairaent o£ thermoregulatory £unction.
INTRODUCTION
Although many studies have examined the e££ect o£ increasing £itness level on
heat tolerance 1-5, vet7 few 6 have looked at the effect o£ deconditioning. There are
many reasons to suspect Chat heaC tolerance vould be impaired following periods of
inactivity, especial ly i£ that inactivity involved physical confinement, £or example,
as ogten occurs in patients con_£ned to bed £or several days or weeks. Bedrest
results not only • reduction in £itness level, but also is known to result in pro-
nounced reduction in body £1uid compartments. 7,8 Hypovolemia both with and vithout
electrolyte losses, has been shown to alter signigicantly both the vasodilatory and
the sweating heat loss responses in exercising humans. 9-11
The e££ect og increasing £itness level on local sweating and skin blood £1ov
responses was studied by Roberts and co-workers. 12 The local sweat response was
measured with sweat capsules placed on the chest and connected to a resistance
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hygrometry _t system. The local sweat rate was then plotted as a function of the
internal body temperature, which was measured with a thermocouple placed in the
esophagus at heart level. A plot of the chest sweat rate (el) as a function of the
r_se in deep body temperature (Tes) characterized the effect o£ increased gitness.
An increase in the slope o5 this $1/Tes relationship indicated that the sensitivity
og the sweating response increased during the training prosr_, which produced an 1I_
increase in the maximum oxygen uptake (V02max) in these subjects. The Tes threshold
at which sweatins began was reduced signigicantly. The skin blood glow (SkBF)
response was measured by electrocapacitance plethysmography. Again this thermoregu-
$atoz7 response was characterized by plotting the skin blood glow values as a gunc-
tion o£ the rise in Tes. The slope o£ the SkBY/Tes relationship was only slightly
altered gollowing trainins. However the Tes threshold at which vasodilation occur-
red. was sign££icantly reduced during the training program,
Thus changes in gitness level may be expected to alter both the sweatin S and the
skin blood glow responses, We would hypothesize further, that after deconditionins,
the internal temperature durins an exercise challense would be elevated to a greatez
extent than before deconditionin S. The hisher core temperature would be due to a
reduction in the slope of the sweatins response, and an elevation in the thresholds
of the sweatinS and skin blood flow responses. Deconditioning as a result o5 bed
confinement would be expected to result in even further _pairment of heat tolerance°
The combined eggects of hypovolemia and deconditioning during bedrest would be pre-
dicted to act in an additive unneT to impair thermal exercise responses.
EXPEIIHEI_TAL METHODS AND RvSULTS
To test our hypothesis that thermoresulatory responses would be i_npaired follow _
ins deconditioning, we studied the exercise responses of twelve young healthy women
begore and agter 12-day prosrems o£ horizontal bedrest. Then to further test the
contribution of hypovolemia on the impsirment of exercise thermal responses, a second
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group of 7 wcaen performed an identical 12-day bedrest protocol, except they were
siren a daily estroaen suppleBent (prmarin) several days before and during the
bedrest. The estrosen suppleaent resulted in an attenuation of the loss of body
fhaids during bedrest so that deconditioniug responses miEht be separated from hypo-
vol emic effects.
Table 1 illustrates the physical characteristics of the two Eroups of women.
All the women in this study reported a normal uenstrual cycle history, with a total
cycle lenEth consistently between 25 and 32 days. Group 1 was composed of 12 women
who did not regularly take medication of any kind. including oral contraceptives.
They were between 21 and 39 years of age, with a group mean age of 27. They were of
average fitness as determined by VO2max testing. Group 2 had similar physical char-
acteristics, but had at some point in their lives used an estrogen-containing oral
contraceptive without suffering siEnificant side effects. These women were in-
structed to ingest one tablet (1.25 mE) of premarin each morning starting on the
third cycle day (where day 1 is the first day of bleeding) immediately before the
bedrest, and to continue this treatment until two days after the bedrest.
The bedrest procedure consisted of 12 days of horizontal bedrest. Each woman
maintained a horizontal position during al 1 but 18 minutes in each 24 hour interval.
These 18 minutes were spent in the sitting position and this was the total accumula-
tive time in which the subjects traveled by wheelchair to and from the bathro_ At
no time did a subject support her weight by standing or walking. At the nae time
each morninE during the bedrest, a blood sample was drawn without stasis to determine
the heaatocrit and hemoglobin concentratio_ These values were used to calculate 13
the relative chanEes in plasma volume between the first and each succeeding day of
the bedrest.
The absolute red cell volume and plasma volume of each woman was determined by
radioisotope dilution. 14 99M technetium pertechnetate was used to label a sample of
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each subject's red blood cells to determine absolute red cell volume, and 991/ techne_
tium-labelled human serum albuman was used to determine absolute plasua volume.
&bsolute red cell and plasma volume determinations were per£ormed one day begore and
wil:hin 48 hours a£ter each bedrest°
Although signigicant reductions in red cell volume have been reported during
longer bedrest procedures 15. in this study there was a tendency to reduce red cell
volume during bedrest, but these di£gerences were not signi£icant (P<0.05 £rom t-test
determinations). Red cell volume averaged 1474 + 44 and 1326 + 95 be£ore bedrest for
Groups 1 and 2 respectively. The red cel 1 volumes got the two groups averaged 1389
42 and 1240 + 90 ml agter bedrest.
_'_e 1
Figure 1 illustrates the changes in plasma volume during the two bedrest proce-
dures. Plasma volume decreased significantly during the £irst 4-5 days o£ bedrest in
the women who did not receive estrogen supplement (Group 1). A narkedly di£ferent
pattern however was seen in Group 2. Plasma volume decreased significantly during
the £irst two days o£ bedrest. Then the decrease in plasma volume was attenuated and
even reversed, such that. the plasma volume in the group o£ women who received
estrogen supplement was not significautly di££erent (P<0.05. Duncan Multiple Range
comparisons) from their £irst day o£ bedrest during 7 of the last 8 days o£ the
bedrest.
Submaxiaal exercise tests were performed in a warm (30 degrees C, 50-60Z rela-
tive humidity) tsmperature-control, led roou. one da_ before and i_ediately after
bedrest. The exercise intensity on the low-sit cycle ergoueter was adjusted to 70:[
of each subjects pre-bedrest VO2nax, which was determined previously and defined by a
plateau in the oxygen consumption/exercise intensity relationship measured during
progressive cycle exercise tests. The submaximal tests continued for 30 minutes, o_
until a subject's heart rate exceeded 95Z of her pre-bedrest maxi_ heart rate
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value.
Subaaximal exercise tolerance was reduced significantly in both groups of rouen
golloving bedfast, despite the marked differences in plasma volume decrease during
bedrest between Croups 1 and 2. Whereas, before bedrest each roman vas able to
comfortably complete the 30-minute exercise task, golloving bedrest, only one woman
in Group 1, and none of the roman in Group 2 could complete the thirty minutes of
exercise vithout being instructed to stop because theft heart rate had reached 95
percent of their maximal heart rate.
• _p=e 2
The heart rate responses during these submaximal tests are illustrated in Figure
2. The average -+ standard error values for the first group of women are shown in the
top panel of this £_ure, for both pre-bedrest and post-bedrest exercise. Since the
submaximal exercise tests vere performed immediately after bedfast, a pastural stress
vas induced by the assumption of the sitting position in the lay-sit cycle for 30
minutes before the start of exercise. Thus even at rest, heart rates vere sign£fi-
cantly h_gher than pre-bedrest values in the post-bedrest tests. Initially, we
attributed at least part of the increase in heart rate after bedrest to a hypovolemic
effect. The average plasma volume at the start of exercise vas 432 ml lover during
the post-bedfast teat than during the pre-bedresc test.
However, the results in the bottom half of Figure 2 illustrate the heart rate
responses in the second group of vomen. The average difference in plasma volume at
the start of exercise between the pre-bedrest and the post-bedrest tests was only 130
ml (non-significant). Yet an examination of the heart rate responses folloving
bedfast, shove a similar pa_Cern as seen in Group I, that is a similar increase in
heart rate post-bedrest.
Yiswre 3
Continuous measurement of body core temperature was obtained during each exer-
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rise test frma a theraocouple placed in the esophagus aC the level of the heart and
these results are illustrated in Figure 3. Asaln the responses from Group I are
shown in the top panel of this figure. Like the heart race responses, the esophageal
tehperaCure (Tes) already was elevated sisuif£cantly above pre-bedrest levels before
the start of the post-bedresc test. Tea remained higher than pre-bedresC time-
matched values throughout exercise following bedrest. A similar pattern of Tea
response occurred in the pre- and post- bedrest tests in Group 2 (bottom panel).
Hoverer, the rise in Tee during posC-bedrest exercise was significantly greater than
before bedrest in group 1 (p • 0.02), buC noC in the group 2 (p • 0.67).
The total sweat output was est_ted in these exercise tests, by accurately
veighing each subject in dry cotton clothing before and after exercise. The changes
in body weight are shown in Table 2.
Table 2
The total change in body weight (g) was less in the posc-bedrest tests, in part
due to the shorter exercise period. When the sweat rate _s expressed as a weight
loss per minute of exercise, (g/sin), the total sweat rate vas siguificantly higher
in the post-bedrest tests for both groups 1 and 2. It appears chac the sweating
response was not inhibited by deconditioning fol lowing bedrest, and that the higher
post-bedrest sweat rate vould be expected to accompany the higher Tea values. We had
predicted an inhibition of mfeating in the hypovolemic exercise condition (Group 1,
post-bedrest), as compared to the normovolemic post-bedrest conditions (Group 2).
Although there vas a tendency for the sveat races Co be lower in Croup ! than in
Group 2 following bedrest, these differences just barely were not significant
(P•O.06).
DISCUSSION
In these studies we have developed a model to examine the effects of bedrest,
both with and without plasma volome reduction, on submaximal exercise responses. We
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predicted that exercise tolerance would be reduced following bedrest for two reasons.
First, a certain degree of physical deconditioning would be expected following 2 days
of bedfast; then, since the same absolute exercise intensity (70Z of the pre-bedrest
V(_2max) was used in the pre- and post-bedfast tests, post-bedfast exercise was per-
formed at a h£gher relative exercise intensity. Second, it has been reported in men
during bedrestlS, that a spontaneous diuresis occurs in the first few days of a
bedfast procedure. PresuBably a Henry-Gauer type of reflex is illicited 16 by an
increase in central blood volume caused by the cephalad movezent of body fluids with
the assumption of the horizontal position. Cardiopulmonary stretch receptors are
then stimulated resulting in an increased urine output and a decrease in total body
fluids. Tn this study the decrease in plasma volume averaged about 20Z in Croup 1.
In previous studies 10"11"17 in which plasma volume was reduced to a si1ilar degree
through the use of diuretics or by blood withdrawal before submaximal exercise, the
thermoregulatory responses were i_rpaired significantly. The surprising finding in
this study was that exercise responses following bedrest were equally impaired in
these subjects, whether the plasma volume was reduced (by about 20Z), or restored to
the pre-bedrest level before exercise testing. An attempt was made to measure the
decrease in VO2max within 48 hours after the end of the bedfast procedure. However,
following bedfast, we were not able to attain consistently our criteria for
determination of V02max; that is, a plateau of the oxygen constzaption/exercise inten-
sity curve. Only peak oxygen uptake values could be obtained, because most subjects
stopped the progressive exercise test due to leg fatigue rather than a cardiovascu-
lar limitation- The peak VO2 value obtained following bedfast in group 1 averaged an
II.SZ ..... "-.=d,_t,vn fr_ th= pre-bedrest values. Croup 2 showed a 2i.5Z average reduc-
tion. There was tremendous variation in the responses of the individual subjects in
each group, and so the decrease in peak VO2 seen following bedrest was not statist-
ically different (p • 0.05) between Group 1 and Croup 2. Thus there is no reason to
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believe that the decondit£onins effect was different between the _ Woupe.
An alteration in themoresulatory responses vas evident after bedrest even
before the start of exercise. The higher restin$ core temperature and heart rate in
thb post-bedrest tests occurred before the initiat£on of the sweating reglex. This
gact, together with the lack og a si_£icant reduction in the sweat rate gollowing
bedrest, argues against the idea that deconditionins may have i_hib£Ced the sweat£ng
response, and thus been responsible for the higher body temperatures a£ter bedreet.
There are t_o other possible explanations got the impaired heat tolerance a£te_
bedrest. The £irst fs that there was a change in the resting metabolic rate agter
bedrest, such that the total body heat product£on increased both at rest and during
exercise. This explanation seems unlikely, as oue would expect that i£ any change
occurred in the resting orygen consumption during bedrest. VO2 would decrease, not
increase.
The second more likely explanation is that there was an alteration in vasomotor
tone £ollowing bedrest, producing a greater vasoconstriction which decreased heat
exchange bet_een the skin sur£ace and the environment. Indirect evidence to support
this hypothesis is the greater venoconstr£ction we reported in a _oup og women at
rest and durins exercise gol lowing bedrest. 18 At the time o£ this report, ve sug-
gested that gollowing bedrest, there vas an increase £n peripheral venocoustr£ctor
tone which helped to compensate for the reduction in plasma voleme, and which gunc-
tioned to uaintain central blood volume. Although in this previous study ve measured
an increase in gorearm venous cone. ve mi4|hC also expect a greater cutaneous arterio-
lar Cone, since both venous and arteriolar constrictor responses are produced by the
increased s_pathetic drive vhich occurs with the onset o£ exercise. Although the
cutaneous vessels _ay show an increase in Cone gollowin8 bedrest, a decrease in the
tone may occur in the deeper blood vessels og the lower extremities or o£ the
splanchnic region. Thus following bedrest when the subjects in this study sat up-
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right just prior to the ezercise tests, blood may have pooled in dependent body
re$ions, illicltinS a vasoconstrictor response and £mpairin$ cutaneous heat ezchange.
The potential for blood poolinS followins bedrest may be so great, that even Id,en the
plasma volume vas restored durinS bedrest (Group 2), blood still pooled in the lower
extremities, produc£us a vasoconstrictor response and i_pairins heat loss. Thus even
an expansion of plasma volume following bedrest may not improve ezercise tolerance,
but may simply lead to greater blood poolins, and in eztreme cases, may produce lower
body edema.
CONCLUSIONS
Bedrest in healthy youns women resulted in impairment of thermores_latory res-
ponses both at rest and during exercise in a vaz_ environment. The higher body
temperature following bedrest may have been due to effects caused by deconditioains
or to effects caused by the hTpovolemia vhich normally accompanies bedrest. In this
study the sweating responses vere not significantly altered following bedrest. It is
most likely that the higher body temperatures were caused by a cutaneous vasocon-
strictor response vhich functioned to oppose blood pooling in the lower extremities.
Restoring blood volume to pre-bedrested values was ineffective in reversing the
impairment of Chermoregulatory responses.
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Table 1: _ CharacCer*nClcs of che_b_
(n=12)
60.5
8.0
.Ccau_ Z
(.=7)
62.7
9.8
27
6
26
4
Pre-BedresC VO2max
-* SD
37.2
7.7
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Table 2: Total Body Sveat Losses Dorlnf Zxerc£se
Grou_ I (Non-esero_en) Grou_ 2 {Esero_en3
Change of body wt. 512 *436 486 409
-+ S.E. 20 19 33 47
Cg)
Minutes of exercise 30 * 21 30 * 16
-+ S.E. 0 2 0 2
Cmtn)
Total Sveat B_tte 17.31 * 22.19 16.19 * 26.84
-+ S.V.. 2..56 4..59 2.73 5.00
0.62 * 0.78 0.89 0.83
0.06 0.07 0.16 0.09
Increase i.=Tes
* Post-Bedrest value significantly different from Pre-Bedrest value
(P__0.05). Paired t/test comparison.
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